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I. ABBREVIATIONS 
 
ABC proteins, ATP-binding cassette transporters 
ACh, acetylcholine  
ADA, adenosine deaminase  
ADO, adenosine 
ADP, adenosine diphosphate 
AHP, prolonged after-hyperpolarization 
AIN, ascending interneuron  
AK, adenosine kinase 
AMP, adenosine monophosphate 
ANO-1, anoctamine 1 
ANS, autonomic nervous system 
AP, alkaline phosphatases 
ATP, adenosine triphosphate 
BDNF, brain-derived neurotrophic factor 
Calb, calbindin  
cAMP, cyclic adenosine monophosphate 
CFTR, cystic fibrosis transmembrane conductance regular 
CGRP, calcitonin gene related peptide  
ChAT, choline acetyltransferase  
C-Kit, tyrosine kinase receptor 
CM, circular muscle 
CNS, central nervous system 
CNT, concentrative nucleoside transporters 
CO, carbon monoxide  
DAG, diacylglycerol 
DIN, descending interneurons 
DMPP, dimethylphenylpiperazinium 
DMSO, dimethyl sulfoxide 
DPCPX, 1,3-dipropyl-8-cyclopentylxanthine 
DSS, dextran sodium sulphate 
DYN, dynorphin  
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EFS, electrical field stimulation 
EMN, excitatory motor neuron  
ENK, enkephalins  
E-NPP, ecto-nucleotide pyrophosphatases/phosphodiesterases 
ENS, enteric nervous system 
ENT, equilibrative nucleoside transporters 
E-NTPDase, ecto-nucleoside triphosphate diphosphohydrolase 
EPAN, extrinsic primary afferent neuron 
ER, endoplasmic reticulum 
fEPSPs, fast excitatory post-synaptic potentials 
FLC, fibroblast-like cell 
GABA, gamma-aminobutyric acid 
GFAP, intermediate filament glial fibrillary acidic protein 
GI, gastrointestinal 
GPCR, G protein-coupled receptors 
GPI, glycosylphosphatidylinositol 
GRP, gastrin releasing peptide  
HO1, heme oxygenase-1 
HPLC, high performance liquid chromatography 
HX, hypoxanthine 
IBD, inflammatory bowel disease 
ICC, interstitial cells of Cajal 
IFN, intestinofugal neuron 
IFN-γ, interferon γ 
IL, interleukin 
IMN, inhibitory motor neuron  
INO, inosine 
iNOS, inducible nitric oxide synthase 
IP3, inositol triphosphate 
IPAN, intrinsic primary afferent neuron 
KO, knockout 
LGIC, ligand-gated ionotropic channel 
LM-MP, longitudinal muscle-myenteric plexus 
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mAChR, muscarinic receptors of acetylcholine 
Min, minutes 
NA, noradrenaline 
nAChR, nicotinic receptors of acetylcholine 
NBTI, S-(4-Nitrobenzyl)-6-thioinosine 
NGF, nerve grow factor 
nNOS,  nitric oxide synthase 
NO, nitric oxide 
NOS, nitric oxide synthetase 
NT, nucleoside transporter 
NT-3, neurotrophin-3 
NT-4, neurotrophin-4 
NYP, neuropeptide Y 
PBS, phosphate saline buffer 
PDGFR-α, a platelet derived growth factor receptor α 
PGP 9.5, protein gene product 9.5 
PLC, phospholipase C 
PLP, periodate-lysine-paraformaldehyde 
PM-ML, plexo mioentérico-músculo longitudinal 
PVG, sympathetic prevertebral ganglia 
ROS, reactive species 
S100, calcium-binding protein 
SAH, S-adenosyl-L-homocysteine hydrolase 
SLC, solute carrier transporters 
SM, submucosal plexus 
SMC, smooth muscle cells 
SMN, secretomotor/ vasomotor neuron 
Sox 10, transcription factor SRY box-containing gene 10  
SP, substance P 
SNS, sympathetic nervous system 
TNBS, 2,4,6-trinitrobenzenesulfonic acid. 
TNF, tumour necrosis factor 
TRC, T cell receptor 
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TTX, tetrodotoxin 
UDP, uridine diphosphate 
UTP, uridine triphosphate 
UV, ultraviolet 
VAChT, ACh vesicular transporter 
VIP, vasoactive intestinal polypeptide  
VNUT, vesicular nucleotide transporter 
5-HT, 5-hydroxytryptamine  
 
 
 
 
 
 
 
 
 
 
 
 
 
 RESUMO 
 
 
13    PhD Thesis: Cátia Andreia Rodrigues Vieira 
 
 
II. RESUMO  
As purinas parecem desempenhar um papel fisiológico na regulação da 
motilidade intestinal, podendo afectar a actividade dos nervos entéricos, das fibras 
musculares, das células entéricas gliais, das células intersticiais de Cajal (ICC) e 
das células do tipo fibroblasto (FLC). A inflamação do intestino provoca alterações 
estruturais e funcionais mais ou menos duradoiras no sistema nervoso entérico 
(SNE) e está associada à elevação dos níveis extracelulares das purinas, 
nomeadamente ATP e adenosina. Partindo de estudos anteriores controversos 
olhando para o controlo da inflamação pelas purinas, este projecto foi desenhado 
para definir o papel da cascata purinérgica no controlo da actividade do SNE após 
uma situação de inflamação aguda. O propósito do trabalho foi apontar possíveis 
alvos farmacológicos para o tratamento das doenças inflamatórias intestinais. 
Neste contexto, foram gerados modelos animais portadores de ileíte induzida 
através da instilação intraluminal de TNBS na ratazana e os mesmos foram 
utilizados para fins experimentais sete dias após a indução – modelo de ileíte pós-
inflamatória. Todas as experiências foram realizadas em preparações de plexo 
mioentérico-músculo longitudinal (PM-ML) de íleo destes animais.  
Neste modelo animal, colocou-se a hipótese da reacção inflamatória induzir 
alterações na densidade da população celular residente (para além da infiltração 
por células inflamatórias) capaz de gerar um desequilíbrio na libertação de 
purinas e, consequentemente, na libertação de ACh[3H] – o neurotransmissor 
mais relevante no controlo da motilidade intestinal. Para responder a essa 
questão, foram usadas preparações de PM-ML do íleo de ratazana marcadas com 
anticorpos específicos para cada um dos componentes celulares envolvidos. Tal 
como seria de esperar, verificou-se um aumento significativo do número de 
células inflamatórias marcadas com CD11B/Ox42 localizadas na região adjacente 
aos gânglios mioentéricos, poupando o seu interior. A reacção inflamatória fez-se 
acompanhar de um aumento da densidade das células gliais, marcadas 
positivamente com GFAP ou S100β, e de uma perda de células intersticiais 
(ICC/FLC) imunoreactivas contra a vimentina e anoctamina-1 (Ano-1). Tal como 
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constatado por outros autores em modelos experimentais de ileíte pós-
inflamatória, não se observaram alterações significativas na densidade e na 
distribuição de dois marcadores neuronais específicos, PGP9.5 e o NF200, 
contrariamente aos resultados obtidos em modelos mais severos de colite 
induzida pelo TNBS, onde a perda neuronal foi evidente.  
Seguidamente exploraram-se as alterações funcionais subjacentes às 
modificações estruturais encontradas no modelo de ileíte pós-inflamatória. A 
estimulação das preparações de PM-ML do íleo de ratazanas submetidas ao 
tratamento com TNBS libertaram menor quantidade de ACh[3H]. Contudo, esta 
diminuição da transmissão colinérgica não foi acompanhada por uma perda 
significativa da imunoreactividade para o transportador vesicular de ACh, VaChT. 
Em animais controlo, a libertação de ACh resulta da exocitose vesicular em 
resposta à despolarização nervosa, sensível à TTX. No entanto, no tecido sujeito 
a inflamação a libertação de ACh para além de se encontrar significativamente 
reduzida, é também, menos sensível ao bloqueio pela TTX. A hipótese de que a 
libertação de ACh nos neurónios inflamados se pode dever à acção de um 
gliotransmissor excitatório capaz de activar directamente os terminais nervosos na 
ausência de potencial de acção foi comprovada através da inibição pelo 
fluoroacetato de sódio. Trata-se de uma toxina que afecta o metabolismo das 
células gliais entéricas e que reduziu significativamente os níveis de ATP 
libertados pelo plexo mioentérico do íleo de ratazana após tratamento pelo TNBS.  
O efeito inibitório do fluoroacetato de sódio sobre a libertação de ACh[3H] 
nas preparações inflamadas pelo TNBS foi reproduzido pelo antagonista selectivo 
dos receptores P2X7, A438079, e pelo o inibidor dos hemicanais contendo 
panexina-1, carbenoxolona. O mesmo efeito não foi observado quando se 
preveniu a actividade das células intersticiais ICC/FLC através da inibição das 
correntes Cav3 (do tipo T) com mibefradil. Estes resultados sugerem que o ATP 
parece ser o gliotransmissor excitatório responsável pela activação directa dos 
terminais mioentéricos através da activação de receptores ionotrópicos do tipo 
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P2X2 e P2X2/3 e que a sua acumulação é dependente da actividade do complexo 
P2X7/ panexina-1.   
Contrariamente ao aumento da quantidade de ATP libertado pelo íleo de 
ratazanas tratadas com TNBS observou-se uma redução significativa dos níveis 
extracelulares do seu metabolito, adenosina, bem como da neuromodulação 
colinérgica mediada pela activação preferencial de receptores facilitatórios de 
subtipo A2A localizados nos terminais nervosos colinérgicos. Os resultados 
mostram que a disparidade entre o aumento da libertação de ATP e o défice de 
formação de adenosina na ileíte pós-inflamatória pode ser atribuída, pelo menos 
em parte, à inibição anterógrada da ecto-5'-nucleotidase/CD73 (a enzima que 
converte AMP em adenosina) devido à acumulação de elevados níveis de ATP e 
ADP na sinapse mioentérica. Esta acumulação deve-se a uma redistribuição da 
localização da NTPDase2 (uma ATPase) da região ganglionar para a junção 
neuromuscular, sem afectar a densidade da NTPDase3 no plexo mioentérico dos 
animais tratados com TNBS, facto que condiciona a formação de ADP a partir do 
ATP naquela região intestinal. O défice de acumulação extracelular de adenosina 
na ileíte pós-inflamatória pode, ainda, dever-se ao aumento da sua inactivação 
em inosina pela ADA (frações membranar e solúvel). Existe um terceiro 
mecanismo passível de ser responsabilizado pela redução da neuromodulação 
adenosinérgica no plexo mioentérico inflamado, que deriva da redução 
significativa da densidade da população de células intersticiais ICC/FLC. De facto, 
a inibição da actividade das ICC/FLC através do bloqueio dos canais de Cav3 (do 
tipo T) característicos destas células, reduz consideravelmente os níveis de 
adenosina libertados pelo plexo mioentérico, tanto em animais controlo como 
injectados com TNBS, situação que contrasta com a ausência de efeito da 
gliotoxina, fluoroacetato de sódio. Sabe-se que as células intersticiais libertam 
quantidades significativas de adenosina por intermédio do transportador 
equilibrativo de nucleósidos sensível ao dipiridamol, mediante a activação de 
receptores muscarínicos do subtipo M3. Este mecanismo pode estar deficitário no 
intestino inflamado, já que a libertação de ACh se encontra atenuada e que a 
densidade de células intersticiais ICC/FLC também está diminuída, situação que 
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culmina no bloqueio do mecanismo de retroalimentação positivo operado pela 
activação de receptores facilitatórios A2A nas terminações nervosas colinérgicas. 
Em conclusão, os resultados mostram que a transmissão colinérgica está 
significativamente afectada no modelo de ileíte pós-inflamatória e que esse 
distúrbio pode resultar da existência de um desequilíbrio entre a neuromodulação 
adenosinérgica, influenciada pela actividade das células intersticiais ICC/FLC 
predominante em situações fisiológicas, e a excessiva activação dos mecanismos 
mediados pelo ATP resultantes da proliferação glial promovida pelo processo 
inflamatório. Se por um lado, a libertação de ATP através da actividade do 
complexo P2X7/panexina-1 pode levar à activação de receptores ionotrópicos dos 
subtipos P2X2 e P2X2/3 nos terminais nervosos colinérgicos mioentéricos 
favorecendo a libertação directa do neurotransmissor para manter o tónus 
colinérgico, por outro lado a metabolização do ATP em ADP, sem a consequente 
formação de adenosina no íleo inflamado, pode quebrar a facilitação da libertação 
de ACh operada pela activação sucessiva dos receptores facilitatórios M3 e A2A 
localizados, respectivamente, nas células intersticiais e nos terminais nervosos 
colinérgicos. Assim, os resultados deste trabalho sugerem que a manipulação da 
libertação diferencial das purinas, a intervenção sobre as suas vias de inactivação 
e a activação de certos subtipos de receptores purinérgicos podem constituir 
alvos terapêuticos interessantes para o tratamento das doenças inflamatórias 
intestinais. 
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III. ABSTRACT  
Purines seem to play a physiological role in the regulation of gut motility by 
affecting the activity of enteric nerves, muscle fibers, enteric glial cells, interstitial 
cells of Cajal (ICC) and fibroblast cells (FLC). Intestinal inflammation may cause 
long-term structural and functional changes in the enteric nervous system (ENS), 
which might be related to increased levels of extracellular purines, namely ATP 
and adenosine. Taking into account controversies in the literature regarding the 
control of enteric inflammation by purines, this project was designed to investigate 
the role of the purinergic cascade in the control of SNE activity following acute 
inflammation. Our aim was to identify putative molecular targets for the 
pharmacological treatment of inflammatory enteric disorders. To achieve this goal, 
we used an animal model of postinflammatory ileitis due to intraluminal instillation 
of TNBS in the rat; experimental animals were used seven days after surgery. All 
experiments were performed in longitudinal muscle-myenteric plexus (LM-MP) 
preparations of rat ileum. 
In this animal model, we hypothesized that inflammation may cause 
relevant changes in the density of resident cell populations (beyond the typical 
inflammatory infiltrates), which may unbalance the release of purines and, 
consequently, the release of [3H]ACh – the most important neurotransmitter in the 
control of gut motility. To answer this question, LM-MP preparations were stained 
with specific antibodies directed against each specific cell type. As expected, we 
observed a significant increase in the number of inflammatory cells stained with 
CD11b/OX42, which were localized adjacent to myenteric ganglia, without 
penetrating this structure. The inflammatory insult, cause a significant increase in 
the density of enteric glial cells, exhibiting positive immunoreactivity against GFAP 
and S100β, and a substantial loss of interstitial cells ICC/FLC expressing vimentin 
and anoctamine-1 (Ano-1). In agreement with the results obtained by other 
authors using the postinflammatory ileitis rat model, we failed to detect any 
changes in the density and distribution of two specific neuronal markers, PGP9.5 
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and NF200. These findings are in contrast with those obtained in more severe 
TNBS-induced colitis where neuronal loss is more evident. 
Next, we investigated functional abnormalities reflected in the enteric 
nervous system that could be motivated by the structural changes detected in the 
postinflammatory ileitis rat model. Stimulation of the myenteric plexus of the ileum 
of rats treated with TNBS released significantly smaller amounts of [3H]ACh than 
their control littermates. However, the reduction in the cholinergic tone was not 
accompanied by changes in the immunoreactivity against the ACh vesicular 
transporter, VAChT. In control animals, ACh release results from vesicle 
exocytosis of depolarized cholinergic nerves sensitive to TTX. Conversely, ACh 
release from inflamed myenteric nerve terminals was less sensitive to action 
potential blockade with TTX, indicating that it might occur through direct activation 
of axon terminals by an excitatory mediator released from non-neuronal cells. 
Implication of ATP released from proliferating glial cells was suggested because 
inhibition of enteric glial cells metabolism with sodium fluoroacetate decreased 
both the release of [3H]ACh and ATP from LM-MP preparations of the ileum of 
TNBS-treated rats. 
The inhibitory effect of sodium fluoroacetate on the release of [3H]ACh was 
reproduced by the P2X7 receptor antagonist, A438079, and by the pannexin-1 
hemichannel blocker, carbenoxolone, but the same effect was not observed in the 
presence of mibefradil, a Cav3 (T-type) channel blocker that prevents the activity 
of interstitial cells ICC/FLC. These results suggest that ATP might be the 
excitatory gliotransmitter responsible for the activation of ionotropic P2X2 and/or 
P2X2/3 receptors operating direct activation of cholinergic nerve terminals and that 
extracellular accumulation of the nucleotide may be dependent on the 
P2X7/pannexin-1 pathway.    
In contrast to the increase in ATP overflow, the ileum of TNBS-treated rats 
accumulate smaller amounts of its metabolite, adenosine, resulting in a reduction 
in the preferential activation of facilitatory A2A receptors located on cholinergic 
nerve terminals. The disparity between increased ATP overflow and adenosine 
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deficits in post-inflammatory ileitis was ascribed, at least in part, to feed-forward 
inhibition of ecto-5'-nucleotidase/CD73 (the enzyme that converts AMP into 
adenosine) by high amounts of ATP and ADP accumulated at the myenteric 
synapse. Redistribution of NTPDase2 (ATPase) from the ganglion region to the 
myenteric neuromuscular synapse, without much affecting NTPDase3, might 
explain surplus ADP accumulation near cholinergic nerve terminals in TNBS-
treated rats. Deficits in extracellular adenosine in postinflammatory ileitis may also 
occur due to increases in adenosine inactivation into inosine by ADA (membrane-
bound and soluble fractions). A third mechanism may also account for the loss of 
adenosine neuromodulation in the inflamed myenteric plexus, which derives from 
a reduction in the density of interstitial cells ICC/FLC population. As a matter of 
fact, inhibition of ICC/FLC activity by blocking Cav3 (T-type) channels, decreases 
significantly endogenous adenosine outflow by LM-MP preparations of both control 
and TNBS-treated rats. This situation was not observed in the presence of the 
gliotoxin, sodium fluoroacetate. It has been shown that interstitial cells release 
significant amounts of adenosine, via a dipyridamole-sensitive equilibrative 
nucleoside transporter, through the activation of muscarinic M3 receptors. This 
mechanism may be deficient in postinflammatory ileitis, since ACh release is 
downregulated and the number of interstitial cells is reduced, leading to blockage 
to the positive feedback loop operated by facilitatory muscarinic M3 (on ICC/FLC) 
and adenosine A2A (on cholinergic nerve terminals) receptors that are responsible 
for maintaining the safety margin of myenteric cholinergic transmission.  
In conclusion, data suggest that cholinergic neurotransmission is severly 
affected in postinflammatory ileitis, a situation that might result from an unbalance 
between adenosinergic neuromodulation (that is dominant in physiological 
conditions) and excessive ATP accumulation attributed to enteric glial cells 
proliferation promoted by the inflammatory insult. In principle, surplus ATP 
overflow gated by P2X7/pannexin-1 pathway may facilitate activation of ionotropic 
P2X2 and/or P2X2/3 receptors on cholinergic nerve terminals resulting in direct 
activation of neurotransmitter release independently of action potential generation, 
in order to keep the cholinergic tone at a critical miminum in the inflamed ileum. 
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But, on the other hand, ATP hydrolysis into ADP without significant adenosine 
formation detected in postinflammatory ileitis may break the facilitatory loop 
required to sustain neurotransmitter release operated by muscarinic M3 and 
adenosine A2A receptors localized on interstitial cells ICC/FLC and cholinergic 
nerve terminals, respectively. Thus, results presented here suggest that selective 
targeting the differential release of purines, the activity of the purinergic 
inactivation mechanisms and the activation of specific purinoceptor subtypes may 
offer novel pharmacological strategies for the treatment of inflammatory intestinal 
diseases.      
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IV. INTRODUCTION 
1. Autonomic nervous system 
Nervous system has an important role in all digestive processes; it’s 
responsible for the control of motility, secretion, sensory perception, and immune 
function (Straub et al., 2006). Autonomic nervous system (ANS) has two main 
functions, excitation and inhibition, of physiological processes. These functions are 
controlled through different kinds of nerve fibres, entitled excitatory and inhibitory. 
So, ANS is responsible for the unconscious control of essential functions for life 
being (e.g. blood circulation, heart function, digestion, temperature, stress). ANS 
has the purpose of preparing the body for stress and recovering the same level of 
activation following stressful conditions. It comprises three fundamental parts 
(figure 1): sympathetic, parasympathetic and enteric nervous system (ENS) 
described in 1921 by Langley (Lundgren et al., 1989).  Sympathetic and 
parasympathetic nervous system establish a connection between the central 
nervous system and peripheral organs.  Sympathetic nervous system (SNS) 
together with the hypothalamic-pituitary-adrenal axis is known by the main role in 
the “fight and flight reaction” during stressful conditions. An efferent sympathetic 
pathway is activated in the brain, goes along the intermediolateral column of the 
spinal cord and come to sympathetic ganglia. Afterwards, the signal goes to 
postganglionic sympathetic nerve fibres, and enters in the intestine wall along 
arteries through the mesenteric serosa surface (Straub et al., 2006). On the other 
hand, parasympathetic nervous system is known by the main role of “rest and 
digestion”; it works predominantly during relaxation conditions. It has one main 
contributor, the vagus nerve. Vagal branches comprise sensory fibres (afferent) 
and motor fibres (efferent). They are responsible for the communication between 
the brain and visceral organs (Stakenborg et al., 2013).  Simple functions like food 
intake, digestion and immunity are controlled by the interaction between the vagal 
nerve fibres and the gut. Extrinsic sympathetic and parasympathetic fibres 
terminate in vessel walls or in enteric plexuses that constitute the ENS. Like it was 
described, ENS can operate dependently of central nervous system, but unlike the 
other systems described so far, it can function independently of the central 
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nervous system, and this activity is exclusive of the gastrointestinal (GI) tract. For 
that reason, ENS was called by several authors the “second brain”. In this work we 
will focus our attention on the ENS.  
 
Figure 1: Diagram representative of Nervous system. 
 
2. Enteric nervous system 
The ENS has approximately 100 million neurons, a number equal to or 
greater than the number of neurons found in the spinal cord (Furness & Costa, 
1980). The ENS is composed by three major ganglionated plexuses and several 
aganglionated plexuses. The myenteric (or Auerbach’s), the submucosal (or 
Meissner’s) and the mucosal are described as the ganglionated plexuses. The 
non-ganglionated plexuses, like the deep muscular plexus, inner submucosal 
plexus, periglandular plexus among others, supply all the layers of the intestine 
(Hansen, 2003).  
The myenteric plexus is placed between longitudinal muscle and circular 
muscle layers and the submucosal plexus is located in the submucosa. 
Concerning to their functions in the ENS, submucosal plexus controls especially 
local gut secretion and local absorption, while myenteric plexus controls mainly GI 
movements and secretion of enzymes from adjacent organs, but these dominant 
functions may be mixed. When stimulated, ENS main effects include: (1) increase 
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of gut wall tonic contraction, (2) augmentation of the rhythmic contractions, (3) 
slight increase of the contraction rate, and (4) enhancement in the transmission 
velocity of excitatory waves along the gut wall. These effects originate an increase 
of the gut peristaltic waves.  
The myenteric plexus is one continuous network of little nervous ganglia that 
are throughout the entire GI tract. Ganglia are sometimes called the nodes of 
plexus, because they are located in junction areas. So, they are usually called 
internodal or interganglionic strands. These ganglia can be distorted by muscle 
movements (Furness, 2006).  
 
Figure 2: Schematic representation of the ENS. ENS is formed by two ganglionated plexuses: MP 
and Submucosal Plexus, located between two layers of muscle: the longitudinal muscle and 
circular muscle layer. 
 
About 150 years ago, Auerbach described  three essential components of the 
myenteric plexus (figure 3): (1) primary plexus, related to ganglia and internodal 
strands; (2) secondary (interfascicular) plexus, related to nerve strands which are 
parallel to the circular muscle; and a (3) tertiary plexus, found in the longitudinal 
muscle layer (Furness, 2006).   
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Figure 3: Schematic draw of components of the myenteric plexus. 
2.1. Enteric neurons 
Enteric neurons are organized in networks of enteric ganglia that are 
connected by intraganglionic strands that extend from the upper oesophagus to 
the internal anal sphincter (Costa et al., 2000; Furness et al., 1998). There are 
different classes of enteric neurons, classified based on their morphology, 
electrical properties, neurochemical code and function (Table 1). In that way, it 
was identified seventeen different types of neurons in the small intestine, but only 
14 are described as functionally important (Furness, 2000; Hansen, 2003). The 
majority of the studies done on enteric neurons taxonomy were done in the 
guinea-pig small intestine (Costa et al., 1996; Brehmer et al., 1999; Furness, 2000; 
Costa, 2000).  
2.1.1.  Morphology of enteric neurons 
Based on their morphology, in 1899, Dogiel proposed a classification to the 
enteric neurons. He classified enteric neurons as Dogiel type I, II and III. Later, 
were described four more types of enteric neurons (type IV, V, VI, and VII) 
(Brehmer et al., 1999).  Most of enteric neurons are from types I, II and III 
(Furness, 2000). How can these neurons be differentiated? Type I, is 
characterized by having a flattened cell body and numerous dendrites projecting 
into the musculature. The type II, possess an oval cell body with long processes 
projecting to ganglion cells. The type III, is characterized by a rectangular cell body 
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with irregular dendrites. In this latter neurons, the axons project to the mucosa 
(Brehmer et al., 1999).  
2.1.2. Electrophysiological properties of enteric neurons 
Based on different electrophysiological properties, enteric neurons were 
classified in two possible ways, AH neurons and S neurons (Furness et al., 1997). 
When an action potential is generated in the cell body of AH neurons, it is followed 
by a prolonged after-hyperpolarization (AHP), whereas if the same occurs in S 
neurons the action potential is followed by prominent fast excitatory post-synaptic 
potential (fEPSP). Morphologically S neurons are Dogiel type I, whereas AH 
neurons are Dogiel type II (Furness, 2006; Nurgali, 2009).  
2.1.3. Neurochemical code of enteric neurons 
Primary transmitters, transmitters synthesizing enzymes and 
neuromodulators released from enteric neurons include: acetylcholine (ACh), 
norepinephrine (NE), adenosine triphosphate (ATP), serotonin (5-HT), dopamine 
(DA), cholecystokinin (CCK), substance P (SP), vasoactive intestinal polypeptide 
(VIP), somatostatin (SOM), leu-enkephalin (leu-Enk), met-eukephalin (met-Enk) 
and bombesin. These compounds provide to the enteric neurons a neurochemical 
code. Based on that neurochemical code, most enteric neurons are classified 
essentially as nitrergic neurons, cholinergic neurons or peptidergic neurons 
(Furness, 2006). To make this distinction, immunolocalization studies using 
specifically markers, like nitric oxide synthase (nNOS), choline acetyltransferase 
(ChAT), SP, calcitonin-gene related peptide (CGRP) and VIP may be undertaken. 
Co-localization studies indicate the subclasses of neurons that co-express 
neurotransmitters and neuromodulators (Chiocchetti et al., 2009). The 
neurochemical code and density of specific neurons differ between gut regions 
and between animal species (Furness, 2006).  
2.1.4. Function of enteric neurons 
Functionally, enteric neurons were classified as sensory, inhibitory and 
excitatory motor neurons, interneurons, secretomotor/ vasomotor neurons and 
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intestinofugal neurons  (figure 4) (Costa et al., 1996; Furness, 2000; Costa et al., 
2000; Hansen, 2003). The majority of enteric neurons responsible for controling 
motor activity of the gut are located in the myenteric plexus (Costa et al., 1996).  
 
Figure 4: Types of neurons in the small intestine of the guinea-pig: EPAN- Extrinsic primary 
afferent neuron; IPAN- Intrinsic primary afferent neuron; EMN- excitatory motor neuron; IMN- 
inhibitory motor neuron; AIN- Ascending interneuron; DIN-Descending interneurons; SMN-
Secretomotor/ vasomotor neuron; IFN- intestinofugal neuron 
 
2.1.4.1. Sensory neurons  
Sensory neurons are established by a dense network of extrinsic (EPANs) 
and intrinsic (IPANs) primary afferent neurons (figure 5). They are present in 
myenteric ganglia (30% of myenteric neurons) and in submucous ganglia (14% of 
submucosal neurons). Morphologically, they are entitled Dogiel type II and they 
present the electrophysiological properties of AH neurons (Costa et al., 2000).   
EPANs are the vagal and spinal afferents with their cell bodies outside the 
gut wall and IPANs are multipolar and their cell bodies are within the gut wall. Both 
types of neurons communicate with each other. A wide range of membrane 
receptors are expressed by sensory nerves to modulate their sensitivity. They 
include mechanoreceptors, thermoreceptors and chemoreceptors (Hansen, 2003).  
 INTRODUCTION 
 
 
27    PhD Thesis: Cátia Andreia Rodrigues Vieira 
 
 
 
Figure 5: Types of sensory neurons, extrinsic (EPANs) and intrinsic (IPANs) primary afferent 
neurons in the ENS. LM, longitudinal muscle; MP, myenteric plexus; CM, circular muscle; SM, 
submucosal plexus; M, mucosa. 
 
2.1.4.2. Motor neurons 
Are described five types of motor neurons: excitatory muscle motor neurons, 
inhibitory muscle motor neurons, secretomotor/vasodilator neurons, secretomotor 
neurons that are not vasodilator and neurons that are innervating entero-endocrine 
cells (Furness, 2000). Motor neurons belongs to the Dogiel type I morphology and 
presents the electrophysiological properties of S neurons (Costa et al., 2000) 
Longitudinal and circular muscles and the muscularis mucosae are innervated by 
muscle motor neurons. They can be excitatory or inhibitory. In that sense, they 
release neurotransmitters that promote muscle contractions or relaxations 
(Hansen, 2003).  Motor neurons are immunoreactive to ChAT (enzyme 
responsible for the synthesis of ACh) and to SP (Costa et al., 2000; Furness 
2000). Thus, the excitatory muscle motor neurons release transmitters like ACh 
and tachykinins (SP and neurokinin A). On the other hand, inhibitory muscle motor 
neurons release substances like nitric oxide (NO), VIP, ATP, GABA, neuropeptide 
Y (NPY) and carbon monoxide (CO) (Costa et al., 2000; Hansen, 2003).   
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2.1.4.3. Interneurons 
The interneurons have both electrophysiological properties described above, 
may be AH neurons (morphologically, Dogiel type II) or S neurons 
(morphologically, Dogiel type I) (Costa et al., 2000; Hansen, 2003). Ascending 
interneurons (one type of interneurons oriented in the oral direction) and 
descending interneurons (three types of interneurons oriented in the anal 
direction) are the types characterized in the small intestine of the guinea-pig 
(Furness, 2000). Ascending interneurons are essentially cholinergic, while the 
descending interneurons use as a neurotransmitters VIP, NO and some opioid 
peptides (Costa et al., 2000). The three types of descending neurons express 
different chemical codings: ChAT/NOS/VIP, ChAT/SOM and ChAT/5-HT (Furness, 
2000).   
2.1.4.4. Secretomotor and vasomotor neurons 
Secretomotor neurons are responsible for the control of secretions, while 
vasomotor neurons are responsible for the control of blood flow (Hansen, 2003). 
The majority of secretomotor neurons are projected to the mucosa (with their cell 
bodies in the mucosal plexus). Some few neurons are projected from the 
submucosa to the myenteric plexus (Furness, 2000). There are only 1% of these 
neurons in the myenteric ganglia, whereas most of them are located in the 
submucosous ganglia (32-42%) (Costa et al., 2000). There are two classes of 
secretomotor neurons: cholinergic and non-cholinergic. The cholinergic neurons 
release ACh as a transmitter. ACh will act on muscarinic receptors located on 
mucosal epithelium. The non-cholinergic neurons release VIP and mediate most of 
the local reflex responses (Hansen, 2003; Costa et al., 2000). 
2.1.4.5. Intestinofugal neurons 
Intestinofugal neurons are the single neurons that are projected from the 
myenteric ganglia to the sympathetic prevertebral ganglia (PVG), and that relay 
mechanosensory information to the sympathetic prevertebral ganglia neurons. 
They release ACh at the sympathetic prevertebral ganglia and evoke fast 
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excitatory postsynaptic potentials (fEPSPs) (Costa et al., 2000; Szurszewski et al., 
2002). 
Table 1: Morphologic, electrophysiological and functional characterization of enteric neurons 
(Furness, 2000; Hansen, 2003, Furness et al., 2003, Sharkey et al., 1998, Wong et al., 2008) 
 
FUNCTION MORPHOLOGY ELECTROPHYSIOLOGY 
NEUROCHEMICAL 
CODING 
    
Sensory (IPANs/ 
EPANs) 
Dogiel type II AH 
ChAT, Calb, CGRP, 
SP 
Excitatory motor 
neurons 
Dogiel type I S 
ChAT, SP, Calret 
Inhibitory motor 
neurons 
DYN, ENK, NOS, and 
VIP  
Ascending 
interneurons 
Dogiel type I/ II AH/ S 
ChAT, Calret, ENK, 
SP 
Descending 
interneurons 
Dogiel type I/ II AH/ S 
5-HT, DYN, GRP, 
NOS, somatostatin, 
and VIP 
Secretomotor 
neurons 
(Cholinergic) 
Type IV (Stach) S 
 
S 
ChAT, CCK, CGRP, 
DYN, NYP, 
somastostatin, and 
VIP.  
Secretomotor 
neurons (Non-
Cholinergic) 
Dogiel type I 
Intestinofugal 
neurons 
Dogiel type I S 
ChAT, VIP, CCK, 
ENK, DYN, GRP 
ChAT, coline acetyltransferase; Calb, calbindin; CGRP, calcitonin generelated peptide; SP, substance P; 
DYN, dynorphin; GRP, gastrin releasing peptide, ENK, enkephalins, NOS, nitric oxide synthetase; VIP, 
vasoactive intestinal polypeptide; 5HT, 5-hydroxytryptamine; NYP, neuropeptide Y. 
 
2.1.5. Enteric neurons in the longitudinal muscle-myenteric plexus (LM-MP) 
The experimental work presented in this thesis is based on the use of the 
longitudinal muscle-myenteric plexus (LM-MP) preparation of rat ileum described 
by Paton and Vizi (1969). This preparation is highly enriched in cholinergic 
neurons, especially excitatory motor neurons that are projected to the LM (25%). 
They receive inputs from the IPANs (26%) and from the ascending and 
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descending interneurons (17%) (Costa et al., 1996). Although ACh can be 
originated in the pre-ganglionic cholinergic nerve endings, this only represents a 
small proportion of the total content of ACh measured experimentally. This is due 
to the existence of an excessive number of fibers in the ganglion LM-MP 
compared to extrinsic pre-ganglionic fibers in the same preparation (Paton & Vizi, 
1969). 
2.2. Enteric Glial Cells  
Enteric glial cells have huge morphological and molecular similarities to 
astrocytes found in the central nervous system (CNS). Enteric glial cells and 
astrocytes share electrophysiological properties and express two common 
proteins: the GFAP-intermediate filament glial fibrillary acidic protein and a 
calcium-binding protein S100 (Gulbransen & Sharkey, 2012).   
Until very recently, it was thought that enteric glial cells had only a supportive 
function to neuronal cells. More recently, countless papers demonstrate that 
enteric glial cells are able to modulate enteric neural circuits, but their full role on 
this matter is yet to be defined experimentally. Mounting evidences also point 
towards enteric glial cells being neuroprotective and able to communicate with 
neighbouring neurons (Neunlist et al., 2014; Boesmans et al., 2013). They supply 
neurons with neurotransmitter precursors, release neuroactive substances (called 
gliotransmitters), express neurotransmitter receptors and respond to 
neurotransmitters/ neuromodulators, and have the machinery for sequestering and 
degrade neuroactive substances, namely ATP, glutamate, GABA (Rühl, 2005). In 
addition, these cells may exert and housekeeping role by expressing enzymes and 
transporters in order to control the availability of neuroactive substances that are 
toxic to the enteric neurons.  
Around 1899, enteric glial cells in the gut were first described by Dogiel. They 
display an irregular, stellate-shaped, with an extensive array of highly branched 
processes. These cells present a small cell body, with a big nucleus occupying the 
all cell body leaving a little cytoplasmic volume (Gulbransen, 1994).  
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Enteric glial cells are present in all layers of the gut wall and are closely 
associated with neuronal cells within the ganglia, interganglionic fiber strands and 
intramuscular nerve fibres (Neunlist et al., 2014). There are several types of 
enteric glial cells throughout the GI tract (figure 6).  
 
Figure 6: Distribution of enteric glial cells along the GI tract. They form a large and extensive 
network throughout all gut layers.   
 
Hanani was the first to propose a classification for these cells, based only on 
morphological differences (Hanani and Reichenbach, 1994). He classified enteric 
glial cells in four types that are described in more detail in table 2 below. 
To study enteric glial cells there are different markers, such as GFAP, S100β 
and Sox-10 (transcription factor SRY box-containing gene 10) (Neunlist et al., 
2014). To the quantification of glial cells versus neurons, the preferential markers 
are Sox-10 (which labels the nucleus of glial cells) and HuC/D (which labels the 
cell bodies of neurons) (Boesmans et al., 2013). However, nuclear stainings are 
unable to define cell boundaries where neurotransmitter receptors and ion 
channels are located and, therefore, GFAP and S100β were preferred in this study 
(see Table 2). It is also possible to discriminate glial cells from enteric neurons by 
their functional characteristics. For instance, enteric neurons display a strong and 
fast Ca2+ response to high K+ depolarization, electrical field stimulation (EFS) and 
to the activation of nicotinic receptors with 1,1-dimethyl-4-phenylpiperazinium 
(DMPP), while enteric glial cells do not respond to these stimuli directly. They 
show delayed responses compared to neurons, which can be modulated by 
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several components of the purinergic signalling cascade (Boesmans et al., 2013), 
namely NTPDase2 catalysing extracellular ATP hydrolysis and ADP formation 
favouring P2Y1 receptor activation, and the danger signal represented by 
activation of the ionotropic P2X7 receptor secondary to high levels of ATP 
(reviewed in Gulbransen & Sharkey, 2012).  
Despite these functional differences, our knowledge about the 
pathophysiological significance of enteric glial cells communication to neurons and 
vice versa is extremely limited although these cells are ideally positioned to 
participate in diverse aspects of GI functions. Regional particularities, intrincate 
distribution and intimate relationship between enteric glial cells, neurons and other 
non-neuronal cell types like insterstitial cells of Cajal and fibroblast-like cells (see 
below) do not facilitate the study of these complexities, but emphasize the 
importance of any single report concerning this issue.      
Table 2: Types and localization of enteric glial cells (according to Boesmans et al., 2015; 
Gulbransen & Sharkey, 2012).  
 
Type of enteric glial cells Localization Image  
 
Type I (protoplasmic enteric gliocytes)  
 
Ganglia (between the neurons) 
 
 
 
Type II (fibrous enteric gliocytes) Interganglionar 
 
 
Type III (mucosal enteric gliocytes) Extraganglionar region along 
the nerve fibers; can also be 
present along small blood 
vessels 
 
 
Type IV (intramuscular enteric 
gliocytes) 
Intramuscular (circular and 
longitudinal muscle), along the 
nerve fibers. 
 
 
Original immunofluorescence confocal microscopy images of enteric glia from LM-MP of the rat 
ileum using an antibody against calcium-binding protein S100β (green) (obtained in collaboration 
with Doctor Fátima Ferreirinha). 
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2.3. Interstitial cells of Cajal 
Interstitial cells of Cajal (ICC’s) were discovered by Cajal around 1889. In 
that year, he thought that these cells were primitive neurons. But after more than 
100 years of studies by several authors, it was shown that they were not neurons 
and do not originate from the neural crest (Garcia-Lopez et al., 2009). These cells 
have been target of scientific discussion for years, because of their similarities with 
neurons and fibroblasts (Sanders et al., 2014). The most important discover in this 
field was the expression of the tyrosine kinase receptor (c-Kit) at the surface of 
these cells; this receptor plays a crucial role in their development (Maeda et al., 
1992). Nowadays it is recognized that ICC’s are of mesenchymal origin (Wards & 
Sanders, 2001). We also know that ICC’s can be differentiated from other cells 
expressing high amounts of anoctamin 1, Ano-1 (Tmem16A), which is a calcium-
activated chloride channel (Gomez-Pinilla et al., 2009).  
ICC’s are dispersed around nerve plexuses and between smooth muscle 
fibres of the gut. They function as pacemaker cells, because of their important role 
in the control of spontaneous motility of the gut. ICC’s are responsible for the 
propagation of electrical slow waves (Burnstock & Lavin, 2002). These cells have 
no basal lamina and form gap junctions with smooth muscle cells (SMC) (Komuro 
et al., 1996).  
 
Ganglion level Neuromuscular level
 
 
Figure 7: Original immunofluorescence confocal microscopy images of ganglionic (multipolar) and 
intramuscular (bipolar) ICC from LM-MP of the rat ileum using an antibody against Ano-1 (obtained 
in collaboration with Doctor Fátima Ferreirinha). 
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Depending of their location within the various layers of the GI tract, ICC’s 
have a specific arrangement and cell shape (Komuro, 2006) (see table 3). 
  
Table 3: Nomenclature, localization and morphology of ICC (Komuro, 2006) 
Type of ICC Localization Morfology  
 
ICC’s of the subserosa (ICC-SS)  
 
In the subserosal layer. 
 
Stellate cells 
   
ICC’s of longitudinal muscle (ICC-LM) Barely distributed in association 
with rather thicker nerve bundles. 
Bipolar cells  
   
ICC’s of the myenteric plexus (ICC-
MP) 
Around the myenteric plexus in the 
space between the circular and 
longitudinal muscle layers. 
Multipolar cells 
   
ICC’s of the circular muscle (ICC-CM) Along the long axis of surrounding 
smooth muscle cells. 
Bipolar cells 
   
ICC’s of the deep muscular plexus 
(ICC-DMP) 
Closely associated with the nerve 
bundles and circular muscle fibers. 
Multipolar cells 
   
ICC’s of the submucosa and 
submucosal plexus (ICC-SM and ICC-
SMP) 
At the interface between the 
submucosal connective tissue and 
the innermost circular muscle layer.  
Multipolar cells 
 
2.4. Fibroblast like cells (FLC) 
FLC are another mesenchymal cell type, which is described as a kind of 
interstitial cells located on the smooth muscle layer of the GI tract (Kim, 2011). 
FLC are located along processes of enteric neurons, between the longitudinal and 
circular muscle layers, in juxtaposition with ICC’s, and in the subserosal layer. 
These cells are in the vicinity of nerve varicosities and can also form gap junctions 
with SMCs (Kurahashi et al., 2011; Iino & Nojyo, 2009). The gap junctions 
between FLC and SMCs are smaller than those found between ICC’s and SMCs 
(Fujita et al., 2003). This proximity suggests that FLC can be regulated by enteric 
nerves and transmit electrical and molecular signals to the smooth muscle fibres 
and, ultimately, influence muscle tone (Fujita et al., 2003; Iino & Nojyo, 2009). The 
phenotypic characterization of FLC implies the presence of SK3, a small 
conductance Ca2+-activated K+ channel (SK channel) (Fujita et al., 2003), of the 
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platelet-derived growth factor receptor α (PDGFR-α) (Kurahashi et al., 2011), and 
the cell-cell adhesion factor, CD34 (only found in humans) (Iino & Nojyo, 2009).  
According to their morphology, FLC found in the myenteric layer are 
multipolar with thin processes, while FLC found in the muscle layers (circular and 
longitudinal) are bipolar with two main processes (Iino & Nojyo, 2009). SMCs are 
electrically coupled to ICC and PDGFRα-positive cells, forming an integrated unit 
called the SIP syncytium (figure 8) (Sanders et al., 2014). SIP cells are known to 
provide pacemaker activity, propagation pathways for slow waves, transduction of 
inputs from motor neurons, and mechanosensitivity. Loss of interstitial cells has 
been associated with motor disorders of the gut. Nevertheless, in most cases, the 
physiological and pathophysiological roles for SIP cells have not been clearly 
defined. 
 
Figure 8: SIP syncytium, constituted by SMCs, ICC’s and FLC’s.  
 
2.5. Smooth muscle cells 
SMCs are responsible for the contractility in the GI tract. They have the main 
function to mix and propel intraluminal contents, to make a progressive absorption 
of nutrients and evacuation of residues. These functions are modulated by 
electrical and mechanical properties of these cells. SMC are constituted by three 
types of filaments: (1) thin actin filaments; (2) thick myosin filaments; (3) 
intermediate filaments (Bitar, 2003).  
As reported previously, SMCs are connected by gap junctions to other cells, 
like ICC’s and FLC’s, forming the SIP syncytium. Thus, the contractile activity 
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produced by SMCs may occur via a mechanism called electromechanical coupling 
or via a pharmacomechanical coupling.  
The first one, the electromechanical coupling, occurs through several steps 
represented in the following sequence:  
(1) Depolarization of membrane electrical potentials; 
(2) Opening of voltage-gated calcium channels; 
(3) Elevation of cytosolic calcium; 
(4) Activation of contractile proteins. 
The second one, the pharmacomechanical coupling, occurs when chemical 
substances released as signals from nerves or from non-neuronal cells located 
near to the muscle act as a ligand to its receptor on the muscle membrane. As a 
consequence of that occurs the following sequence: 
(1) Opening of calcium channels; 
(2) Elevation of cytosolic calcium, without any change in the membrane electrical 
potential. 
 
3. Purinergic Transmission 
The first description of the extracellular action of adenine nucleotides and 
nucleosides was published in 1929 by Drury and Szent-Györgyi. These authors 
studied the effects of purines in the cardiovascular system of mammals. Despite of 
the clearness of the evidences, the recognition of the physiological role of purines 
as regulators of intercellular communication has generated some resistance for 
many years. In 1972, Burnstock and his collaborators were able to definitively 
establish the importance played by adenosine triphosphate (ATP). He coined the 
terms "purinergic" (relative to the extracellular mechanisms mediated by purines) 
and "purinergic transmission" (denoting to the role of ATP as a neurotransmitter) 
(Abbracchio & Burnstock, 1998). Dale’s principle described that the neurons can 
synthetize, store and release substances. According to Dale’s principle it was 
thought that each neuron released only one neurotransmitter (reviewed in Otsuka, 
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1988).  Around 1976, Burnstock introduced the cotransmitter hypothesis; he 
demonstrated that ATP is a cotransmitter in the most nerves with classical 
neurotransmitters. Nowadays, it is recognized that ATP is released with ACh, NE, 
glutamate, GABA, 5-HT and DA in different types of neurons in the CNS 
(Burnstock, 2008).  ATP can be accumulated into vesicles mediated by a Cl- 
dependent vesicular nucleotide transporter (VNUT) (Abbracchio et al., 2008).  
Although, the concept that ATP is only stored within synaptic vesicles and 
released by exocytosis from nerve terminals and some non-neuronal cells upon 
stimulation, has been changing over the past few years. ATP can also be released 
by other mechanisms, as follows:  
(1) ATP can be released through the activation of ABC proteins (ATP-binding 
cassette transporters) (Linton, 2007). This mechanism remains a subject of 
controversy. Even though some studies reported that there are systems that 
express these ABC proteins capable of transporting ATP, others showed the 
inability of these proteins to carry this purine. ABC proteins are the cystic fibrosis 
transmembrane conductance regular (CFTR) (Bodin & Burnstock, 2001).   
(2) ATP can be released via connexin- and pannexin-containing hemichannels 
(Abbracchio et al., 2008).  The majority of hemichannels display permeability to 
ATP and small dyes, like propidium and ethidium iodide, YoPro and Lucifer yellow. 
Membrane depolarization can promote the opening of connexins and pannexins, 
but unlike pannexin-1, connexin hemichannels close at normal millimolar Ca2+ 
concentrations (e.g. 1.8 mM CaCl2 in physiological solutions) and open under Ca
2+ 
depletion conditions (Fasciani et al., 2013). This particularity leaves room for 
pannexin-1 hemichannels playing a dominant role in ATP translocation under 
normal physiological conditions. Pannexins and connexins have a similar protein 
structure: four transmembranar domains, with N and C-terminal located in the 
cytosol (Lazarowski et al., 2011). 
(3) Huge amounts of ATP can be released from damaged or dying cells upon 
membrane cell breaking events.   
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ATP released from cells is quickly hydrolysed by ectonucleotidases (ecto-
enzymes) present in the synaptic cleft, giving rise to biologically active 
metabolites, such as ADP, AMP and adenosine (ADO) (Zimmermann, 2000).  
Burnstock, in 1978, reported that the physiological effects of adenosine (ADO), 
ATP and ADP were mediated by ADO-sensitive P1 receptors and nucleotides-
activated P2 receptors (Abbrancchio & Burnstock, 1998).  
 
 
Figure 9: Purinergic signalling pathways. ATP is sequentially metabolised into ADP and AMP, by 
NTPDases. AMP is then hydrolysed into ADO via ecto-5’-nucleotidase. ADO is deaminated into 
inosine (INO) by adenosine desaminase (ADA). The nucleosides can activate P1 receptors and the 
nucleotides can activate P2 receptors.  
 
3.1. Ectonucleotidases 
Extracellular nucleotides (ATP, ADP and AMP) are hydrolysed into 
nucleosides (ADO) through the action of ectoenzymes. The product final of this 
metabolic chain, ADO, can be further inactivated by deaminase adenosine (ADA) 
into INO. Ectonucleotidases include several members of ENTPDase (ecto-
nucleoside triphosphate diphosphohydrolases), E-NPP (ecto-phosphodiesterase/ 
nucleotide phosphohydrolases), ecto-alkaline phosphatase and ecto-5’-
nucleotidase (CD73) (Robson et al., 2006). The distribution of these enzymes 
throughout tissues is very diverse. They are usually anchored to the membrane, 
but some of them can detach from their membrane link and keep activity in the 
soluble form, being called exonucleotidases (Zimmermann, 2000). NTPDases are 
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generally cell surface-located enzymes with an extracellular catalytic site, but 
some of them can exhibit an intracellular localization (Robson et al., 2006). 
Nucleoside triphosphates (ATP and UDP) and diphosphates (ADP and UDP) are 
desphosphorylated by NTPDases in the presence of divalent cations (Ca2+ and 
Mg2+) (Kukulski et al., 2005). 
Eight NTPDases (NTPDase 1 to 8) have been discovered, cloned and 
characterized functionally. NTPDases 1, 2, 3 and 8 are expressed on cell surface. 
NTPDases 5 and 6 are also expressed intracellularly. NTPDases 4 and 7 are 
located exclusively intracellularly (Yegutkin, 2008). NTPDases 4, 5, 6 and 7 are 
associated with intracellular organelles, such as the Golgi (Cardoso et al., 2015).  
In this work, we will focus in four the ENTPDases that are located on the cell 
surface. ENTPDases are extremely important to control signalling through P2 
receptors and they can influence ADO formation rate and, subsequently, P1 
receptors activation (Kukulski et al., 2005). 
Ecto-5’-nucleotidase is an ecto-enzyme responsible for the hydrolysis of 
AMP into ADO and phosphate. This enzyme is considered the limiting step for 
ADO formation in the majority of the tissues (Cardoso et al., 2015). Ecto-5’-
nucleotidase is attached to the plasma membrane via a glycosyl 
phosphatidylinositol (GPI) anchor, which may be cleaved from cell membranes 
through hydrolysis of the GPI anchor by phosphatidylinositol-specific 
phospholipases or by proteolysis, retaining its catalytic activity in the soluble form 
(Sträter, 2006). Ecto-5’-nucleotidase, in both membrane and soluble forms, can be 
inhibited by micromolar concentrations of ATP and ADP - feed-forward inhibition 
(Vieira et al., 2014). These nucleotides act as competitive inhibitors of this enzyme 
because they have the ability to bind to the catalytic site of ecto-5’-nucleotidase 
without being hydrolysed.  
Adenosine deaminase (ADA) is another important enzyme that is located 
predominantly in the cytosol, but can also appear bound to the plasma membrane 
in inumerous cells. The irreversible deamination of ADO and 2’-deoxyadenosine 
into INO and 2’-deoxyinosine, respectively, is catalysed by ADA (Yegutkin, 2008). 
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Like ecto-5’-nucleotidase, active soluble forms of ADA (exo-ADA) may be released 
from activated cells (Correia-de-Sá et al., 2006) or result from membrane cell 
damage (Vieira et al., 2014). ADO acts in all P1 receptor subtypes, while INO can 
activate A1 and A3 adenosine receptors under certain conditions (Cardoso et al., 
2015).  
 
Alkaline phosphatases (AP) represent a family of enzymes with low affinity 
for nucleotides. They are usually attached to the plasma membrane via a GPI 
anchor (Zimmermann, 2000). These enzymes promote the release of inorganic 
phosphates, pyrophosphates and adenine nucleosides, with a pH optimum for this 
catalytic reaction from 8 to 11 (Yegutkin, 2008).   
 
The ecto-nucleotide pyrophosphatase/phosphodiesterase (E-NPP) family 
has seven structurally-related ecto-enzymes (NPP1-NPP7). They hydrolyse 5’-
phosphodiester bonds in nucleotides and their derivatives, with the subsequent   
release of 5’-nucleoside monophosphates (Goding et al., 2003). This family has a 
high substrate specificity to hydrolyse pyrophosphate and phosphodiester bounds 
in nucleotides, nucleic acids and nucleotide sugars. However, only the first three 
enzymes of this family (NPP1-NPP3) are relevant in the hydrolysis of extracellular 
nucleotides, being important to the purinergic signalling cascade. NPP enzymes 
are considered really important for the metabolism of extracellular diadenosine 
polyphosphates in vertebrate tissues (Yegutkin, 2008). Structurally, they are type II 
transmembrane metalloenzymes, characterized by a short intracellular domain N-
terminus, a single transmembrane domain and an extracellular domain containing 
a conserved catalytic site (Zimmermann, 2000; Goding et al., 2003). These 
enzymes can act as ecto-enzymes, anchored to the cellular membrane, or upon 
proteolytic cleavage from cell membranes as exo-enzymes (Goding et al., 2003).   
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Table 4: Role of enzymes of the purinergic cascade and their molecular characteristics (Yegutkin, 
2008; Cardoso et al., 2015; Kukulski et al., 2005; Vieira et al., 2014; Robson et al., 2006). 
ENZYME STRUCTURE FUNCTION 
ENTPDase 1 
(ATPDase, 
CD39 or 
Apyrase) 
Contain two transmembranar 
domains at the N- and C-
terminus 
Dephosphorylates ATP directly into AMP, with 
minimal accumulation of ADP; 
Hydrolyses  ATP, ADP, UTP and UDP with 
similar efficacy; 
Converts ATP to ADP and ADP to AMP; 
Active in pH ranging from 7 to 10. 
ENTPDase 2 
(ecto-
ATPase, 
CD39L1) 
Contain two transmembranar 
domains at the N- and C-
terminus 
Preferential triphosphonucleosidase; 
Hydrolyses ADP 10 to 15 times less efficiently 
than ATP; 
Converts ATP and UTP to  ADP and UDP; 
Active at physiological pH as well in acidic 
conditions. Is inactive at pH > 9 
ENTPDase 3 
(CD39L3 or 
HB6) 
Contain two transmembranar 
domains at the N- and C-
terminus 
Functional intermediate between NTPDase 1 
and 2; 
Active in pH ranging from 5 to 11. 
ENTPDase 8 Contain two transmembranar 
domains at the N- and C-
terminus 
Functional intermediate between NTPDase 1 
and 2. 
Ecto-5’-
Nucleotidase 
(CD73) 
Contain a glycosyl 
phosphatidylinositol (GPI) 
anchor, by which the mature 
protein is attached to the cell 
membrane via the C-terminal 
serine residue linked to a 
complex oligoglycan and a 
sphingolipidinositol group. 
Dephosphorylates AMP into ADO. 
Usually the rate limiting step for ADO formation 
from released adenine nucleotides. 
ADA (CD26) More than 90% intracellular 
It is also located at the cell 
surface. 
 
Converts ADO to the inactive metabolite, INO. 
 
3.2. Purinergic receptors 
Adenine nucleotide and nucleosides modulate cell functions through the 
activation of receptors bound to the plama membrane. Purinoceptors are 
subdivided in P1 and P2 receptors. P1 receptors are preferentially activated by 
ADO, while P2 receptors are activated by both adenine (ATP, ADP, adenosine 
polyphosphates) and uracil (UTP, UDP) nucleotides. Receptor classification has 
been coined by Burnstock (1978) and further modified to the actual nomenclature 
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adopted by the International Union of Pharmacology (IUPHAR) (Abbrachio & 
Burnstock, 1998).  
3.2.1. Adenosine Receptors (P1 receptors) 
Adenosine receptors are classified in four subtypes, A1, A2A, A2B and A3, 
based on molecular cloning, pharmacologic profile and their ability to couple with 
different second messenger pathways, including the adenylyl cyclase cyclic AMP 
system (table 5). A1 and A2A receptors exhibit high affinity for ADO (activated by 
low ADO amounts), while A2B and A3 possess low affinity for the nucleoside and 
require higher levels of ADO to become activated, at least in rodents (Fredholm et 
al., 2001). It has been proposed that high-affinity P1 receptors are predominantly 
activated under physiological processes, while the low-affinity receptors may be 
relevant only during pathological conditions, when the extracellular ADO levels 
become elevated (Antoniolli et al., 2008; Bozorov et al., 2009). All adenosine 
receptors belong to the family of G protein-coupled receptors (GPCR). Structurally, 
they show a seven transmembrane α-helical, with an extracellular amino-terminus 
and an intracellular carboxy-terminus (Fredholm et al., 2001; Sheth et al., 2014). 
  
Table 5: Classification of adenosine receptors, based on their differential coupling to second 
messenger transduction systems (Fredholm et al., 2001; Sheth et al., 2014) 
ADENOSINE 
RECEPTORS 
G PROTEIN COUPLING 
(PRIMARY) 
EFFECTS OF G PROTEIN 
COUPLING 
A1 (High affinity) Gi/0 proteins  
Adenylyl cyclase inhibition; ↓cAMP 
Inhibition of Ca
2+ 
currents  
Increase in GIRK currents 
A2A (High affinity) Gs proteins Adenylyl cyclase activation; ↑cAMP 
A2B (Low affinity) Gs proteins/ Gq11 proteins 
Adenylyl cyclase activation; ↑cAMP¸ 
Stimulation of phospholipase C 
/IP3/diacylglycerol; ↑ IP3/DAG (PLC) 
A3 (Low affinity in 
rodents, high affinity in 
humans) 
Gi/0 proteins/ Gq/11 proteins 
Adenylyl cyclase inhibition; ↓cAMP/ 
Stimulation of phospholipase C 
/IP3/diacylglycerol; ↑ IP3/DAG (PLC) 
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As all other metabotropic receptors, activation of adenosine receptors can 
lead to desensitization by several mechanisms. The A1 receptor may be 
phosphorylated and internalized gradually, with a half-life of several hours; A2A and 
A2B receptors desensitization lasts about one hour, and that of the A3 receptor 
recovers within a few minutes (Sheth et al., 2014).   
3.2.1.1. Adenosine  
Production, metabolism and transport are the three main pathways for 
generating ADO in living cells. ADO can be produced intracellularly and 
extracellularly. ADO produced inside nerve cells is originated from its immediate 
precursor, the 5’-adenosine monophosphate (5’-AMP), through the action of 
intracellular 5’-nucleotidase. Then, ADO can either be inactivated into INO by ADA 
(Sheth et al., 2014) or transported to the extracellular milieu, via equilibrative 
nucleoside transporters (ENT) (figure 10).  
 
Figure 10: Intracellular production of ADO. 
Extracellularly, ADO can be generated from the catabolism of ATP co-
released with classical neurotransmitters. Released ATP is sequential hydrolyzed 
by ecto-nucleotidases into ADP, AMP and, finally to ADO (figure 11). All these 
metabolites can act on membrane-bound purinoceptors to modulate the activity of 
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both neuronal and non-neuronal cells in the vicinity (Sheth et al., 2014; Latini & 
Pedata, 2001).  
 
Figure 11: Extracellular production of ADO. 
 
Reduction of ADO levels can occur in three different ways. Inside the cell, 
ADO can either be phosphorylated to AMP by adenosine kinase (AK) or 
deaminated into INO by ADA. Outside the cell, ADO is inactivated to INO through 
the action of adenosine deaminase (ADA) (figure 10 and 11), because AK is 
located exclusively in the cytoplasm. This enzyme presents a higher affinity for 
ADO (10 to 100 times) than ADA, which makes ADO phosphorylation the 
preferential pathway responsible for maintaining low intracellular concentrations of 
the nucleoside under normal physiological conditions. Intracellular deamination of 
ADO by ADA only becomes relevant when cytoplasmic levels of ADO rise and the 
phosphorylation pathway becomes saturated (Latini & Pedata, 2001). Thus, 
inhibition of both AK and ADA results in the increase of intracellular ADO levels 
forcing the exit of the nucleoside via equilibrative transporters. The same occurs in 
metabolically stressed cells, in which decreases in the cellular energy charge is 
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accompanied by extensive catabolism of adenine nucleotides leading to increased 
formation of ADO.    
The third pathway used for intracellular ADO inactivation is the reversible 
reaction catalysed by S-adenosyl-L-homocysteine hydrolase (SAH hydrolase) 
requiring NAD+ as a cofactor. This reaction results in the formation of S-adenosyl-
L-homocysteine from ADO and L-homocysteine (Latini & Pedata, 2001). 
3.2.1.2. Adenosine Transport 
ADO transport across the plasma membrane is really important to regulate 
the extracellular ADO levels. Nucleoside transporters (NT) are members of the 
superfamily of solute carrier (SLC) transporters (Köse & Schiedel, 2009). In the 
literature, are described two broad families of adenosine transporters: (1) SLC29 
family of equilibrative nucleoside transporter (ENT), which are facilitated-diffusion 
nucleoside transporters (sodium independent manner), and (2) SLC28 family of 
concentrative nucleoside transporters (CNT), which transport nucleosides actively 
against their gradient (sodium dependent manner) (Thorn & Jarvis, 1996; Köse & 
Schiedel, 2009).   
Four types of ENTs exist, which are classified as ENT1, ENT2, ENT3 and 
ENT4. All these members of the SLC29 family share the ability of transport ADO, 
but they differ in the ability of transport nucleosides and nucleobases (Thorn & 
Jarvis, 1996; Yao et al., 1997; Köse & Schiedel, 2009).  
Classically, ENTs were classified based in their sensitivity to the inhibition 
by the synthetic nucleoside analogue, nitrobenzylthioinosine (NBTI).  ENT1 
(equilibrative-sensitive transporters, es) are inhibited at low nanomolar 
concentrations of NBTI and dipyridamole, while ENT2, ENT3 and ENT4 
(equilibrative-insensitive transporters, ei) are inhibited only by micromolar 
concentrations of NBTI (Latini & Pedata, 2001). ENT1, ENT2 and ENT4 can be 
found at the plasma membrane, while ENT3 is mostly intracellularly (Köse & 
Schiedel, 2009).  
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Concerning the SLC28 family of CNT, three members were identified, 
CNT1, CNT2 and CNT3. They differ in their substrate specificities, being CNT1 
more specific for pyrimidine-nucleosides, CNT2 for purine-nucleosides and CNT3 
for both pyrimidine and purine nucleosides (Gray et al., 2004).  
 
3.2.2. P2 Receptors 
Extracellular purine and pyrimidine nucleotides (ATP, UTP, ADP, UDP) are 
originated in response to tissue stress, cell damage, and pore formation, but can 
also be released from non-damaged cells through several mechanisms, including 
vesicle exocytosis (Lazarowski et al., 2011; Bodin & Burnstock, 2001). They exert 
their action through the activation of two different families of P2 receptors, namely 
P2X and P2Y receptors. P2X receptors are trimeric ligand-gated ionotropic 
channels (LGIC), while P2Y receptors are metabotropic G-protein-coupled 
receptors (GPCR). Cellular responses to ionotropic P2X receptors are faster than 
to activation of P2Y receptors (Jacobson, 2010; Burnstock & Williams, 2000; 
Abbrachio et al., 2006). 
 
Figure 12: Schematic representation showing the membrane topology of a typical P2X and P2Y 
receptor. P2X receptors are ion channels with two transmembrane domains, while P2Y receptors 
are G-protein-coupled receptors with seven transmembrane domains. 
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3.2.2.1. P2X Receptors 
There are 7 subtypes of P2X receptors: P2X1, P2X2, P2X3, P2X4, P2X5, 
P2X6 and P2X7. Activation of P2X receptors by binding to extracellular ATP 
generates an influx of cations, such as sodium and calcium, leading to 
depolarization of excitable cells and activation of cytosolic enzymes (Jacobson, 
2010). In neurons, they modulate neurotransmitter release acting presynaptically 
or trigger fast excitatory signals in the postsynaptic membrane (Kaczmarek-HájeK 
et al., 2012).   
The subcellular distribution of the seven P2X receptor subtypes may differ 
from cell to cell. Most of them are expressed at the plasma membrane, but some 
of them may be in the endoplasmic reticulum (ER) or within endosomes and 
lysosomes. Localization of these receptors depends on their trafficking properties 
(Robinson & Murrell-Lagnado, 2013). P2X receptors are able to form heteromers 
and homomers (Jacobson, 2010).  All P2X receptor subunits can form homomers, 
with the exception of the P2X6; the same occurs regarding heteromer formation, 
the exception in this case is the P2X7 receptor subtype (Ren & Bertrand, 2008). 
All these receptors have a similar topology consisting of two transmembrane 
domains, a large extracellular ligand binding loop, and intracellular N and C 
terminals (Kaczmarek-HájeK et al., 2012). 
All subtypes of P2X receptors are activated by ATP, but they can be 
distinguished by the required concentrations of the nucleotide. Based on that, P2X 
receptors can be grouped in three main classes (Jacobson, 2010; Burnstock & 
Williams, 2000): 
(1) Receptors with high affinity for ATP (EC50=1 µM), which are rapidly activated 
and desensitized: P2X1 and P2X3 receptors. 
(2) Receptors with lower affinity for ATP (EC50=10 µM), showing slow 
desensitization and sustained depolarizing currents: P2X2, P2X4, P2X5 and 
P2X6 receptors.  
(3) Receptors with very low affinity for ATP (EC50=300-400 µM), exhibiting little or 
no desensitization and capable of forming large pores: P2X7 receptors.  
 INTRODUCTION 
 
 
48    PhD Thesis: Cátia Andreia Rodrigues Vieira 
 
 
3.2.2.2. P2Y Receptors 
Purine nucleotides (ATP and ADP) and pyrimidine nucleotides (UTP and 
UDP and UDP-glucose) activate metabotropic P2Y receptors. Abbracchio and 
collaborators (2006) described eight distinct mammalian subtypes of P2Y 
receptors, namely P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13 and P2Y14. 
According to the pharmacological profile, the P2Y receptors can be 
subdivided into four main groups: 
(1) Adenine nucleotide-preferring receptors, responding essentially to ATP and 
ADP: P2Y1, P2Y12, P2Y13 and human P2Y11; 
(2) Uracil nucleotide-preferring receptors, responding respectively to UTP and 
UDP: P2Y4 and P2Y6; 
(3) Receptors with mixed selectivity: P2Y2, P2Y4 and P2Y11; 
(4) Receptors responding to sugar nucleotides, UDP-glucose and UDP-galactose: 
P2Y14. 
 
Table 6: Main characteristics of P2Y receptor subtypes: agonist preference and G protein-coupling 
(Abbracchio et al., 2006; White et al., 2003). 
Receptor Agonist (preferential) Primary G protein coupling/ Second Messenger 
   
P2Y1 ADP (ATP partial agonist) Gq/11; PLC activation; Gi/o; Potassium channel 
P2Y2 UTP=ATP Gq/11; PLC activation 
P2Y4 UTP>ATP Gq/11; PLC activation 
P2Y6 UDP>>UTP (partial agonist) Gq/11; PLC activation 
P2Y11 ATP>UTP Gs; AC stimulation; Gq/11; PLC activation  
P2Y12 ADP (selective) Gi/0; AC inhibition 
P2Y13 ADP>>ATP Gi/0; AC inhibition 
P2Y14 UDP>UDP-glucose/UDP 
galactose 
Gi/0; AC inhibition; Gq/11; PLC activation; can activate 
PLCβ via beta/gamma subunits. 
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4. Cholinergic Transmission  
Acetylcholine (ACh) is the prime neurotransmitter of autonomous nervous 
system and its release originates a type of transmission, entitled cholinergic.  The 
discovery of pharmacological effects of ACh was done in studies in adrenal glands 
by Reid Hunt around 1900. In 1914, in a study of the pharmacological actions of 
ACh, Dale distinguished two types of activity, muscarinic and nicotinic. When 
injecting muscarine (active ingredient of mushroom Amanita muscaria) in animals 
he reproduced the same effects of ACh. These effects were blocked with small 
doses of atropine (poisonous constituent of Atropa belladonna). After blocking the 
muscarinic effects with atropine, higher doses of ACh produced similar effects to 
nicotine (reviewed in Rang et al., 2004).  
In 1953, Dale was the responsible for the establishment of the term 
cholinergic to refer to any neuron that releases ACh as a neurotransmitter.  
 
Figure 13: ACh metabolism in cholinergic nerve terminals. ACh is synthetized from choline and 
acetyl-coenzime A (acetyl-CoA) through the action of ChAT. ACh is stored in synaptic vesicles by 
means of a vesicular ACh transporter (VaChT). Following its release into the synaptic cleft, ACh is 
metabolized by the acetylcholinesterase (AChE). Choline originated from ACh inactivation by 
AChR is re-uptaken by the terminal through a high-affinity sodium-dependent choline transporter. 
ACh exocytosis occurs when an action potential reaches the presynaptic nerve terminal, which 
promotes calcium influx via voltage-sensitive channels and, consequently, vesicles fusion to the 
plasma membrane releasing the neurotransmitter.  
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ACh is synthetized in axonal terminals of cholinergic neurons by the action 
of ChAT. ChAT catalyses the reaction between acetyl coenzyme-A (acetyl-CoA) 
and choline. ACh and coenzyme-A (CoA) result as reaction products. Acetyl-CoA 
is originated in the mitochondria from the complete oxidation of pyruvate. The 
formation of acetyl-CoA is catalyzed by an enzyme complex called pyruvate 
dehydrogenase complex. Choline that is need for the synthesis of ACh comes 
from various sources, including the circulating choline in the plasma, the hydrolysis 
of phospholipids of cell membranes and from the recycling of choline resulting 
from the action of acetylcholinesterase (AChE) on ACh released into the synaptic 
cleft. Reuptake of choline is mediated by a concentrative transporter existing in 
cholinergic nerve terminals, which exhibits high-affinity for choline (Km between 1 
and 5 µM) and is dependent on temperature and transmembrane Na+ gradient. 
Synthesis of ACh is limited by the availability of choline. Synthesized ACh is 
transported into synaptic vesicles by an antiport mechanism. When an action 
potential reaches nerve terminals, it triggers the influx of Ca2+ from the 
extracellular milieu via voltage-sensitive channels, which promotes the fusion 
synaptic vesicles to the plasma membrane and, consequently, the exocytotic 
release of ACh to the synaptic cleft (Rang et al., 2004). Once in the extracellular 
space, released ACh may activate two subtypes of cholinergic receptors, 
muscarinic (mAChR) and nicotinic (nAChR).  
5. Purinergic and cholinergic transmission in the Myenteric Plexus 
ACh is the prime regulator of intestinal motility and the dominant excitatory 
neurotransmitter of the myenteric plexus (Costa et al., 1996). In this tissue, ATP 
may be co-released with ACh, but also with other neurotransmitters (White, 1982). 
Both excitatory and inhibitory effects may result from activation of purinoceptors by 
ATP and its metabolites, ADP and ADO, depending on the receptor subtype being 
activated, their location, and target cells. 
ACh release from cholinergic enteric nerve terminals is modulated by 
purines via the activation of both P1 and P2 purinoceptors, which can promote or 
inhibit ACh release (De Man et al., 2003).  
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5.1. P1 Receptors 
All subtypes of P1 receptors (adenosine A1, A2A, A2B and A3 receptors) were 
found in whole-mount preparations of the LM-MP of rat ileum (Vieira et al., 2011). 
Results from this study demonstrate substantial heterogeneity in the distribution of 
P1 receptors in this tissue. Concerning high-affinity adenosine receptor subtypes, 
the adenonsine A1 receptor is predominantly located in neuronal cell bodies of 
myenteric ganglia, while the A2A receptor is expressed mainly on VAChT-positive 
cholinergic nerve fibres. Regarding to the low affinity adenosine receptor subtypes, 
our group showed that the A2B receptor is dominantly expressed on myenteric glial 
cells, while the A3 receptor is co-localized with the A1 receptors on neuronal cell 
bodies of myenteric ganglia.  
From the four adenosine receptor subtypes found in the LM-MP of the rat 
ileum, only the A2B receptor is not directly involved in cholinergic 
neurotransmission. Besides the well-characterized inhibitory effect of ADO in the 
GI tract mediated by A1 receptors, our group demonstrated that endogenously 
generated ADO facilitates [3H]ACh release from myenteric neurons through 
preferential activation of prejunctional A2A receptors (Duarte-Araújo et al., 2004a). 
Upregulation of ACh release was also obtained by stimulating low affinity A3 
receptors localized at myenteric cell bodies way from the synaptic region, which 
activation may facilitate action potential generation; synergism between A3 
receptors activation and the A2A facilitatory receptors localized on axon terminals, 
has been observed (Vieira et al., 2011).  
The co-existence of high-affinity inhibitory A1 and excitatory A2A receptor 
subtypes on cholinergic neurons prompted the question of how endogenous ADO 
discriminates between these two receptors to regulate synaptic transmission in the 
myenteric plexus of the rat ileum. At the rat myenteric plexus, ADO may be 
originated from the extracellular catabolism of released adenine nucleotides 
through the ectonucleotidase pathway (Duarte-Araújo et al., 2009). However, 
hydrolysis of released ATP contributes only partly to the total extracellular 
concentration of the nucleoside; the other component is probably carried out by 
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the outflow of ADO as such via dipyridamole-sensitive ENTs (Correia-de-Sá et al., 
2006). Results from these studies also demonstrate that extracellular ADO 
deamination by ADA secreted into the extracellular mileu (Correia-de-Sá et al., 
2006) is the most efficient mechanism to regulate the endogenous levels of the 
nucleoside at the myenteric synapse (Duarte-Araújo et al., 2004a). Thus, 
extremely high extracellular ADA activity, along with a less-efficient ADO uptake 
mechanism, may restrict endogenous ADO actions to the synaptic region near the 
release/production sites channelling to the activation of facilitatory A2A receptors 
(Duarte-Araújo et al., 2004a; Correia-de-Sá et al., 2006).  
5.2. P2X Receptors 
P2X receptors are expressed on myenteric and submucosal motor, 
sensory, and secretomotor neurones; they are also found on enteric glial cells, 
ICCs and smooth muscle fibres (Burnstock, 2012) (see table 7).  
In the myenteric plexus, ATP that acting on P2X receptors contributes to 
facilitate electrically-evoked fast excitatory postsynaptic potentials (fEPSPs) 
(Galligan, 2002). fEPSPs in the myenteric plexus of guinea-pigs have a dominant 
purinergic component (67%) mediated by P2X2 and P2X3 receptor subtypes. 
Purinergic fEPSPs are more evident in the ileum when compared with other 
regions of the intestine. P2X2 receptors (20%) and P2X3 receptors (80%) are also 
located in intrinsic sensory neurons (Ren & Bertrand, 2008).  
Functional interactions between P2X and nicotinic ACh receptors have 
been described. Both ionotropic receptors are co-expressed in myenteric neurons, 
indicating that their interaction might be physiologically relevant (Ren & Bertrand, 
2008). In this context, our group showed that ATP transiently activates facilitatory 
P2X receptors mediating non-stimulated ACh release from myenteric motor 
neurons (Duarte-Araújo et al., 2009). 
Burnstock & Lavin (2002) identified P2X2 and P2X5 receptors in ICCs of 
the guinea-pig myenteric plexus, but no immunostaining was detected for P2X1, 
P2X3, P2X4, P2X6 or P2X7. These authors proposed that ATP released from 
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enteric nerves, enteric glial cells or during smooth muscle contractions can 
activate P2X2 or P2X5 receptors in ICCs, leading to increases in intracellular 
[Ca2+], impacting the activity of slow waves.   
Table 7: P2X receptor subtypes and respective locations in the gut (based on data from the 
following papers: Burnstock, 2012; Galligan, 2002; Liña-Rico et al., 2015; Van Crombruggen et al., 
2007; Silva et al., 2015; Burnstock & Lavin, 2002). 
 
RECEPTORS LOCATION 
P2X1 Smooth muscle of rat submucosal arterioles.  
Smooth muscle of the rat distal colon. 
Smooth muscle of enteric blood vessel. 
Enteric glial cells (rat distal colon) 
Resident macrophages 
Highly expressed in human submucous plexus. 
Co-localized with P2X2 in the majority of submucous neurons.  
P2X2 Myenteric neurons: descending interneurons, NOS-containing motor neurons;  
Nerve fibres in the myenteric plexus (rat distal colon) 
Nerve fibres in the submucosal ganglia: inhibitory motor neurons, VIP-
containing secretomotor; intrinsic sensory neurons. 
Longitudinal and circular muscle of the colon.  
Epithelial cells (rat distal colon). 
ICC’s. 
P2X3 Small subpopulation of myenteric ganglion neurons, but in a larger number of 
ganglion neurons in the submucous plexus;  
Cholinergic neurons of submucous plexus of the guinea-pig ileum. 
Intrinsic sensory neurons; AH-type neurons. 
Nerve fibres of submucous and myenteric plexus (rat distal colon). 
Neurons of the human myenteric plexus, but not in the submucous plexus. 
Longitudinal smooth muscle fibres.  
Epithelial cells (rat distal colon). 
P2X4 Only present in resident macrophages (rat distal colon). 
P2X5 Longitudinal smooth muscle fibres. 
Myenteric plexus: nerve fibers surrounding ganglion cell bodies and possibly 
on glial cell processes.  
Submucous plexus: intracellularly and on the plasma membranes of neurons. 
ICC’s. 
P2X6 Intrinsic sensory neurons. 
Enteric Glial cells of myenteric and submucous plexus (rat distal colon). 
P2X7 Myenteric and submucosal ganglia in stomach, small intestine, and colon. 
Surrounding ganglion cell bodies in both myenteric and submucous plexuses.  
Enteric glial cells of myenteric and submucous plexus (rat distal colon). 
Not present in smooth muscle cells, ICCs, and fibroblast-like cells. 
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5.3. P2Y Receptors 
ATP acting on metabotropic P2Y receptors is responsible for slow EPSPs in 
the ENS (Ren & Bertrand, 2008). Slow EPSPs are modulated by ACh acting on 
muscarinic receptors and by tachykinins acting on neurokinin receptors. Slow 
EPSPs is also mediated by ATP acting at P2Y receptors.  
It has been proposed that P2Y1 and P2Y2 receptors have a dominant 
neuronal localization, while the P2Y4 receptor is located in another cell types, like 
enteric glial cells and ICCs. Our group demonstrated that activation of P2Y1 
receptors by ADP generated from released ATP via NTPDase2 restrains ACh 
release during prolonged stimulation periods of myenteric motor nerves (Duarte-
Araújo et al., 2009). Please refer to table 8 for the distribution of P2Y receptors 
along the GI tract.  
Mounting evidences are now available about the physiological impact of 
neuron-to-glia communication (Boesmans et al., 2013; Gulbransen & Sharkey, 
2009; Gulbransen et al., 2010). Enteric glial cells respond to ATP and UTP 
released by neurons, via P2 receptors, by increasing intracellular [Ca2+]i,. Previous 
studies implicated P2Y4, and possibly the P2Y11, receptors in ATP-mediated 
effects in enteric glial cells (Gulbransen & Sharkey, 2009; Gulbransen et al., 2010), 
but the P2Y1 receptor activated by ADP generated from the extracellular hydrolysis 
of ATP may also be involved (Gulbransen & Sharkey, 2012). Neuron-to-glia 
neurotransmission has been proposed in the myenteric plexus of the guinea pig 
distal colon. In this model, the stimulation of primary afferent fibres releases 
neurotransmitters, such as ATP, CGRP and SP, resulting in the activation of 
presynaptic enteric nerve terminals leading to ACh and ATP co-release. These 
compounds act respectively on ionotropic nicotinic ACh and P2X receptors on 
postsynaptic enteric neurons. Evidence suggest, however, that enteric glia 
respond mainly to ATP released from discrete populations of enteric sympathetic 
nerves  under specified circumstances, which by activating P2Y4 receptors 
stimulated Ca2+ responses in the surrounding enteric glia (Gulbransen et al., 
2010). 
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Table 8: P2Y receptor subtypes and respective locations in the gut (based on data from the 
following papers: Ren & Bertrand, 2008; Burnstock, 2014; Van Crombruggen et al., 2007; Van 
Nassauw et al., 2006). 
 
RECEPTORS LOCATION 
P2Y1 Myenteric and submucous plexus (mouse); 
NOS immunoreactive neurons (descending interneurons or inhibitory motor 
neurons); Secretomotor neurons in submucous plexus. 
ICC’s, in human and murine small intestine. 
FLC.  
Enteric glial cells in rat distal colon. 
Smooth muscle cells in rat distal colon. 
P2Y2 Myenteric plexus of the rat colon (Dogiel type I neurons); Almost a quarter of 
the neurons co-expressed nNOS. 
Co-localize with a majority of calretinin immunoreactive neurons in the 
myenteric plexus (ascending interneurons and excitatory motor neurons). 
All NPY-immunorecative neurons in the submucous plexus (secretomotor 
neurons) 
Enteric glial cells. 
P2Y4 ICC’s, in human and murine small intestine. 
Enteric glial cells (in rat distal colon and in guinea-pig colon). 
P2Y6 
 
 
 
 
Myenteric plexus (all regions of the guinea pig GI tract); Not in the 
submucous plexus.  
Co-localize with NOS immunoreactive neurons (32%), descending 
interneurons and inhibitory motor neurons. 
Co-localize to calretinin immunoreactivity neurons (45%), ascending 
interneurons and excitatory motor neurons.  
Enteric glial cells and in enteric smooth muscle cells (in rat distal colon). 
P2Y11 Enteric glial cells (in rat distal colon). 
Smooth muscle cells of the guinea-pig colon. 
P2Y12 Localized to calbindin immunoreactive neurons (AH-type sensory neurons), in 
the guinea pig small intestine. 
In the myenteric plexus, in the rat colon. 
In neurons exhibiting a Dogiel type II morphology and in uniaxonal neurons 
(in rat distal colon). 
P2Y13 Enterocytes (in rat distal colon). 
P2Y14 Some neurons of submucous plexus (in rat distal colon). 
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ICCs and FLCs are electrically coupled to smooth muscle fibres via gap 
junctions from a multicellular functional syncytium termed the SIP Syncytium. Cells 
that make up the SIP syncytium are highly specialized containing unique 
receptors, ion channels and intracellular signalling pathways, which may be 
affected by neurotransmitters to regulate the excitability of GI muscles (reviewed in 
Blair et al., 2014). For instance, purines activating P2Y1 receptors in FLCs 
stimulate the PLC transduction pathway, which culminates in IP3 production and 
Ca2+ recruitment from intracellular stores leading to increases in SK3 channels 
permeability and cells hyperpolarization (Don Koh & Rhee, 2013). 
5.4. Nicotinic and Muscarinic Receptors 
ACh activates directly two subclasses of receptors, muscarinic and nicotinic 
receptors. Because nicotinic ACh receptors are ligand-gated ion channels, they 
mediate fast synaptic transmission in the ENS. It was shown that nicotinic 
receptors-mediated neurotransmission prevails in ascending pathways, whereas it 
has only a minor contribution in descending pathways (Galligan, 2002). Schneider 
and Galligan (2000) showed distinct populations of presynaptic nicotinic receptors 
in the myenteric plexus. They demonstrated that nicotinc receptors are located in 
the nerve terminals and in the somatodendritic region of AH and S neurons. Our 
group provided evidences suggesting that ACh mediates a positive feedback 
mechanism via the activation of prejunctinal nicotinic receptors, presumably by 
mediating the influx of Ca2+ directly through the receptor pore and, thus, 
independently of voltage-sensitive calcium channels (Duarte-Araújo et al., 2004b). 
Interestingly, this mechanism seems to be tonically regulated by endogenous ADO 
through the activation of A2A receptors coupled to the adenylate cyclase/cyclic 
AMP transducing system. 
 Immuncytochemistry studies showed that nicotinic receptors containig α3-, 
α5-, and β2- subunits are most abundant primary cultured myenteric neurons, 
whereas the α7- subunit stained only a small number of these neurons (Zhou et 
al., 2002). Glushakov and colleagues (2004) showed that submucosal neurons of 
the guinea-pig ileum express nicotinic receptors containing α3-, α5- and α7-
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subunits, but not α4 subunits. Moreover, Obaid and colleagues (2005) using 
radioimmunoassays and immunocytochemistry reached the conclusion that guinea 
pig enteric ganglia express α3-, α5-, β2-, β4- and α7-subunits.  
In addition to nicotinic receptors, ACh can also activate muscarinic 
receptors (North et al., 1985). The GI tract of healthy dairy cows contains M1 
receptors in the submucosal and myenteric plexus, M2 receptors in SMCs, M3 
receptors in the lamina propria, nerve terminals and intermuscular nerve fibers, 
and in microvessel myocyte, and M5 in microvessel myocyte and SMCs. M4 
receptors were not found in these tissues (Stoffel et al., 2006). At the LM-MP of 
the mouse ileum, M2 and M4 receptors may mediate muscarinic autoinhibition in 
ACh release (Takeuchi et al., 2005). Using the rat ileum, we demonstrated that 
ACh exerts a dual neuromodulatory effect on its own release through the 
activation of inhibitory M2 receptors and excitatory M3 receptors, depending on the 
stimulation train length (Vieira et al., 2009). The participation of M1 receptors in the 
control of ACh release was discarded.  
Goyal (2013) revised the role of ICCs in cholinergic neurotransmission in 
the gut. It was proposed that ICCs may be intermediates in cholinergic 
neuromuscular transmission at the SIP syncytium. ICC’s are endowed with 
muscarinic receptors (mainly M3 receptors), which have a prime role in this 
process. Activation of muscarinic receptors in ICCs generates a depolarizing 
potential and activates different signalling pathways that are driven to smooth 
muscle fibres leading to muscle contraction. M3 receptors are coupled to Gq/11 
leading to activation of phospholipase C (PLC) resulting in IP3 and DAG formation, 
with subsequent recruitment of intracellular Ca2+ and protein kinase C activation, 
respectively (Koh & Rhee, 2013). Increases in intracellular Ca2+ can strengthen 
activation of the protein kinase C, which may subsequently stimulate ADO outflow 
by equilibrative transporter ENT1. Increase in protein kinase C activity may also 
stimulate the activity of 5’-nucleotidase inside the cell and/or inhibit AK, enhancing 
intracellular accumulation and efflux of ADO from the cell. Thus, the muscarinic M3 
positive feedback mechanism facilitating ACh release from stimulated myenteric 
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neurons may be indirectly mediated by the release of ADO from ICCs leading to 
activation of prejunctional facilitatory A2A receptors in a novel neuron-to-glia and 
back glia-to-neuron communication pathway operated by muscarinic M3 and 
adenosine A2A receptors. 
Increasing evidences have been produced showing that ICCs are crucial in 
the transduction of cholinergic signals to smooth muscle fibres in the GI tract. 
However, in the absence of ICCs ACh can couple to Gq12/13 protein and trigger 
activation of the Rho-kinase (RhoK) pathway to cause contraction in SMCs (Koh & 
Rhee, 2013).   
 
6. Inflammatory bowel diseases 
In Portugal, inflammatory bowel diseases (IBD) have a prevalence of 146 
patients per 100 000 inhabitants (Azevedo et al., 2010). IBDs include Crohn’s 
disease, ulcerative colitis and indeterminate colitis. Ulcerative colitis occurs only in 
the colon and within the gut wall tissue damage is restricted to the mucosa and 
lamina propria. On the other hand, Crohn’s disease can occur in any region of the 
gut and tissue damage may penetrate the entire thickness of the organ (Geboes & 
Collins, 1998). Peristaltic changes are common clinical symptoms in IBS. Since in 
these chronic GI disorders etiopathogenesis remains unclear, therapeutic 
management is usually empiric, extrapolated from ulcerative colitis and Crohn’s 
disease. The most typically used drugs are intestinal anti-inflammatory drugs, 
systemic corticosteroids, immunosupressants, biologic therapy and antibiotics 
(Azevedo et al., 2010). The determination of inflammatory activity is a really 
important step for the assessment of disease activity, for choosing an adequate 
therapy, and for contributing to ameliorate the quality of patients’ life (Vilela et al., 
2012).   
Structural abnormalities of the ENS are observed in IBD. In Crohn’s 
Disease are often observed nerve fibre modifications, such as damage, 
hypertrophy, and reactive hyperplasia, and enteric glial cells hyperplasia. Neuronal 
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hypertrophy of the Meissner’s plexus is a common pathological feature of 
ulcerative colitis (Geboes & Collins, 1998). In both diseases, neutrophils and 
lymphocytes (positive for CD4) are the predominant cells in the inflamed mucosa. 
Increases in the number of B cells, macrophages, dendritic cells, plasma cells, 
eosinophils and mast cells are also very common (Roberts-Thomson et al., 2011).  
During an inflammatory insult in the gut, activated leukocytes infiltrate the 
gut wall. Various cells of the mucosal immune system produce a number of pro- 
and anti-inflammatory cytokines, which induce chemotaxis and leukocytes 
proliferation (Neurath, 2014; Schepper et al., 2008). Cytokine levels and cytokine 
expression are similar in Ulcerative colitis and Crohn’s disease. Increases in TNF-
α and IFN-γ are consistent with a Th1 response. The proinflammatory cytokines 
described in these disorders are: TNFα, IL-12, IL-23, and perhaps IL-17 and IFN-γ 
(Roberts-Thomson et al., 2011). The released cytokines also induce morphological 
and functional alterations in the neural apparatus, such as sprouting, neuronal 
necrosis, and neuronal sensitization (Schepper et al., 2008). 
Enteric plasticity comprises a wide range of structural and/or functional 
changes in enteric neurons, glial cells and pacemaker cells of Cajal. As a result of 
adaptive responses to different types of pathophysiological conditions, enteric 
neurons are able to rapidly change their structure, function and chemical 
phenotype in order to maintain homeostasis of gut functions. These plasticity 
changes occur in distinct situations as a consequence of the wide array of 
pathological conditions, ranging from enteric neuropathies to extra-intestinal (e.g. 
Parkinson’s disease) or intestinal diseases (e.g. IBD) (Vassina et al., 2006).  
Even though the period of inflammation may be brief, and the region of 
overt inflammatory damage is circumscribed, its effects on enteric neurons are 
long-lasting and significant changes in organ function are observed in regions that 
are remote from the inflammatory site (Pontell et al., 2009). 
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6.1. Ileitis 
Inflammation of the ileum is called ileitis. It is often caused by Crohn’s 
disease, although it may be caused by other diseases, such as ischemia, 
neoplasms, medication-induced, eosinophilic enteritis, and others. Inflammation of 
the ileum may be acute or in more severe conditions, can be chronic (DiLauro et 
al., 2010).  
 
6.2. Animal models of inflammatory bowel diseases 
A wide variety of animal models of IBD appeared in last years (table 9). IBD 
animal models have proven to be important tools for detecting potential 
therapeutic agents and for investigating the mechanisms involved in its 
pathogenesis (Jurjus et al., 2004; Wirtz and Neurath, 2007a,b). It is considered an 
appropriate animal model, the one that display certain key characteristics: 
 
(1) Morphologic alterations; 
(2) Inflammation; 
(3) Pathophysiology and course similar to human IBD. 
 
 
 
The most widely accepted models are those resulting from the instillation of 
chemical irritants using trinitrobenzene sulfonic acid (TNBS) or dextran sodium 
sulphate (DSS) (Jurjus et al., 2004; Wirtz and Neurath, 2007a,b). In the present 
work, it will be used the chemically-induced model by the instillation of TNBS into 
the lumen of the ileum. So, now I will focus mostly in this model. 
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Table 9: Animal models categories and subcategories of IBD. 
Models (categories) 
 
Subcategories 
 
Gene Knockout (KO) models 
 
(1) Interkeukin-2 KO/IL-2 receptor (R)α KO mice 
(2) IL-10 KO mice models 
(3) T cell receptor (TCR) mutante mice 
(4) TNF-3’ untranslated region (UTR) KO mice 
(5) Trefoil factor-deficient mice 
 
Transgenic mouse and rat models 
(1) IL-7 transgenic mice 
(2) Signal transducer and activating transcription 
(STAT)-4 transgenic mice 
(3) HLA B27 transgenic rats 
 
Spontaneous Colitis models 
(1) C3H/HejBir mice 
(2) SAMP1/Yit mice 
 
Inducible models (Chemically induced) 
(1) Acetic acid 
(2) Iodoacetamide 
(3) Indomethacin 
(4) TNBS 
(5) Oxazolone 
(6) DSS 
(7) Peptidoglycan –polysaccharide (PG-PS) colitis 
 
Adoptive transfer models 
(1) Colitis induced by transfer of heat shock 
protein (hsp) 60-specific CD8 T cells. 
(2) CD45RB transfer model 
 
 
6.2.1. TNBS-Induced ileitis 
Ileitis can be induced by a intraluminal instillation of 2,4,6-
trinitrobenzenesulfonic acid (TNBS) in ethanol, which is required to break the 
mucosal barrier (Martinolle et al., 1997; Wirtz et al., 2007).  
This model is also frequently used to induce colitis. The model in the colon 
seems to be more aggressive than in the ileum. In colon, the chronic phase is 
more easily achieved than in the ileum. This difference may be due to the absence 
of specific ileum resident bacteria found in the colon. The resident flora is needed 
to keep the inflammatory response to TNBS (Moreels et al., 2001). These authors 
sustain that TNBS-induced ileitis in the rat lacks the chronic phase and it is 
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accompanied by functional hypocontractility of longitudinal SMCs during the acute 
inflammatory phase. They claim that the contractility of the longitudinal muscle is 
increased in this phase due to structural changes. Moreels and colleagues (2001) 
concluded that the rat model of TNBS-induced ileitis is characterized by an acute 
transmural inflammation. 
 In 1992, Selve & Wöhrmann published a study where they described a 
model of chronic IBD with TNBS, in the rat ileum. In this work, chronic 
inflammation was only achieved 3 to 4 weeks after starting TNBS application. The 
protocol implicates a previous immunization and a daily application of TNBS (via a 
catheter). This chronic phase in the ileum is characterized by the following 
pathological alterations: 
(1) Intense hyperemia and oedema of the mucosal surface; 
(2) Inflammatory cell infiltration (by lymphocytes and histiocytes in all layers of the 
gut wall; 
(3) Without neutrophil infiltration; 
(4) Transmural granulomatous inflammation of the gut wall.  
In the model of TNBS-induced ileitis used more often, pathological 
alterations are the following: 
(1) Substantial increase in the thickness of the intestinal wall (Tsujikawa et al., 
1999); 
(2) Transmural lesions, that involves Th-1 mediated macrophage expression of 
cytokines, such as TNF-α, IFN-γ and IL-12 (Merritt et al., 2002). 
(3) Mucosal infiltration by mononuclear and polynuclear cells (Martinolle et al., 
1997); 
(4) Increased production of inflammatory mediators such as leukotrienes, 
prostaglandins, platelet-activating factor, SP and NO (Martinolle et al., 1997). 
(5) T lymphocytes and eosinophils are found more close to myenteric ganglia 
(Pontell et al., 2009).  
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(6) Increased neuronal excitability persists for at least 8 weeks (Pontell et al., 
2009).  
(7) Critical changes in spontaneous contractile activity of circular and longitudinal 
muscle (Martinolle et al., 1997). 
TNBS-induced ileitis results in different effects on the electrophysiological 
properties of distinct types of neurons of the small intestine. Dogiel type I neurons 
from inflamed ileum of the guinea-pig had prominent late afterhyperpolarizing 
potentials (AHPs) after a single action potential triggered by an intracellular current 
pulse. Dogiel type II neurons were hyperexcitable compared to the controls 
(Nurgali et al., 2007). It was described also by Stewart and colleagues, in 2003, 
that there is an increase of excitability of intestinal sensory neurons by modulation 
of ion channels (Na+ and K+) in guinea-pig ileitis. The appearance of tetrodotoxin-
resistant sodium currents is increased, while potassium currents are supressed.  
One group has provided insights on the effects of inflammation on cell 
proliferation in the myenteric plexus of the guinea-pig ileum (Bradley et al., 1997). 
These authors concluded that inflammation of the ileum does not stimulate the 
appearance of new myenteric neurons, but stimulates significantly enteric glia cells 
proliferation.They also observed an increase in the number of macrophages and 
T-cells in the tissue. It appears that the increased number of macrophages is not a 
result of cells proliferation, but may be a consequence of the infiltration of resident 
cells. Apparently inflammatory cell infiltrates spare the myenteric ganglia and, for 
this reason, they designate myenteric ganglia as an immune-privileged tissue 
where immunocytes do not penetrate. 
Reports from the literature refer to impairments of the purinergic modulation 
of enteric neurotransmission during chronic inflammation of the mouse ileum (De 
Man et al., 2003).  During an inflammatory insult, the P2Y11 receptor is activated in 
immune cells by low concentrations of ATP, while the P2X7 receptor requires high 
concentrations of ATP (>100 µM) to become activated. The release of 
inflammatory mediators may be accomplished by the activation of P2X3 and P2X7 
receptors (Sanger, 2012). Increases of the P2X3 receptor expression has been 
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observed in human patients with IBD, which implicates a potential role for this 
receptor in enteric dismotility and pain (Yiangou et al., 2001). Increase expression 
of the P2Y6 receptor has also been observed in epithelial cells, thus promoting the 
epithelial release of cytokines and chemokines that indirectly modulate the severity 
of GI inflammation (Grbic et al., 2008; Roberts et al., 2012) 
Nowadays, there is an increasing interest on the involvement of ADO in the 
pathophysiology of intestinal disorders (Antonioli et al., 2008). In addition, an 
active role of extracellular ATP and its receptors in the alterations motivated by 
intestinal inflammation has been suggested (Burnstock, 2008). In IBD models, not 
only morphological but also changes in the excitability and synaptic properties of 
enteric neurons might justify the GI dysfunction. 
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V. GOALS 
 
The main goals of this study were to investigate the following aspects in a model 
of postinflammatory ileitis caused by intraluminal instillation of TNBS in the rat: 
(1) The kinetics of the extracellular catabolism of ATP and ADO formation/ 
inactivation cycle in order to comprehend the overall homeostatic role of the 
purinergic cascade on enteric excitability. 
(2) The action of endogenous adenosine on electrically evoked [3H]ACh 
release from myenteric motor neurons in postinflammatory conditions, using 
selective antagonists to adenosine receptors.  
(3) Changes in the electrically-evoked release of purines (ATP and ADO) and 
ACh in the myenteric plexus of control and TNBS-treated rats.  
(4) Changes in purine releasing sites, their relation to cell type and density 
changes, in order to propose novel therapeutic targets for inflammatory 
intestinal diseases.  
Understanding how ubiquitous neuromodulators, such as adenine 
nucleotides and ADO, affect plastic adaptations of enteric neurotransmission 
during inflammatory insults may prompt for novel therapeutic targets to manage 
inflammatory intestinal diseases.  
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ABSTRACT  
Purinergic signalling is remarkably plastic during GI inflammation. Thus, 
selective drugs targeting the “purinome” may be helpful for inflammatory GI 
diseases. The myenteric neuromuscular transmission of healthy individuals is fine-
tuned controlled by ADO acting on A1 inhibitory and A2A excitatory receptors. Here, 
we investigated the neuromodulatory role of ADO in TNBS-inflamed LM-MP of the 
rat ileum. Seven-day postinflammation ileitis lacks ADO neuromodulation, which 
may contribute to accelerate GI transit. The loss of ADO neuromodulation results 
from deficient accumulation of the nucleoside at the myenteric synapse despite 
that increases in ATP release were observed. Disparity between ATP outflow and 
ADO deficit in postinflammatory ileitis is ascribed to feed-forward inhibition of ecto-
5’-nucleotidase/CD73 by high extracellular ATP and/or ADP. Redistribution of 
NTPDase2, but not of NTPDase3, from ganglion cell bodies to myenteric nerve 
terminals leads to preferential ADP accumulation from released ATP, thus 
contributing to prolong inhibition of muscle-bound ecto-5’-nucleotidase/CD73 and 
to delay ADO formation at the inflamed neuromuscular synapse. On the other 
hand, depression of endogenous ADO accumulation may also occur due to 
enhancement of ADA activity. Both membrane-bound and soluble forms of ecto-5’-
nucleotidase/CD73 and ADA were detected in the inflamed myenteric plexus. 
These findings provide novel therapeutic targets for inflammatory gut motility 
disorders.  
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plexus; purinergic receptors; soluble enzymes. 
 
INTRODUCTION 
The ENS undergoes a series of adaptive responses to different pathological 
conditions (e.g. inflammatory and/or ischemic insults) (Sharkey et al., 2001; 
Vassina et al., 2006). For instance, enteric neurons rapidly change their structure, 
function or chemical phenotype in order to maintain gut homeostasis. Even if the 
inflammatory insult is brief and the damage circumscribed, its repercussion on 
enteric neurons may be long-lasting leading to significant changes in intestinal 
function, which can be observed in remote regions from the inflammation site. The 
postinflammatory status is frequently accompanied by substantial increases in 
enteric motility (Pontell et al., 2009). 
Inflammation of the GI tract causes marked changes in the release of 
purines leading to subsequent adaptive modifications of purinoceptors expression 
and/or function (reviewed in Roberts et al., 2012). The underlying mechanisms of 
disturbed purinergic modulation are not completely understood, in part because 
the study of purinoceptors may be hampered by the presence of distinct nucleotide 
release sites and cell surface enzymes that rapidly break down extracellular 
nucleotides into nucleosides (Kukulski et al., 2011). In healthy individuals, ATP is 
released predominantly from stimulated enteric neurons (White & Leslie, 1982), 
but its release from non-neuronal cells (e.g. smooth muscle fibres, ICC) might also 
occur (Nitahara et al., 1995). Four members of the ecto-nucleoside triphosphate 
diphosphohydrolase (E-NTPDase) family, namely NTPDase1, NTPDase2, 
NTPDase3 and NTPDase8, and two members of the ecto-nucleotide 
pyrophosphatases/phosphodiesterases (E-NPP) family, NPP1 and NPP3, are 
located at the plasma membrane and hydrolyse extracellular nucleotides (Kukulski 
et al., 2011; Kukulski et al., 2005; Stefan et al., 2005). The relative contribution of 
distinct ecto-enzymes to the modulation of purinergic signalling depends on 
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differential tissue and cell distribution, regulation of expression, targeting to 
specific membrane domains, but also on substrate preference and availability.  
Regarding the substrate preference, NTPDase1 (CD39 or apyrase) 
dephosphorylates ATP directly into AMP, with minimal accumulation of ADP. 
NTPDase2 (ATPase) is a preferential nucleoside triphosphatase hydrolysing ADP 
10 to 15 times less efficiently than ATP, leading to minimal AMP accumulation 
(Kukulski et al., 2005). NTPDase3 and NTPDase8 are functional intermediates 
between NTPDase1 and NTPDase2 (Kukulski et al., 2005). Because of their 
involvement in physiological processes, namely blood clotting, vascular 
inflammation, immune reactions and certain types of cancer, NTPDases are now 
considered as potential drug targets (Gendron et al., 2002). As for NPP1 and 
NPP3, they release nucleoside 5’-monophosphate from a variety of nucleotides, 
but intriguingly, their phosphorylated product (e.g. AMP) bind to NPPs with a 
higher affinity than substrates do, and thus inhibit catalysis (Stefan et al., 2009). 
Finally, AMP is hydrolysed to ADO and inorganic phosphate by ecto-5’-
nucleotidase (CD73), which is concentrated in the myenteric smooth muscle cell 
layer (Nitahara et al., 1995). Interestingly, ecto-5’-nucleotidase (CD73) may be 
cleaved from cell membranes through hydrolysis of the GPI anchor by 
phosphatidylinositol-specific phospholipases or by proteolysis while retaining its 
catalytic activity in the soluble form (Sträter et al., 2006). 
At the myenteric neuromuscular synapse, ATP is primarily metabolized into 
AMP, which is then dephosphorylated into ADO; alternative conversion of ATP into 
ADP is more relevant at high ATP concentrations (Duarte-Araújo et al., 2009). 
Thus, gradients of ATP and its breakdown products (ADP and ADO) may provide 
fine tuning control of peristaltic motor performance in the gut during stressful 
situations, such as sustained neuronal activity, ischemia and inflammation, when 
extracellular ATP reaches high levels (see Milusheva et al., 1990; De Man et al., 
2003). ATP transiently facilitates ACh release from non-stimulated nerve terminals 
via prejunctional P2X (probably P2X2) receptors. Hydrolysis of ATP directly into 
AMP and subsequent formation of ADO activates inhibitory A1 receptors in smooth 
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muscle fibres (Nicholls et al., 1996) and in ganglionic cell bodies of myenteric 
neurons (Vieira et al., 2011), where it downmodulates the release of excitatory 
neurotransmitters, such as SP (Moneta et al., 1997)  and ACh (Duarte-Araújo et 
al., 2004). Besides the well characterized inhibitory A1 receptors, myenteric nerve 
terminals are endowed with prejunctional A2A receptors mediating facilitation of 
ACh release (Duarte-Araújo et al., 2004; Correia-de-Sá et al., 2006; Vieira et al., 
2011).  
Previous findings from our group demonstrated that the ecto-nucleotidase 
pathway contributes only partially to the total interstitial ADO concentration in the 
myenteric plexus (Correia-de-Sá et al., 2006). ADO released as such from either 
neuronal or non-neuronal cells seems to be the main source of endogenous ADO 
in the ENS (Duarte-Araújo et al., 2004). This release is sought to be mediated by 
facilitated diffusion via nucleoside transporters, which can be regulated by 
endogenous signaling molecules, such as ACh via muscarinic M3 receptors 
(Correia-de-Sá et al., 2006; Vieira et al., 2011). On the other hand, we 
demonstrated the extracellular deamination by ADA represents the most effective 
mechanism regulating synaptic ADO levels in the LM-MP of the ileum from healthy 
animals (Duarte-Araújo et al., 2004; Correia-de-Sá et al., 2006). ADA is a 
ubiquitous purine metabolic enzyme localized on the cell surface (ecto-ADA) 
(Pettengil et al., 2013). Upon proteolytic cleavage from cell membranes, soluble 
forms of ADA (exo-ADA) retain their catalytic activity and may be found in 
interstitial fluids (Franco et al., 1997). We detected a relatively high ADA activity 
(~0.6 U/ml) in superfusates collected after stimulating LM-MP preparations, which 
is in keeping with the hypothesis that “ADA secretion” may restrict endogenous 
ADO actions to the synaptic region near the release / production sites (Correia-de-
Sá et al., 2006). ADA secretion increases in various diseases and may be 
originated from monocyte/macrophage lineages, thus reflecting the involvement of 
the cellular immune system. De Man and colleagues (2003) reported that chronic 
intestinal inflammation enhanced the enteric contractile activity in part due to an 
impairment of purinergic modulation of cholinergic nerve activity (De Man et al., 
2003).     
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Because, adenine nucleotides and nucleosides (and ADA itself) may be 
released from activated inflammatory cells (Marquard et al., 1984), as well as from 
neighbouring neuronal and non-neuronal enteric cells (Stead et al., 1989; Bogers 
et al., 2000), there is an increasing interest in the neuromodulatory effects exert by 
ADO during inflammatory insults. The therapeutic potential of ADO-related 
compounds for controlling intestinal motility and inflammation (De Man et al., 2003; 
Antonioli et al., 2008), prompted us to investigate the kinetics of ADO formation/ 
inactivation cycle in order to understand the overall homeostatic role of the 
nucleoside on enteric excitability in postinflammatory ileitis caused by intraluminal 
instillation of TNBS in the rat. 
 
MATERIAL AND METHODS  
Animals 
Rats of either sex (Wistar, ~200 g) (Charles River, Barcelona, Spain) were 
kept at a constant temperature (21) and a regular light (06.30-19.30 h)-dark 
(19.30-06.30 h) cycle, with food and water) and a regular light (06.30-19.30 h)-
dark (19.30-06.30 h) cycle, with food and water ad libitum. All studies involving 
animal experiments are reported in agreement with ARRIVE guidelines. Animal 
handling and experiments were in accordance with the guidelines prepared by 
Committee on Care and Use of Laboratory Animal Resources (National Research 
Council, USA) and followed the European Communities Council Directive 
(86/609/EEC).  
TNBS-induced intestinal inflammation model 
Intestinal inflammation was produced by the instillation of 2,4,6-
trinitrobenzenesulfonic acid (TNBS) into the lumen of the rat ileum. After a fasting 
period of 4-8 hours with free access to drinking water, rats undergo median 
laparotomy under anaesthesia with an association of medetomidine (10 mg/Kg) 
and ketamine (75 mg/Kg) given subcutaneously. At the end of the procedure 
animals were retrieved with atipamezole (10 mg/Kg). The terminal ileal loop was 
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gently exteriorized, and TNBS (40 mM) was injected through the enteric wall into 
the lumen of the ileum, 10 centimeters proximal to the ileocolonic junction. 
Controls received 1 ml of 0.9% saline. Sixty minutes after surgery, the rats were 
allowed to eat and drink ad libitum. After surgery, pain was controlled with 
tramadol hydrochloride (10 mg/Kg). To have a control of time course of body 
weight loss and recovery after injection of TNBS, rats were weighed prior to TNBS 
administration and daily following surgery. Animals with intestinal inflammation 
(TNBS) transiently lose weight for three to four days after surgery, and regain 
weight thereafter. Seven days after surgery, animals were sacrificed following an 
overnight fasting period. 
Histological findings and gastrointestinal motility 
The postinflammatory phase of TNBS-induced ileitis was characterized in 
haematoxylin-eosin stained sections using Pontell and Jergens criteria, which is 
based in the loss of normal tissue architecture, epithelial damage and infiltration of 
inflammatory cells (Pontell et al., 2009; Jergens, 1999; Engel et al., 2009; Wirtz & 
Neurath, 2007). Evaluation of GI motility was performed in vivo by oral 
administration of a gavage containing the methylene blue dye. Dye progression in 
the GI tract was evaluated after 30 minutes, both in control and TNBS-injected 
animals: the total length of the small intestine was used to normalize data. 
3H-Acetylcholine release experiments 
Sections of the rat ileum not including the terminal five centimetres were 
used. The longitudinal muscle strip with the myenteric plexus attached was 
separated from the underlying circular muscle according to the method of Paton 
and Vizi (1969). This preparation is highly enriched in cholinergic neurons, mainly 
excitatory neurons projecting to the longitudinal muscle (25%) that receive inputs 
from intrinsic primary afferents (26%) and from ascending and descending 
pathways (17%) (Costa et al., 1996). 
The procedures used for labelling the preparations and measuring evoked 
[3H]-Acetylcholine ([3H]-ACh) release were previously described (Duarte-Araújo et 
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al., 2004; Duarte-Araújo et al., 2009; Correia-de-Sá et al., 2006; Vieira et al., 2011) 
and used with minor modifications. LM-MP strips were mounted in 3 ml capacity 
vertical perfusion chambers heated at 37 C. After a 30 min equilibration period, 
myenteric neurons were labelled for 40 min with 1 µM [3H]-choline (specific activity 
2.5 µCi nmol-1) under EFS (1 Hz-frequency, 1 ms pulse width). Following loading, 
the washout Tyrode’s solution contained hemicholinium-3 (10 µM) to prevent 
choline uptake. After a 60 min period of washout, bath samples (3 ml) were 
automatically collected every 3 min using a fraction collector (Gilson, FC203B, 
France). Tritium content of the samples was measured by liquid scintillation 
spectrometry (% counting efficiency: 40±2%).  
Test drugs were added 15 min before S2. The change in the ratio between 
the evoked [3H]-ACh release during the two stimulation periods (S2/S1) relative to 
that observed in control situations (in the absence of test drugs) was taken as a 
measure of the effect of the tested drugs. None of the drugs changed significantly 
(P>0.05) basal tritium outflow. 
Kinetic experiments of the extracellular catabolism of purines and HPLC 
analysis 
For the kinetic experiments of the extracellular catabolism of adenine 
nucleotides and ADO, strips from the longitudinal muscle with the myenteric 
plexus attached (LM-MP) were mounted in a 2 ml organ bath. All experiments 
were performed at 37C. Preparations were superfused with gassed (95% O2 and 
5% CO2) Tyrode’s solution containing (mM): NaCl 137, KCl 2.7, CaCl2 1.8, MgCl2 
1, NaH2PO4 0.4, NaHCO3 11.9 and glucose 11.2. After a 30 min equilibration 
period, the preparations we incubated for 45 min with Tyrode’s solution to 
eliminate endogenous interfering compounds. Following a washout period of 10 
min, the preparations were then incubated with 30 µM of ATP, ADP, AMP or ADO 
(zero time). Samples of 75 µl were collected from the organ bath at different times 
up to 45 min for HPLC (with UV detection) analysis of the variation of substrate 
disappearance and product formation (Duarte-Araújo et al., 2004; Duarte-Araújo et 
al., 2009; Correia-de-Sá et al., 2006; see also Pinheiro et al., 2013). The 
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concentrations of the substrate and products were plotted as a function of time 
(progress curves). In some experiments, we measured unbound 5’-nucleotidase 
and ADA activities in the fluid retained in the bath after removing the LM-MP 
preparation. We followed a similar experimental protocol to that used for studying 
the kinetics of the extracellular catabolism of adenine nucleotides and ADO in the 
presence of the preparations. 
Release of ATP and adenine nucleosides (adenosine plus inosine)  
Experiments were performed using an automated perfusion system for 
sample collecting for given time periods, therefore improving the efficacy of HPLC 
(with diode array detection) and bioluminescence analysis. After the 30 min 
equilibration period, the preparations were incubated with 1.8 ml gassed Tyrode’s 
solution, which was automatically changed every 15 min by emptying and refilling 
the organ bath with the solution in use. The preparations were electrically 
stimulated once, 15 min after starting sample collection (zero time), using 3000 
square wave pulses of 1 ms duration delivered at a 5 Hz frequency. In these 
experiments, only the sample collected before stimulus application and the two 
samples collected after stimulation, were retained for analysis. Bath aliquots (50-
250 µL) were frozen in liquid nitrogen immediately after collection, stored at -20C 
(the enzymes are stable for at least 4 weeks) and analysed within 1 week of 
collection by HPLC with diode array detection (Finigan Thermo Fisher Scientific 
System LC/DAD, equipped with an Accela Pump coupled to an Accela 
Autosample, a diode array detector and an Accela PDA running the X-Calibur 
software chromatography manager). Chromatographic separation was carried out 
through a Hypersil GOLD C18 column (5 µM, 2.1 mm x 150 mm) equipped with a 
guard column (5 µm, 2.1 mm x 1 mm) using an elution gradient composed of 
ammonium acetate (5 mM, with a pH of 6 adjusted with acetic acid) and methanol. 
During the procedure the flow rate was set at 200 µl/min and the column 
temperature was maintained at 20°C. The autosampler was set at 4°C and 50 µl of 
standard or sample solution was injected, in duplicate, for each HPLC analysis. In 
order to obtain chromatograms and quantitative analysis with maximal sensibility, 
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the diode array detection wavelength was set at 259 nm for ADO and 248 nm for 
INO. In parallel, the ATP content of the same samples was evaluated with the 
luciferin-luciferase ATP bioluminescence assay kit HS II (Roche Applied Science, 
Indianapolis, Indiana) (see e.g. Pinheiro et al., 2013;  Timóteo et al., 2014). 
Luminescence was determined using a multi detection microplate reader (Synergy 
HT, BioTek Instruments). Stimulation-evoked release of adenine nucleotides and 
nucleosides was calculated by subtracting the basal release, measured in the 
sample collected before stimulation, from the total release of adenine nucleotides 
and nucleosides determined after stimulus application.  
Immunofluorescence staining and confocal microscopy observation 
LM-MP fragments were isolated from the rat ileum as previously described. 
The LM-MP fragments were stretched to all directions and pinned onto Petri 
dishes coated with Sylgard®. The tissues, then, were fixed in PLP solution 
(paraformaldehyde 2%, lysine 0.075 M, sodium phosphate 0.037 M, sodium 
periodate 0.01 M) for 16 h at 4 °C. Following fixation, the preparations were 
washed three times for 10 min each using 0.1 M phosphate buffer. At the end of 
the washout period, tissues were cryoprotected during 16 h with a solution 
containing anhydrous glycerol 20% and phosphate buffer 0.1 M at 4 °C and, then, 
stored at -20 °C for further processing. Once defrosted, tissue fragments were 
washed with tamponated phosphate saline buffer (PBS) and incubated with a 
blocking buffer, consisting in foetal bovine serum 10%, bovine serum albumin 1%, 
Triton X-100 0.3% in PBS, for 2 h; washout was facilitated by constant stirring of 
the samples. After blocking and permeabilization, samples were incubated with  
selected primary antibodies (see Table 10) diluted in the incubation buffer (foetal 
bovine serum 5%, serum albumin 1%, Triton X-100 0.3% in PBS), at 4 °C, for 48 
h. For double immunostaining, antibodies were combined before application to 
tissue samples. Following the washout of primary antibodies with PBS 
supplemented with Triton-X 0.3% (3 cycles of 10 min), tissue samples were 
incubated with species-specific secondary antibodies in the dark for two hours, at 
room temperature. Finally, tissue samples were mounted on optical-quality glass 
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slides using VectaShield as mounting media (VectorLabs) and stored at 4 °C. 
Observations were performed and analyzed with a laser-scanning confocal 
microscope (Olympus FluoView, FV1000, Tokyo, Japan). 
Table 10: Primary and secondary antibodies used in immunohistochemistry experiments. 
ANTIGEN CODE SPECIES DILUTION SUPPLIER 
 
Primary antibodies 
    
Adenosine receptor A
1
 AB1587P Rabbit (rb) 1:50 Chemicon 
Adenosine receptor A
2A
 A2aR21-A Rabbit (rb) 1:150 Alpha Diagnostics 
NTPDase1 rN1-6LI4 Rabbit (rb) 1:1000 http://ectonucleotidases-
ab.com 
NTPDase2 rN2-6L Rabbit (rb) 1:400 http://ectonucleotidases-
ab.com 
NTPDase3 rN3-1LI5 Rabbit (rb)  1:150 http://ectonucleotidases-
ab.com 
NTPDase8 rN8-8CI5 Guinea-pig 
(gp) 
1:600 http://ectonucleotidases-
ab.com 
Ecto-5'-nucleotidase rNu-9LI5 Rabbit (rb) 1:1000 http://ectonucleotidases-
ab.com 
ADA sc-25747 Rabbit (rb) 1:50 Santa Cruz 
 
Secondary antibodies 
        
Alexa Fluor 488 anti-rb  A-21206 Donkey 1:1000 Molecular probes 
TRITC 568 anti-gp 706-025-148  Donkey 1:150 Molecular probes 
 
Antibody production 
All primary antibodies used in this study have previously been validated 
(Enjyoji et al., 1999; Heine et al., 2001; MartínSantué et al., 2009; Bartel et al., 
2006; Fausther et al.,  2007): rabbit rN1-6L to rat NTPDase 1, rabbit rN2-6L to rat 
NTPDase2, rabbit rN3-1L to rat NTPDase3, guinea pig rN8-8C to rat NTPDase8, 
rabbit rNU-9L and rabbit rNU-4L to rat ecto-5′-nucleotidase/CD73. Genetic 
immunization protocol was carried out with plasmids (pcDNA3.1) encoding each 
protein, in New Zealand rabbits for antibodies against rat NTPDase1, rat 
NTPDase2, rat NTPDase3, rat ecto-5’-nucleotidase and Hartley guinea pigs for rat 
NTPDase8 antibodies. All procedures were approved by the Canadian Council on 
Animal Care and the Université Laval Animal Welfare Committee. 
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Materials and solutions 
Adenosine 5’-triphosphate (ATP), adenosine 5′-diphosphate (ADP), 
adenosine 5′-monophosphate (AMP), ADO, INO, hypoxanthine (HX); 2,4,6-
trinitrobenzenesulphonic acid (TNBS); choline chloride, paraformaldehyde (prills), 
lysine, sodium periodate, anhydrous glycerol, fetal bovine serum (Sigma, St Louis, 
MO, USA); serum albumin, Triton X-100, metanol, potassium dihydrogen 
phosphate (KH2PO4) (Merck, Darmstadt, Germany); dipyridamole (Boehringer 
Ingelheim, Germany); 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) (Research 
Biochemicals, Natick, MA, USA); mibefradil dihydrochloride, tetrodotoxin (TTX), (4-
(2-[7-amino-2-(2-furyl{1,2,4}-triazolo{2,3-a{1,3,5}triazin-5-yl-aminoethyl) phenol 
(ZM 241385) (Tocris Cookson Inc., UK); [methyl-3H]-choline chloride (ethanol 
solution, 80 Ci mmol-1) (Amersham, UK); Pic®A reagent (Waters corporation, 
Milford, USA); ATP bioluminescence assay kit HS II (Roche Applied Science, 
Indianapolis, Indiana); medetomidine hydrochloride (Domitor®, Pfizer Animal 
Health); atipamezole hydrochloride (Antisedan®, Orion, Espoo, Finland); ketamine 
hydrochloride (Imalgene®, Merial, Lyon, France); Sodium chloride 0,9%, tramadol 
hydrochloride (Labesfal, Santiago de Besteiros, Portugal).  
All drugs were prepared in distilled water. All stock solutions were stored as 
frozen aliquots at -20°C. Dilutions of these stock solutions were made daily and 
appropriate solvent controls were done. No statistically significant differences 
between control experiments, made in the absence or in the presence of the 
solvents at the maximal concentrations used (0.5 % v/ v), were observed. The pH 
of the perfusion solution did not change by the addition of the drugs in the 
maximum concentrations applied to the preparations.   
Presentation of data and statistical analysis 
The values are expressed as mean ± SEM, with n indicating the number of 
animals used for a particular set of experiments. Statistical analysis of data was 
carried out using paired or unpaired Student’s t-test or one-way analysis of 
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variance (ANOVA) followed by Dunnett’s modified t-test. P<0.05 represents 
significant differences. 
RESULTS 
Postinflammatory ileitis led to increases in gastrointestinal transit in the rat  
Histology sections of the ileum of TNBS-injected rats were characterized 
using the criteria proposed by Pontell and Jergens (see Materials and Methods) 
(Pontell et al., 2009; Jergens, 1999). One week after the TNBS treatment we 
observed a proliferative regeneration of the mucosal integrity. Postinflammatory 
infiltrates consisting mainly with eosinophils, lymphocytes and macrophages were 
scarcely seen, but when present extended to the submucosa, enteric plexuses 
and muscular layers. At that time, the total ileal wall thickness of TNBS-treated 
rats was increased due to increase in thickness of both mucosal and muscular 
layers.  
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Figure 14: Progression of methylene blue dye gavage along the GI tract during 30 minutes in 
control and TNBS-injected animals. The total length of the small intestine was used to normalize 
data. The vertical bars represent SEM. *P<0.05 (unpaired Student’s t-test) represents significant 
differences as compared to the control situation. 
 
The GI motility was evaluated prior to sacrifice of the animals. This was 
done by measuring the progression of methylene blue dye gavage during 30 min. 
Figure 14 shows that methylene blue dye progression was significantly (P<0.05) 
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faster in TNBS-injected animals than in control animals, indicating that GI 
propulsion is increased in postinflammatory ileitis. Although TNBS-ileitis in the rat 
lacks a typical chronic phase, the postinflammatory phase is characterized by 
increases in motility (see e.g. Moreels et al., 2001). 
Adenosine neuromodulation is impaired in postinflammation ileitis 
Previous reports suggested that the purinergic control of cholinergic nerve 
activity may be significantly impaired during chronic intestinal inflammation, both in 
the colon of rabbits and guinea-pigs (Deporotere et al., 2002; Strong et al., 2010), 
and in mice ileum (De Man et al., 2003). Despite the differences in the 
mechanisms used to produce intestinal inflammation among these groups, all are 
unanimous on the indication for the need of more studies in order to investigate 
the underlying pathways responsible for disturbed purinergic neuromodulation. 
Hence, we focused our attention on the net tonic action of endogenous ADO on 
electrically-evoked [3H]-ACh release from myenteric motoneurons seven days after 
an inflammatory insult to the rat ileum. In preparations from healthy rats, the A1 
receptor antagonist, DPCPX (10 nM) increased the release of [3H]-ACh by 27±4% 
(n=4) (Figure 15A). Conversely, selective blockade of adenosine A2A receptors 
with ZM 241385 (50 nM) significantly decreased the evoked tritium outflow by 
37±10% (n=6). The results indicate that endogenous adenosine exerts a dual role 
on evoked [3H]-ACh release via the activation of inhibitory A1 and excitatory A2A 
receptors in the rat ileum (cf. Duarte-Araújo et al., 2004; Correia-de-Sá et al., 
2006). However, when similar experiments were conducted in the LM-MP seven 
days after ileal inflammation none of the adenosine receptor antagonists caused 
any measurable change on evoked transmitter release (Figure 15A). These results 
indicate that ADO modulation of cholinergic nerve activity is severely impaired in 
postinflammation ileitis, as previously suggested using both myographic 
recordings and electrophysiology methods (see above).  
Several authors hypothesized that purinoceptors downregulation in the ENS 
can occur during prolonged contact with purines. This was predicted since purines, 
such as ATP and ADO, can be released from activated inflammatory cells 
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(Marquardt et al., 1984) in the vicinity of myenteric neurons (Bogers et al., 2000). 
To elucidate this contention, we performed immunolocalization studies by confocal 
microscopy to assess changes in the expression and localization of both A1 and 
A2A adenosine receptors that could contribute to explain the lack of endogenous 
ADO neuromodulatory tonus in the inflamed ileum. The immunoreactivity against 
A1 receptors is located predominantly on cell bodies of myenteric neurons of the 
ileum in control as well as in TNBS-injected rats (Figure 15B). The LM fibers also 
stain positively with the adenosine A1 receptor antibody (data not shown). Yet, no 
significant differences were observed between control and inflamed preparations 
(Figure 15B).  
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Figure 15: (A) Actions of selective adenosine A1 and A2A receptor antagonists on [
3
H]-ACh release 
from myenteric motoneurons stimulated electrically (5 Hz, 200 pulses, 1 ms duration). DPCPX (10 
nM, A1 receptor antagonist) and ZM 241385 (50 nM, A2A receptor antagonist) were added to the 
incubation media before the second period of stimulation (S2) and were present throughout the 
assay. The ordinates are changes in S2/S1 ratios compared to the S2/S1 ratio obtained in control 
conditions, i.e. with no drugs added. The data are means ± SEM of three to five individual 
experiments. *P<0.05 (one-way ANOVA followed by Dunnett’s modified t-test) represent significant 
differences when compared to the situation where no drugs were added (dashed line). (B) 
Confocal images of whole-mount preparations of LM-MP preparations of the ileum from control and 
TNBS-injected rats. Adenosine A1 receptor immunoreactivity is predominantly present in ganglion 
neuronal cell bodies in control and TNBS-injected preparations. Adenosine A2A receptor 
imunoreactivity is mainly present in nerve bundles and axon terminals of myenteric neurons 
(triangles). In inflamed preparations, adenosine A2A receptor staining is also observed in few 
mononuclear cells infiltrating the neuromuscular layer (arrows). 
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Likewise, the A2A receptor immunoreactivity, which is more evident on 
myenteric nerve terminals, also did not significantly differ among control and 
inflamed tissues (Figure 15B). Interestingly, we observed staining against the A2A 
receptor in few mononuclear cells (probably lymphocytes) infiltrating the 
neuromuscular level, which might be responsible for the immunosuppressant 
effect of A2A receptors activation in experimental ileitis (Odashima et al., 2005; 
Cavalcante et al., 2006). Mononuclear infiltrates containing A2A-positive immune 
cells may contribute to the increased mRNA expression of this receptor found in 
chronic inflamed intestinal tissues (Antonioli et al., 2011). Although we cannot 
exclude at this stage differences in the intracellular signaling pathway triggered by 
activation of the two high affinity adenosine receptor subtypes, A1 and A2A, in the 
LM-MP of the rat ileum, our data suggest that receptors expression is fairly 
conserved in the ileum seven days following an inflammatory insult and, 
apparently, does not underscore the lack of ADO neuromodulation tonus in this 
condition (see e.g., De Man et al., 2003; Antonioli et al., 2011; Antonioli et al., 
2013).      
Postinflammatory ileum releases more ATP, which is not followed by 
adenosine formation  
It has been hypothesized, but not yet proven, that disruption in ATP release 
and/or breakdown as most likely explanations for the suppression of purinergic 
neuromuscular transmission in inflamed regions of the distal colon (Strong et al., 
2010). It is possible that inflammatory mediators affect mitochondrial function, and 
therefore ATP synthesis, in the ulcerated region of the chronic inflamed intestine. 
Another possibility is that there may be increased expression of ectonucleotidases, 
which are responsible for the breakdown of ATP (Duarte-Araújo et al., 2009; 
Neshat et al., 2009), as has been demonstrated in the purinergic sympathetic 
regulation of submucosal blood vessels (Neshat et al., 2009). Here, we measured 
the extracellular accumulation of ATP (by bioluminescence) in parallel with ADO 
plus INO content (by HPLC with diode array detection) in samples collected 
immediately before and after electrical stimulation of LM-MP preparations of the 
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ileum of both control and TNBS-injected rats. Figure 16 shows that, in healthy 
animals, stimulation of the LM-MP at a frequency of 5 Hz (3000 pulses of 1 ms 
duration) yield increased amounts of ATP in the incubation fluid, which was 
followed by even higher extracellular accumulation of adenine nucleosides, 
consisting mostly of ADO and INO. This pattern was totally reversed seven days 
after inflammation of the rat ileum. Basal levels of ATP significantly (P<0.05) 
increase (Figure 16A), whereas the baseline of endogenous ADO plus INO 
decreased (Figure 16B), in the fluid collected from TNBS-treated LM-MP of the rat 
ileum as compared to control tissues. Although the amount of ATP and adenine 
nucleosides increased from baseline following electric stimulation of LM-MP 
preparations in both animal groups, released ATP levels reached higher values in 
inflamed preparations than in controls (Figure 16A), but the opposite was 
observed regarding the content of ADO plus INO (Figure 16B).  
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Figure 16: Effect of EFS on extracellular accumulation of purines in the LM-MP of control and 
inflamed rat ileum. The preparations were incubated with Tyrode’s solution for 15 min and then 
subject to EFS (5 Hz frequency, 3000 pulses of 1ms duration). Samples collected from the 
incubation media were analysed by HPLC to separate and quantify purine nucleosides; ATP 
outflow was assessed using the luciferin-luciferase bioluminescence assay. Illustrated are ATP (A) 
and purine nucleosides (B) content of bath samples collected immediately before (Pre-EFS) and 
after (Post-EFS) LM-MP stimulation expressed in pmol/mg of tissue. Data are means ± SEM of an 
n number of individual experiments. *P <0.05 (one-way ANOVA followed by Dunnett’s modified t 
test) represent significant differences as compared to control animals. 
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These results indicate that, in contrast to previous hypothesis, the amount 
of ATP released in basal conditions and following electric stimulation of TNBS-
treated ileal preparations was significantly higher than in control tissues, although 
one could not discard at this stage that ATP accumulation could also result from a 
decrease in the extracellular breakdown of the nucleotide (see below). Despite this 
increase in ATP accumulation, the content of ADO plus INO in the superfusates 
from TNBS-treated animals was severely decreased, which might contribute to 
explain the lack of endogenous ADO neuromodulatory tonus in postinflammatory 
ileitis (Figure 15; see also Antonioli et al., 2011).   
In healthy tissue, but not in the ileum following the inflammatory insult, stimulus-
evoked ADO release was partially dependent on neuronal activity. This was 
evidenced because pretreatment of the preparations with tetrodotoxin (TTX), 
applied in a concentration (1 µM) that essentially abolished evoked [3H]-ACh 
release, reduced by about 50% adenine nucleosides outflow from control tissues 
with almost no effect in TNBS-treated preparations (Figure 17). These findings 
indicate that barely half of the extracellular ADO released from stimulated LM-MP 
preparations from healthy rats comes from TTX-sensitive neuronal cells, but this 
source may be severely affected in the postinflammation phase of TNBS-ileitis due 
to neuronal dysfunction, as demonstrated by several authors. Under conditions 
leading to myenteric neuronal dysfunction such as chronic inflammation, ATP 
release may be shifted from a neuronal origin towards other cell sources (e.g. 
smooth muscle fibers, glial cells, ICC, infiltrating immune cells) (see e.g., Nitahara 
et al., 1995). As a matter of fact, evoked ATP release from TTX-resistant non-
neuronal sources increased (P<0.05) above baseline from 7.4±0.6 fmol/mg (n=4) 
in control animals to 13.2±0.2 fmol/mg (n=4) in TNBS-treated preparations.  
Smaller amounts of adenosine released from inflamed ileum originates from 
activated pacemaker interstitial cells of Cajal via equilibrative nucleoside 
transporters  
Considering that ADO may also be released as such from non-neuronal 
cells at the tripartite myenteric synapse, we tested whether stimulus-evoked 
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smooth muscle contraction and activation of pacemaker ICCs affected the outflow 
of adenine nucleosides from the ileum of control and TNBS-injected rats. Blockade 
of smooth muscle contractions with the Cav1 (L-type) voltage-sensitive calcium 
channel inhibitor, nifedipine (1-5 µM), did not affect the accumulation of adenine 
nucleosides in bath samples collected immediately before and after electric field 
stimulation to the LM-MP from healthy animals (Correia-de-Sá et al., 2006). 
However, selective blockade of Cav3 (T-type) calcium channels located 
predominantly in ICCs with mibefradil (3 µM) significantly (P<0.05) depressed the 
outflow of adenine nucleosides from both control and TNBS-treated preparations 
(Figure 17). The results indicate that ICCs are the main source of ADO released 
from stimulated LM-MP of the ileum in the postinflammation phase. Data also 
indicate that ICCs cooperate with myenteric neurons to increase extracellular ADO 
in preparations from healthy rats. 
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Figure 17: Influence of tetrodotoxin (TTX, 1 µM), mibefradil (3 µM) and dipyridamol (0.5 µM) on 
stimulation-evoked release of purine nucleosides (ADO plus INO) from the LM-MP of control and 
TNBS-injected rat ileum. Drugs were in contact with the preparations for at least 15 min before 
stimulus application (5 Hz frequency, 3000 pulses of 1 ms duration). Samples collected from the 
incubation media were analysed by HPLC with diode array detection. Illustrated is the purine 
nucleosides content of bath samples collected immediately before (Pre-EFS) and after (Post-EFS) 
stimulation of LM-MP expressed in pmol/mg of tissue. Data represent the means ± SEM of an n 
number of individual experiments. *P <0.05 (one-way ANOVA followed by Dunnett’s modified t test) 
represent significant differences from the evoked amount of purine nucleosides detected in control 
conditions where no drugs were added to the preparations. 
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Given that ADO is neither stored nor released as a classical 
neurotransmitter and previous findings from our laboratory demonstrated that the 
ecto-nucleotidase pathway contributes only partially to the total interstitial ADO 
concentration in the myenteric plexus (Correia-de-Sá et al., 2006), we tested the 
involvement of ENTs to extracellular ADO released from tissues isolated from 
control and TNBS-injected rats. The nucleoside transport inhibitor, dipyridamole 
(0.5 µM), decreased proportionally and by a similar magnitude to that obtained 
with mibefradil (3 µM) the outflow of adenine nucleosides from both control and 
inflamed tissues (Figure 17). Thus, it is likely that extracellular ADO detected in 
ileum following an inflammatory insult originates predominantly from activated 
ICCs via ENTs. 
 
Another potential source of endogenous ADO in the rat ileum may be 
adenosine 3',5'-cyclic monophosphate (cAMP) extruded from activated cells, 
which may be converted to AMP and then to ADO by ecto-phosphodiesterase and 
ecto-5'nucleotidase/CD73, respectively (Giron et al., 2008). Despite the existence 
of a functional extracellular cAMP-adenosine pathway in the rat ileum, we were 
unable to detect any measurable amounts of cAMP by HPLC analysis (with diode 
array detection) of the samples used to quantify adenine nucleosides, even though 
we could identify a chromatographic peak corresponding to cAMP spectrum but 
with a higher retention time than ADO using a 30 µM external standard (data not 
shown). These results suggest that, under the present experimental conditions, 
the cAMP-adenosine pathway does not account significantly for endogenous ADO 
formation in the LM-MP of the rat ileum.      
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The kinetics of the extracellular catabolism of adenine nucleotides (ATP and 
ADP) was not different in control and postinflammation preparations of the 
rat ileum  
Despite the observation that the ileum in the postinflammation phase 
releases more ATP than control preparations, we observed a decrease in the 
extracellular ADO content in samples collected both under basal and stimulated 
conditions. It is, therefore, possible that disruption of ATP catabolism into ADO via 
ecto-NTPDases may occur in the inflamed LM-MP of the ileum. Figure 18 
illustrates the time course of the extracellular catabolism of ATP and ADP in the 
LM-MP of the rat ileum from control and TNBS-treated rats. No significant 
differences (P>0.05) were observed among the half-degradation times of ATP (30 
µM) and ADP (30 µM) in control and TNBS-treated preparations, i.e. the half 
degradation time of the two adenine nucleotides ranged from 6 to 7 min 
independently of the experimental condition. 
 
 
Extracellular ATP (30 µM) was metabolized into ADP, AMP, ADO, INO and 
HX, whose concentrations increased with time. Higher amounts of AMP as 
compared to ADP were detected in the bath at all time points following ATP (30 
µM) application (Figure 18A). ADP (30 µM) catabolism led to AMP, ADO, INO and 
HX (Figure 18B). Interestingly, we detected differences in the accumulation of 
AMP and its degradation product, ADO, between control and postinflamed 
preparations incubated either with ATP (30 µM) or ADP (30 µM). The extracellular 
AMP content increased (orange bars), whereas ADO decreased (green bars), 
proportionally in the incubation fluid of TNBS-treated preparations as compared to 
those isolated from control rats following incubation with either ATP (30 µM) or 
ADP (30 µM) (Figure 18). Increases in AMP content of bath samples from 
postinflammation ileum reached the control levels 45 min after starting incubation 
with either ATP (30 µM) or ADP (30 µM), i.e. when the concentration of adenine 
nucleotides reached minimum (Figure 18).   
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Figure 18: Kinetics of the extracellular catabolism of ATP (A) and ADP (B) in the LM-MP of the 
ileum of control and TNBS-injected rats. ATP and ADP (30 µM) were incubated at zero time (see 
Methods). Collected samples were analysed by HPLC with UV detection to separate and quantify 
ATP (black), ADP (red), AMP (orange), ADO (green), INO (dark grey) and HX (light grey). Average 
results obtained in four experiments. 
 
Feed-forward inhibition of ecto-5’-nucleotidase/CD73 by adenine nucleotides 
controls adenosine formation in postinflammation ileitis 
Data from Figure 18 clearly indicate that differences in ADO formation from 
the extracellular catabolism of adenine nucleotides in postinflammation ileitis 
implicate AMP dephosphorylation by ecto-5’-nucleotidase, which is the rate limiting 
enzyme for ADO formation in the rat myenteric plexus (Duarte-Araújo et al., 2009). 
Surprisingly, we did not observe significant changes (P>0.05) in the half 
degradation time of AMP (30 µM) between control and TNBS-treated preparations 
(Figure 19A). If any difference has to be mentioned, is the fact that the inflamed 
ileum accumulated proportionally less ADO in the extracellular milieu as compared 
to control tissues when AMP (30 µM) was used as substrate (Figure 19A). Overall, 
the results indicate that ADO is being rapidly converted into INO by ADA in the 
extracellular space of both control and TNBS-treated preparations (see below), 
given that stoichiometry of AMP conversion into ADO, INO and HX is kept 
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unaltered ruling out a significant contribution of the nucleoside uptake system (cf. 
Duarte-Araújo et al., 2004).  
 
t½(AMP)=142 min. t½(AMP)=121 min. t½(AMP)=668 min. t½(AMP)=216 min.
A B
C
 
Figure 19: Kinetics of the extracellular catabolism AMP (30 µM) in the LM-MP of the ileum of 
control and TNBS-injected rats (A). The residual ecto-5’-nucleotidase/CD73 activity (soluble form) 
in the incubation fluid after removing the preparations from the organ bath, is also shown (B). AMP 
(30 µM) was incubated at zero time (see Methods). Collected samples were analysed by HPLC 
with UV detection to separate and quantify AMP (orange), ADO (green), INO (dark grey) and HX 
(light grey). Average results obtained in four experiments. Panel (C) shows that immunoreactivity 
against ecto-5’-nucleotidase/CD73 in longitudinal smooth muscle fibres of the ileum from TNBS-
treated rats is much more evident than in control animals. 
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Since ecto-5’-nucleotidase/CD73 may be cleaved from its membrane GPI 
anchor by proteolysis retaining its catalytic activity in the incubation fluid, we 
decided to test whether binding of this enzyme to the plasma membrane was 
somehow affected during chronic inflammation in order to explain the differences 
detected in ADO formation from the hydrolysis of adenine nucleotides. To this end, 
we evaluated the 5’-nucleotidase activity in the fluid remaining in the bath after 
removing the preparation following a 45-min incubation period (Figure 19B). Under 
these experimental conditions, the half-life of AMP (30 µM) was significantly 
(P<0.05) decreased in TNBS-treated preparations (t½=21±6 min, two-times slower 
than with the tissue present) as compared to controls (t½=66±8 min, almost five-
times slower than with the tissue present). Data suggest that postinflammation 
ileitis causes an increase in unbound soluble forms of 5’-nucleotidase, which 
contribute to dephosphorylation of extracellular AMP into ADO without changing 
the global enzyme activity in the tissue. Notwithstanding, functional repercussions 
may be expected from this fact taking into consideration that ecto-5’-
nucleotidase/CD73 is concentrated in the myenteric smooth muscle cell layer of 
healthy ileum (Nitahara et al., 1995), whereas unbound soluble forms of the 
enzyme may generate ADO from extracellular AMP way from the most common 
site at the myenteric neuromuscular synapse in the inflamed ileum.   
Given that we did not observe any significant differences in the AMP 
catabolism between control and TNBS-treated preparations (see Figure 19A) and 
we, still, detected increases in ecto-5’-nucleotidase/CD73 immunoreactivity in the 
longitudinal neuromuscular layer of the inflamed rat ileum (Figure 19C; see also 
(Antonioli et al., 2011), we hypothesized that ecto-5’-nucleotidase/CD73 could be 
feed-forwardly inhibited by high extracellular levels of ATP and/or ADP which bind 
to the catalytic site of the enzyme blunting ADO formation from AMP in inflamed 
preparations (Figure 16; see also Magalhães-Cardoso et al., 2003). The ecto-5’-
nucleotidase activity was evaluated by quantifying the ratio [Nucleosides]:[Total 
nucleotides] per min, which is a direct measure of the activity of ecto-5’-
nucleotidase, using either ATP (30 µM) or ADP (30 µM) as substrates. Figure 20A 
shows that this ratio increased progressively with time upon consumption of ATP 
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or ADP in the incubation media. The activity of ecto-5’nucleotidase/CD73 was 
significantly (P<0.05) impaired in the LM-MP of the ileum following an 
inflammatory insult, particularly when ADP (30 µM) was used as substrate. These 
findings agree with data from Figure 18, showing that ADO formation is delayed 
with a compensatory increase in AMP accumulation in the inflamed ileum as 
compared to control preparations which is compatible with our hypothesis that 
ATP and/or ADP feed-forwardly inhibit ecto-5’-nucleotidase/CD73 in 
postinflammation ileitis.  
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Figure 20: Activity of ecto-5’-nucleotidase/CD73 when ATP (A) and ADP (B) were used as 
substrates of the ectonucleotidase cascade in the LM-MP of the ileum of control and TNBS-injected 
rats. ATP and ADP (30 µM) were incubated at zero time. Ecto-5’-nucleotidase/CD73 activity was 
evaluated by quantifying the ratio [Nucleosides]:[Nucleotides]/min. Average results obtained in four 
experiments; the vertical bars represent the SEM and are shown when they exceed the symbols in 
size. *P <0.05 (one-way ANOVA followed by Dunnett’s modified t test) represent significant 
differences as compared to control animals. 
 
Tissue distribution changes of NTPDase2, NTPDase3 and NTPDase8 in 
postinflammation ileitis 
The relative amounts of ATP and/or ADP near the ecto-5’-
nucleotidase/CD73, which is concentrated in the myenteric smooth muscle layer 
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(Nitahara et al., 1995; see also Figure 19C), is paramount to predict the magnitude 
of feed-forward inhibition of the enzyme by released adenine nucleotides. This 
may be determined by the expression and co-localization of NTPDases 
responsible for the kinetics of the catabolism of adenine nucleotides in control as 
well as in inflamed ileum.  
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Figure 21: Localization of NTPDase1, NTPDase2, NTPDase3 and NTPDase8 immunoreactivity in 
single confocal images of whole-mount preparations of the LM-MP of the ileum of control and 
TNBS-injected rats. In healthy animals, NTPDase 1 immunoreactivity is present only in blood 
vessels (asterisks); NTPDase2 immunoreactivity is present predominantly in ganglion neuronal cell 
bodies (triangles) and large ramifications (primary meshwork) of the myenteric plexus, whereas 
NTPDase3 is also evident on myenteric axon terminals (arrows). In TNBS-treated preparations the 
NTPDase2 staining acquires a pattern that is very similar to that of NTPDase3, with NTPDase2 
immunoreactivity also appearing in nerve bundles and axon terminals of myenteric neurons. 
NTPDase8 stains few ganglion neuronal cell bodies and large ramifications (primary meshwork) of 
the myenteric plexus; this pattern did not significantly change among control and TNBS-treated 
animals. No staining was obtained when non-immune sera from host species (rabbit, Rb, and 
guinea-pig, Gp) were used instead of interest primary antibodies.     
 
Figure 21, shows that in control LM-MP preparations the immunoreactivity 
against NTPDase2 is restricted to ganglion cell bodies and large ramifications 
(primary meshwork) of the myenteric plexus (cf. Braun et al., 2004). This contrasts 
 ORIGINAL RESEARCH ARTICLES 
 
 
93    PhD Thesis: Cátia Andreia Rodrigues Vieira 
 
 
with the localization of NTPDase3 immunoreactivity, which is also evident on 
myenteric nerve trunks and terminals corresponding to secondary and tertiary 
neuronal meshworks, respectively (Lavoie et al., 2011). At this time, we cannot 
exclude the presence of this enzyme on intramuscular ICCs. This pattern changes 
in the postinflammation ileum. In TNBS-treated preparations, the NTPDase2 
immunoreactivity is also observed in the secondary and tertiary neuronal 
meshwork, meaning that ADP formation from released ATP by stimulated enteric 
neurons (White & Leslie, 1982) and smooth muscle fibres (Nitahara et al., 1995) 
may contribute to prolong feed-forward inhibition of muscle-bound ecto-5’-
nucleotidase/CD73 at the myenteric neuromuscular synapse following an 
inflammatory insult.  
Apparently no significant differences were found in the expression and 
localization of NTPDase3 in the inflamed LM-MP of the rat ileum. Regarding 
NTPDase8, we were able to demonstrate its presence in few neuronal cell bodies 
of myenteric ganglia, with much lesser expression at the neuromuscular layer 
(Figure 21). Phenotypic characterization of NTPDase8 positive neuronal cell 
bodies deserves future investigations. Like NTPDase3, we found no gross 
changes in NTPDase8 immunoreactivity between control and TNBS-treated 
animals. We focused our attention on these three ectoenzymes, because we 
detected no immunoreactivity against NTPDase1 in the LM-MP of the rat ileum 
besides few blood vessels (Figure 21).  
Postinflammation ileitis is accompanied by higher adenosine deaminase 
(ADA) activity: contribution of membrane-bound (ecto-ADA) and soluble 
(exo-ADA) forms of the enzyme 
The bath concentrations of ADO (30 µM) decrease progressively with time 
yielding to the formation of INO and HX in the LM-MP of the rat ileum (see 
Correia-de-Sá et al., 2006). The extracellular catabolism of ADO (30 µM) was 
faster (t½=24±3 min, n=4) in TNBS-treated than in control preparations (t½=52±10 
min, n=4). The rate of extracellular ADO inactivation can be best appreciated by 
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calculating ADA activity in the present experimental conditions, which is 
represented in Figure 22A.  
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Figure 22: (A) Activity of ADA during the extracellular catabolism of ADO in the LM-MP of the 
ileum of control and TNBS-injected rats. ADO (30 µM) was incubated at zero time. Average results 
obtained in four experiments; the vertical bars represent the SEM and are shown when they 
exceed the symbols in size. *P <0.05 (one-way ANOVA followed by Dunnett’s modified t test) 
represent significant differences as compared to control animals. (B) Localization of ADA 
immunoreactivity in single confocal images of whole-mount preparations of the LM-MP of the ileum 
of control and TNBS-injected rats, taken both at ganglia and neuromuscular layers. Please note 
that ADA immunoreactivity is much more exuberant in preparations from TNBS-treated rats than in 
control animals. The figure insert details ADA staining in mononuclear inflammatory cells infiltrating 
myenteric ganglia.    
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Data indicate that the LM-MP of the ileum following an inflammatory insult 
has increasing amounts of ADA that we confirmed by immunofluorescence 
confocal microscopy (Figure 22B). ADA immunoreactivity was detected both at the 
ganglion level, as well as at the neuromuscular layer probably attached to smooth 
muscle fibers. In TNBS-treated preparations, ADA staining was also observed in 
mononuclear cells, most probably T lymphocytes and macrophages, infiltrating the 
myenteric plexus at the ganglion level (Martin et al., 1995; Conlon & Law, 2004). 
Likewise, Antonioli and col. (2010) demonstrated by Western blot analysis 
increases in the expression of ADA at the level of inflamed colonic tissues. Like 
the ecto-5’-nucleotidase/CD73, extracellular ADA can be found attached to the 
plasma membrane (ecto-ADA) (Pettengill et al., 2013), as well as in soluble forms 
after proteolytic cleavage from cell membranes (exo-ADA) (Franco et al., 1997). 
Both forms retain catalytic activity. Figure 22A, also shows that the activity of the 
soluble form of ADA retained in the incubation fluid is highest during the first 5 min 
after removing the LM-MP preparation from the bath. Soluble ADA activity was not 
accompanied by any modification of lactate dehydrogenase activity, thus indicating 
that its activity is not due to damaged cells (see e.g. Correia-de-Sá et al., 2006).  
The soluble ADA activity was further increased in the incubation fluid which 
had been in contact for 45 min with preparations treated with TNBS. This implies 
that ADA is secreted in high amounts from the inflamed ileum, thus contributing to 
explain the lack of ADO neuromodulatory tonus. Even though INO may 
accumulate in postinflammation ileitis as a result of increased extracellular ADO 
deamination (see Figures 18 and 19), we failed to detect any variation on evoked 
[3H]-ACh release when INO was applied to the incubation fluid of control and 
TNBS-treated preparations in concentrations as high as 1 mM (data not shown). 
Catabolic degradation of ADO by soluble ADA may also result in the impairment of 
immune modulation by endogenous ADO (via A2A receptors on mononuclear cells, 
see Figure 15B) and the consequent worsening of inflammation and tissue injury 
(Antonioli et al., 2010). 
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DISCUSSION AND CONCLUSIONS 
Enteric plasticity comprises a wide range of structural and/or functional 
changes in enteric neurons, glial cells and pacemaker ICCs, which are located 
between the muscle layers of GI tract. Different types of pathophysiological 
conditions drive to distinct adaptive responses. Enteric neurons are known to 
control all GI functions. They are able to rapidly change their structure, function or 
chemical coding to maintain the gut homeostasis (e.g. during inflammatory 
disorders) (Lakhan et al., 2010). Despite heterogeneity of enteric adaptive 
responses, involvement of ubiquitous purine nucleotides and nucleosides provide 
fine tuning control of peristaltic motor performance in the gut during stressful 
situations, such as sustained neuronal activity, ischemia and inflammation 
(reviewed in Pettengill et al., 2013). Numerous studies have described the 
potential role of purinergic function regulators in inflammation and immunity 
(Robson et al., 2006; Antonioli et al., 2013; Louis et al., 2008; Sotnikov & Louis, 
2010). There is recent evidence that blockade of adenosine kinase, which results 
in increased endogenous levels of ADO, downregulates the inflammatory 
response in experimental colitis (Siegmund et al., 2001). In addition, Mabley et al. 
(2003) showed that INO resulting from the breakdown of ADO effectively reduced 
the inflammatory response in a murine model of colitis, despite we showed in this 
study that INO accumulation might not be sufficient to explain the purinergic 
neuromodulatory changes observed in postinflammation ileitis. These, and many 
other findings, suggest that ADO can mediate both pro-inflammatory (via A1 or A2B 
receptors) and/or anti-inflammatory/ immunosuppressant activities (mainly through 
A2A and A3 receptors) in inflammatory gut diseases, and they have potential for the 
treatment of these diseases (reviewed in Antonioli et al., 2013). However, much is 
unknown to what extent the immune-modulatory role of purines during 
inflammation interferes with neuromodulation of the ENS (De Man et al., 2003).  
Control of cellular activity by purines depends on the activation of two 
families of membrane-bound purinoceptors, P1 and P2, which are sensitive to 
ADO and to adenine and/or uracil nucleotides, respectively.  Interestingly, P1 and 
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P2 purinoceptors are also present on immune cells and there is evidence that 
ADO and ATP are generated at sites of inflammation (see, for a review (Cronstein, 
1994). Purinoceptors activation is fine-tuned regulated by the extracellular 
conversion of released adenine and uracil nucleotides leading to the formation of 
other biologically active products, namely ADP/UDP and ADO, via a cascade of 
membrane-bound ectonucleotidases (Kukulski et al., 2005; Yegutkin, 2008). Thus, 
cellular expression and topology of ectonucleotidase enzymes, as well as factors 
that extrinsically affects their catalytic activity (e.g. ionic concentration, nucleotide 
binding), create gradients of adenine nucleotides and their breakdown products, 
which may discriminate which nearby purinoceptor is more likely to be activated. 
For instance, under basal conditions ATP transiently facilitates ACh from non-
stimulated myenteric neurons via prejuctional P2X (probably P2X2) receptors; 
however, increases in the amount of ATP released from stimulated neurons create 
conditions favourable to ADP accumulation at the myenteric synapse, leading to 
downregulation of transmitter release via the P2Y1 receptor (Duarte-Araújo et al., 
2009). Strategic manipulation of the activity of ectonucleotidases has been 
proposed as a novel therapeutic approach to modify pathogenic purinergic 
signalling cascades (reviewed in Burnstock & William’s, 2000). 
At the myenteric plexus, the rate limiting enzyme responsible for 
extracellular ADO formation from released adenine nucleotides is ecto-5’-
nucleotidase/CD73 (Duarte-Araújo et al., 2004, Duarte-Araújo et al., 2009). This 
enzyme acts in a concerted manner with ADO inactivation pathways, both cellular 
uptake and ADA, to control extracellular levels of the nucleoside and, thereby, the 
activation of co-localized P1 receptors (Correia-de-Sá et al., 2006). Interestingly, 
although much less has been explored in functional terms, the enzymes most 
relevant to control ADO levels in the extracellular milieu, both ecto-5’-
nucleotidase/CD73 and ADA, may be cleaved from their anchor to the plasma 
membrane while retaining their catalytic activity in the soluble form (Pettengill et 
al., 2013). Coincidently or not, significant increases in ecto-5’-nucleotidase/CD73 
and ADA mRNA expression were observed in inflamed colonic tissues (Antonioli 
et al., 2014). Fragile docking of these enzymes to the plasma membrane is more 
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likely to occur within the context of inflammatory reactions, given that recruitment 
of inflammatory cells release a huge number of cytokines, chemokines and 
enzymes, some of these with proteolytic activity. One of these enzymes is 
glycosylphosphatidylinositol-specific phospholipase, which plays a role in 
inflammation since it can hydrolyse the GPI anchor of several membrane proteins 
and its hydrolytic products up-regulate cytokine expression in macrophages 
(O’Brien et al., 1999). The widespread distribution of soluble forms of ecto-5’-
nucleotidase/CD73 and ADA create conditions to unbalanced bulk production 
and/or inactivation of ADO way from its original location, thus affecting mass organ 
function. Likewise, inflammatory infiltrates including T lymphocytes, which are 
endowed with NTPDase1/CD39 and ecto-5’-nucleotidase/CD73 enzymes, may 
additionally contribute to ADO accumulation disturbance and to unpredictable P1-
receptor-mediated responses in inflamed tissues. In light of these compelling 
hypotheses, this work was designed to investigate the kinetics of the catabolism of 
adenine nucleotides and ADO accumulation in the myenteric plexus of the ileum 
following an inflammatory insult.               
Data from this study evidenced a disparity between higher amounts of ATP 
detected in the extracellular fluid released from TNBS-treated ileal preparations 
and deficits in the ADO levels measured in the same samples, both under baseline 
conditions and after electrical stimulation. This puzzling contradiction has not been 
detected before. On the contrary, indirect evidences made by other authors led to 
the hypothesis that the disruption of ATP release could be due to mitochondrial 
dysfunction induced by inflammatory mediators (Neshat et al., 2009; Strong et al., 
2010), which was not confirmed in the present study. In postinflammation ileitis, 
higher ATP amounts can be originated from infiltrating immune and non-neuronal 
cells, such as glial cells, ICCs and smooth muscle contractions (see e.g., (Nitahara 
et al., 1995); reviewed in Burnstock & Lavin, 2002, considering the proposed 
inflammatory neuronal dysfunction. Hemichannels containing pannexins may act 
as conduits for ATP release from non-neuronal cells in response to physiological 
and pathological stimuli. These channels are able to form signalling complexes 
with the purinergic P2X7 receptor, which activation leads to large pore formation 
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and consequently to further release of ATP (Diezmos et al., 2013; Gulbransen et 
al., 2012). These authors proposed a model where high extracellular levels of ATP 
chronically activate neuronal P2X7, pannexins and caspases. This relationship 
between P2X7 and pannexins has been related to the loss of enteric neurons 
during inflammatory conditions (Lakhan & Kirchgessner, 2010; Gulbransen et al., 
2012, Sanger, 2012). Moreover, our data add some information to explain the 
impairment of purinergic signalling during intestinal inflammation detected in other 
reports (De Man et al., 2003, Depoortere et al., 2002, Strong et al., 2010) which 
has been expanded in this study by showing a lack of ADO neuromodulatory 
control of ACh release from postinflammation myenteric plexus. We provided 
compelling evidences that most of the ADO originated in the inflamed myenteric 
plexus of the rat ileum was derived from activated ICC’s by the release of the 
nucleoside as such via dipyridamole-sensitive equilibrative transporters. This also 
agrees with previous findings from our group showing that ADO formation from 
released ATP, via the ecto-nucleotidase cascade, contributes only partially to the 
total interstitial ADO concentration in the myenteric plexus of healthy rats (Correia-
de-Sá et al., 2006). 
The apparent disturbance of ADO generated from the extracellular 
catabolism of released ATP may be due to feed-forward inhibition of ecto-5’-
nucleotidase/CD73 as a consequence of high extracellular levels of ATP, and 
particularly ADP, accumulated in the inflamed myenteric synapse [cf. Magalhães-
Cardoso et al., 2003). ATP and ADP are competitive inhibitors of ecto-5’-
nucleotidase/CD73 with inhibition constants in the low micromolar range. This 
indicates that they can bind to the active site of this enzyme, like AMP, but they 
cannot be hydrolysed (Sträter, 2006; Fausther et al., 2012); recovery of ecto-5’-
nucleotidase/CD73 activity occurs once extracellular ATP and ADP levels 
decrease below the micromolar range. Redistribution of NTPDase2 from ganglion 
cell bodies, which is the preferential localization of this enzyme in healthy animals, 
towards myenteric nerve terminals affords the most probable explanation for the 
unpredicted ADP accumulation in postinflammation neuromuscular synapse. This 
is possible because NTPDase2 is a preferential nucleoside triphosphatase 
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hydrolysing ADP 10 to 15 times less efficiently than ATP (Kukulski et al., 2005), 
and we detected no changes in the distribution of NTPDase3 and NTPDase8 
present in the myenteric plexus. Notably, no evidence of NTPDase1 expression 
was detected in the rat myenteric plexus, besides a few blood vessels. Thus, 
during postinflammation ileitis the hydrolysis of ATP into ADO at the myenteric 
synapse may be transiently interrupted by feed-forward inhibition of ecto-5’-
nucleotidase/CD73, which makes a shift from P1 receptors activation (by ADO) to 
a preferential P2 receptors activation (by ATP or ADP). These data are in 
agreement with the hydrolysis of ATP by NTPDase2 and ecto-5’-
nucleotidase/CD73 in the rat liver (Cunha, 2001). Indeed, depending with which 
NTPDase subtype ecto-5’-nucleotidase/CD73 co-localizes different amounts of 
ADO will be generated (Cunha, 2001). The functional interpretation of these 
findings in order to justify the increase in GI motility may be complicated by 
disturbances in compartmentalization originated by the release of significant 
amounts of soluble forms of the enzyme (Pettengil et al., 2013; Sträter, 2006). 
Nevertheless, our results fully agree with other authors suggesting that ecto-5’-
nucleotidase/CD73 might play a significant role in the modulation of purinergic 
signalling during enteric inflammation (Louis et al., 2008; Antonioli et al., 2013). 
Previous findings from our group demonstrated that extracellular 
deamination by ADA is the most efficient mechanism regulating synaptic ADO 
levels and, consequently, tonic activation of facilitatory A2A receptors in myenteric 
nerve terminals of healthy rats (Duarte-Araújo et al., 2004). Besides the very high 
level of activity of ecto-ADA, a less-efficient nucleoside transport system sensitive 
to dipyridamole may also contribute to inactivation of extracellular ADO. Owing to 
the effectiveness of both inactivation mechanisms, endogenous ADO actions may 
be restricted to the release/production region at the myenteric cholinergic synapse, 
while exogenously added ADO seems to activate preferentially extrajunctional 
inhibitory A1 receptors (Duarte-Araújo et al., 2004; Vieira et al., 2011). A question 
remains unanswered regarding the tonic effect of endogenous ADO on low affinity 
excitatory A3 receptors, although selective agonists to this receptor have been 
shown to beneficially influence inflammation in experimental models (Guzma et al., 
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2006, Antonioli et al., 2010). Tandem localization of adenosine A3 (on cell bodies) 
and A2A (on nerve varicosities) receptors along myenteric neurons explains why 
the A3 receptor activation may be prevented by ZM 241385 (50 nM), a selective 
A2A receptor antagonist with low affinity for A3 receptors (Ki>10 µM). This implies 
that endogenous ADO acts preferentially on prejunctional A2A under normal 
conditions making the activation of low affinity A3 receptors by ADO high unlikely 
during the postinflammatory phase of TNBS-ileitis due to suppression/inactivation 
of the nucleoside (this study). The putative activation of A3 receptors by 
endogenously formed INO via ADA also cannot explain the loss of the 
neuromodulatory influence of nucleosides in postinflammation ileitis. While we are 
uncertain regarding the extracellular levels of ADO at both particular locations, 
both in vivo and in vitro models suggest that the balance between inhibitory A1 and 
excitatory A2A may be important in regulating intestinal motility. For instance, De 
Man et al. (2003) reported that chronic intestinal inflammation enhanced enteric 
contractile activity in part due to a loss of the cholinergic neuromodulation 
mediated by A1 receptors (De Man et al., 2003). It is worth noting that human post-
ganglionic myenteric neurons co-express adenosine A1 and A2A receptors, which 
exhibit a heterogeneous distribution (Christofi, 2001). Therefore, there is a 
considerable interest in the neuroprotective effects exerted by ADO during 
inflammatory (and ischemic) insults, and it is conceivable that adenosine 
accumulation disturbances may contribute to enteric excitability during 
pathological conditions.  
Besides the proposed interruption of the ectonucleotidase cascade at the 
level of ecto-5’-nucleotidase/CD73 leading to AMP accumulation and low ADO 
formation in the inflamed myenteric plexus, our data also show that ADA activity is 
significantly enhanced in postinflammation ileitis thus contributing to decrease the 
extracellular ADO levels and, thereby, tonic activation of P1 receptors. ADA is the 
enzyme responsible for the deamination of ADO into INO. This enzyme has a wide 
phylogenetic distribution and its amino acid sequence is highly conserved, 
suggesting that ADA is a key enzyme in purine metabolism. Besides the classical 
intracellular form, ADA is reported to bind to the cell surface of T lymphocytes, via 
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the activation cell marker CD26 (Cristalli et al., 2001). The presence of ADA in 
nerve terminals has also been demonstrated in many brain regions and it was 
hypothesize that ADA-containing terminals may release ADO or the enzyme itself, 
which could serve to regulate purinergic neurotransmission (Nagy et al., 1990; 
Nagy et al., 1996). In the rat myenteric plexus, we first described that ADA activity 
increased in bath samples collected after tissue stimulation in parallel with the 
interstitial accumulation of ADO and its metabolites (Correia-de-Sá et al., 2006). 
This implies that the amount of ADO detected following stimulation of the 
preparation was largely underestimated as compared to the levels of the 
nucleoside in the biophase. Secretion of ADA may occur in several diseases, 
namely those affecting hematopoietic and immune (Ungerer et al., 1992). To our 
knowledge, this is the first study reporting an increase in the activity of soluble 
ADA in the chronic inflamed myenteric plexus of the rat ileum. Our findings unravel 
the mechanism by which inhibition of ADA might attenuate inflammation in 
experimental colitis (Antonioli et al., 2007). 
In conclusion, data indicate that postinflammation ileitis suppresses ADO 
neuromodulation, which may contribute to increase GI motility. Impairment of ADO 
neuromodulation is most probably due to deficient accumulation of the nucleoside 
at the myenteric synapse despite the paradoxical increase in ATP release. 
Discrepancy between ATP outflow and ADO deficiency in the chronic inflamed 
ileum can be ascribed to feed-forward inhibition of ecto-5’-nucleotidase/CD73 by 
high extracellular levels of ATP and/or ADP. Interestingly, redistribution of 
NTPDase2, but not of NTPDase3, from ganglion cell bodies to myenteric nerve 
terminals leads to preferential ADP accumulation from released ATP, thus 
contributing to prolong inhibition of muscle-bound ecto-5’-nucleotidase/CD73 and 
to delay ADO formation at the inflamed neuromuscular synapse. On the other 
hand, depression of endogenous ADO accumulation may also occur due to 
enhancement of ADA activity. We observed a remarkably increase in the activity of 
soluble forms of ecto-5’-nucleotidase/CD73 and ADA in the postinflammatory 
phase of TNBS-ileitis, which may contribute to unbalanced bulk production and/or 
inactivation of ADO way from its location in the native tissue thus affecting organ 
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function. Thus, our findings suggest that pharmacological inhibition of ADA, and/or 
the use of AMP-derived prodrugs able to selectively activate P1 receptor co-
localized with ecto-5’-nucleotidase/CD73, represent promising therapeutic 
strategies to ameliorate motility disturbances and immune reactivity inherent to 
inflammatory enteric disorders. 
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ABSTRACT  
Uncoupling between ATP overflow and extracellular adenosine formation 
changes purinergic signalling in postinflammatory ileitis. Loss of adenosine 
neuromodulation was ascribed to feed-forward inhibition of ecto-5’-
nucleotidase/CD73 by high extracellular adenine nucleotides in the inflamed ileum. 
Here, we hypothesized that inflammation-induced changes in cellular density may 
also account to unbalance the release of purines and their influence on [3H]ACh 
release from TNBS-treated longitudinal muscle-myenteric plexus preparations of 
the rat ileum. The population of S100β-positive glial cells increase and a loss of 
ANO-1-positive interstitial cells of Cajal/fibroblast-like cells (ICC/FLC) were noted 
in the ileum 7-days after the inflammatory insult. In the absence of changes on 
VAChT-positive cholinergic nerves by confocal microscopy, the inflamed myenteric 
plexus released smaller amounts of [3H]ACh, which also became less sensitive to 
neuronal block with TTX (1µM). Instead, [3H]ACh release was attenuated by 
sodium fluoroacetate (5mM), carbenoxolone (10µM) and A438079 (3µM), which 
prevent activation of glial cells, pannexin-1 hemichannels and P2X7 receptors, 
respectively. Sodium fluoroacetate also decreased ATP release without 
significantly affecting adenosine levels indicating that surplus ATP overflow 
parallels reactive gliosis in postinflammatory ileitis. Conversely, loss of ICC/FLC 
may explain the lower adenosine levels in TNBS-treated preparations, since 
blockade of Cav3 (T-type) channels existing in ICC/FLC with mibefradil (3µM) or 
inhibition of equilibrative nucleoside transporters with dipyridamole (0.5µM), both 
decreased extracellular adenosine. Data suggest that postinflammatory ileitis 
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operates a shift on purinergic neuromodulation reflecting the upregulation of ATP-
releasing enteric glial cells and the depletion of ICC/FLC that account for 
decreased adenosine overflow via nucleoside transporters.        
Keywords: Postinflammatory ileitis; Acetylcholine release; Adenosine release; ATP 
release; Myenteric plexus; Enteric glia; Interstitial cells. 
 
INTRODUCTION 
Inflammation of the gastrointestinal (GI) tract triggers a series of adaptive 
morphological, chemical and functional changes in the cellular components 
responsible for maintaining gut homeostasis (Sharkey & Kroese, 2001). These 
involve the number and chemical coding of enteric neurons, but also the relative 
abundance and activity of adjacent non-neuronal cells such as enteric glia, 
interstitial cells of Cajal, fibroblast-like cells and smooth muscle fibers, directly or 
indirectly influenced by inflammatory infiltrates. Adaptive cellular responses may 
impact on the coordination of motor function, local blood flow, GI secretions and 
also on the endocrine and immune reactions (Costa et al., 2000). As a matter of 
fact, the postinflammatory status is frequently accompanied by significant changes 
in enteric motility (Pontell et al., 2009; Vieira et al., 2014). 
Changes in the release of purines together with adaptive modifications of 
purinoceptors expression and/or function are hallmarks of inflammatory reactions 
in most tissues, with the GI tract being no exception (Roberts et al., 2012). 
Although purinergic signaling modifications underlying inflammatory responses of 
the GI tract are not fully understood, the extreme plasticity of the purinergic system 
and its pathophysiological impact on immune reactions, enteric neuronal 
networking and cellular communication make drugs targeting the purinergic 
cascade ideal candidates for treating inflammatory GI diseases. Purines, such as 
ATP and adenosine, are released from activated infiltrating inflammatory cells 
(Marquardt et al., 1984), as well from resident neuronal and non-neuronal enteric 
cells (Stead et al., 1989; Bogers et al., 2000). ATP released in response to 
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inflammatory mediators is crucial for neutrophil activation and immune defense 
(Lazarowski et al., 2011), but can also function as a danger signal preventing cells 
invasion of immune-privileged tissues, like myenteric ganglia (Bradley et al., 
1997).  
In healthy individuals, ATP is co-released by vesicular exocytosis from 
enteric neurons with other neurotransmitters, like acetylcholine (ACh) (Burnstock, 
1976). Mounting evidences indicate that ATP release from non-neuronal cells is 
also critical to control organ functions, in both normal and stressful conditions 
(Bodin & Burnstock, 2001; Lazarowski et al., 2011; Mutafova-Yambolieva, 2012; 
Silva et al., 2015). Non-neuronal release of ATP may be carried out by vesicular 
ATP transporters (VNUT) (Sawada et al., 2008; Lazarowski et al., 2011), as well 
as via other mechanisms involving activation of ABC proteins and hemichannels 
containing connexins and/or pannexins (Bodin & Burnstock, 2001; Lazarowski et 
al., 2011; Timóteo et al., 2014; Carneiro et al., 2014; Silva et al., 2015).  
Once released from either neuronal or non-neuronal cells, ATP modifies 
organ functions by activating directly ionotropic P2X and metabotropic P2Y 
purinoceptors or indirectly, via P1 receptors, after being metabolized into 
adenosine through ecto-nucleotidases. At the myenteric neuromuscular synapse, 
ATP transiently facilitates [3H]ACh release from non-stimulated nerve terminals via 
the activation of P2X (most probably P2X2 or P2X2/3) receptors (Duarte-Araújo et 
al., 2009). Fast conversion of ATP directly into AMP catalyzed by NTPDases 2 
and 3 (Vieira et al., 2015) and, subsequent, formation of adenosine by ecto-5’-
nucleotidase/CD73, controls evoked [3H]ACh release through stimulation of high-
affinity excitatory A2A and/or inhibitory A1 receptors located on nerve terminals and 
ganglion cells bodies of myenteric nerves, respectively  (Duarte-Araújo et al., 
2004; 2009; Vieira et al., 2011). However, inflammation may lead to 
overexpression of NTPDase2 at the myenteric synapse (Vieira et al., 2014), which 
is a preferential nucleoside triphosphatase hydrolysing ADP 10 to 15 times less 
efficiently than ATP (Kukulski et al., 2011). This promotes ADP accumulation and 
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subsequent downregulation of transmitter release via prejunctional inhibitory P2Y1 
receptors (Duarte-Araújo et al., 2009). 
In contrast to ATP, adenosine is not stored nor released from synaptic 
vesicles. Our group demonstrated that the ecto-nucleotidase pathway contributes 
only partially to the total interstitial adenosine concentration in the myenteric 
plexus (Correia-de-Sá et al., 2006). Adenosine released as such from either 
neuronal or non-neuronal cells seems to be the main source of endogenous 
adenosine in the enteric nervous system (Duarte-Araújo et al., 2004). This release 
is sought to be mediated by facilitated diffusion via equilibrative nucleoside 
transporters (Gu et al., 1995; Duarte-Araújo et al., 2004; Correia-de-Sá et al., 
2006) existing predominantly in interstitial cells of Cajal and/or fibroblast-like cells 
(ICC/FLC) (Vieira et al., 2014). Another potential source of endogenous adenosine 
could be adenosine 3',5'-cyclic monophosphate (cAMP) extruded from activated 
cells, which can be converted to AMP and then to adenosine by ecto-
phosphodiesterase and ecto-5'nucleotidase/CD73, respectively (Giron et al., 
2008), but this pathway does not account significantly for endogenous adenosine 
formation in the myenteric plexus of the rat ileum (Vieira et al., 2014).   
Uncoupling between ATP overflow and extracellular adenosine formation 
has been observed in postinflammatory ileitis (Vieira et al., 2014). This situation, 
which disrupts the purinergic control of gut motility, has been ascribed to feed-
forward inhibition of ecto-5’-nucleotidase/CD73 by high extracellular levels of 
adenine nucleotides together with an enhancement of adenosine deaminase 
(ADA) activity in the inflamed ileum. While these findings explain, at least partially, 
the loss of adenosine neuromodulation in the inflamed ileum, they miss the point 
regarding enhancement of the ATP-mediated tone. In this study, we hypothesized 
that inflammation-induced changes in the density of specific enteric resident cells 
could also account to unbalance the release of purines and, thus, their influence 
on evoked [3H]ACh release from longitudinal muscle-myenteric plexus 
preparations of rats with TNBS-induced postinflammatory ileitis.     
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MATERIAL AND METHODS 
TNBS-induced intestinal inflammation rat model 
Rats of either sex (Wistar,∼200 g) (CharlesRiver, Barcelona, Spain) were 
kept at a constant temperature (21°) and a regular light- (06.30–19.30 h) dark 
(19.30–06.30 h) cycle, with food and water) and a regular light- (06.30–19.30 h) 
dark (19.30–06.30 h) cycle, with food and water ad libitum. Intestinal inflammation 
was produced by the instillation of 2,4,6-trinitrobenzenesulfonic acid (TNBS) into 
the lumen of the rat ileum. After a fasting period of 4–8 hours with free access to 
drinking water, rats undergo median laparotomy under anaesthesia with an 
association of medetomidine (10 mg/Kg) and ketamine (75 mg/Kg) given 
subcutaneously. At the end of the procedure animals were retrieved with 
atipamezole (10 mg/Kg). The terminal ileal loop was gently exteriorized, and TNBS 
(40 mM) was injected through the enteric wall into the lumen of the ileum, 10 
centimeters proximal to the ileocolonic junction. Controls received 1 mL of 0.9 % 
saline. Sixty minutes after surgery, the rats were allowed to eat and drink ad 
libitum. After surgery, pain was controlled with tramadol hydrochloride (10 mg/Kg). 
To have a control of time course of body weight loss and recovery after injection of 
TNBS, rats were weighed prior to TNBS administration and daily following surgery. 
Animals with intestinal inflammation (TNBS) transiently lose weight for three to 
four days after surgery and regain weight thereafter. Seven days after surgery, 
animals were sacrificed following an overnight fasting period. 
 [3H]-acetylcholine release experiments 
Sections of the rat ileum not including the terminal five centimetres were 
used. The longitudinal muscle strip with the myenteric plexus attached was 
separated from the underlying circular muscle according to the method of Paton 
and Vizi (1969). This preparation is highly enriched in cholinergic neurons, mainly 
excitatory neurons projecting to the longitudinal muscle (25%) that receive inputs 
from intrinsic primary afferents (26%) and from ascending and descending 
pathways (17%) (Costa et al., 1996).  
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The procedures used for labelling the preparations and measuring evoked 
[3H] acetylcholine ([3H]ACh) release were previously described (Duarte-Araújo et 
al., 2004, 2009; Correia-de-Sá et al., 2006; Vieira et al., 2011) and used with minor 
modifications. Longitudinal muscle-myenteric plexus (LM-MP) strips were mounted 
in 365 µL chambers of a semi-automated 12-sample superfusion system (SF-12 
Suprafusion 1000, Brandel, Gaithersburg, MD, USA) heated at 37°C. After a 30-
min equilibration period, nerve terminals were labelled during 40 min with 1 µM of 
[3H]choline (specific activity 5 µCi/nmol) under electrical field stimulation (1 Hz 
frequency, 1 ms pulse width) using two platinum-made grid electrodes placed 
above and below the muscle strip (transmural EFS stimulation). Following loading, 
the washout superfusion (1 ml/min) of the preparations was performed during 80 
min with Tyrode’s solution supplemented with the choline uptake inhibitor, 
hemicholinium-3 (10 µM). Tritium outflow was evaluated by liquid scintillation 
spectrometry (TriCarb2900TR, Perkin Elmer, and Boston, USA; % counting 
efficiency: 56±2%) in 0.6 ml bath samples automatically collected every 1 min 
using the SF-12 suprafusion system. [3H]ACh release was evoked by two periods 
of EFS (S1 and S2), each consisting of 200 square wave pulses of 1 ms duration 
delivered at a 5-Hz frequency.  
Test drugs were added 8 min before S2 and were present up to the end of 
the experiments. The change in the ratio between the evoked [3H]ACh release 
during the two stimulation periods (S2/ S1) relative to that observed in control 
situations (in the absence of test drugs) was taken as a measure of the effect of 
the tested drugs. Positive and negative values represent facilitation and inhibition 
of evoked [3H]ACh release, respectively. None of the drugs significantly (P>0.05) 
changed the basal tritium outflow. 
Release of ATP and adenine nucleosides (adenosine plus inosine) 
The procedures used to measure ATP and adenine nucleosides were 
previously described (Vieira et al., 2014). Experiments were performed using an 
automated perfusion system for sample collecting for given time periods, therefore 
improving the efficacy of HPLC (with diode array detection) and bioluminescence 
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analysis. After a 30-min equilibration period, the preparations were incubated with 
1.8 mL gassed Tyrode’s solution, which was automatically changed every 15 min 
by emptying and refilling the organ bath with the solution in use. The preparations 
were electrically stimulated once, 15 min after starting sample collection (zero 
time), using 3000 square wave pulses of 1ms duration delivered at a 5-Hz 
frequency. In these experiments, only the sample collected before stimulus 
application and the two samples collected after stimulation were retained for 
analysis. Bath aliquots (50–250 𝜇L) were frozen in liquid nitrogen immediately after 
collection, stored at −20C (the enzymes are stable for at least 4 weeks) and 
analysed within 1 week of collection by HPLC with diode array detection (Finigan 
Thermo Fisher Scientific System LC/DAD, equipped with an Accela Pump coupled 
to an Accela Autosample, a diode array detector and an Accela PDA running the 
X-Calibur software chromatography manager). Chromatographic separation was 
carried out through a Hypersil GOLD C18 column (5 𝜇M, 2.1mm × 150 mm) 
equipped with a guard column (5 𝜇m, 2.1mm × 1 mm) using an elution gradient 
composed of ammonium acetate (5mM, with a pH of 6 adjusted with acetic acid) 
and methanol. During the procedure the flow rate was set at 200 𝜇L/min and the 
column temperature was maintained at 20C. The autosampler was set at 4C and 
50 𝜇L of standard or sample solution was injected, in duplicate, for each HPLC 
analysis. In order to obtain chromatograms and quantitative analysis with maximal 
sensibility, the diode array detection wavelength was set at 259 nm for adenosine 
and 248 nm for inosine.  
In parallel, the ATP content of the same samples was evaluated with the 
luciferin-luciferase ATP bioluminescence assay kit HS II (Roche Applied Science, 
Indianapolis, Indiana). Luminescence was determined using a multi detection 
microplate reader (SynergyHT, BioTek Instruments).  
Stimulation-evoked release of adenine nucleotides and nucleosides was 
calculated by subtracting the basal release, measured in the sample collected 
before stimulation, from the total release of adenine nucleotides and nucleosides 
determined after stimulus application.  
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Myographic recordings of ileal contractile activity 
The contractile activity of the LM-MP was recorded as previously described 
(Vieira et al. 2009, 2011; Mendes et al., 2015). Ileum strips from control and 
TNBS-treated rats were mounted along the longitudinal axis in 14 ml capacity 
perfusion chambers connected to isometric force transducers. The changes in 
tension were recorded continuously with a PowerLab data acquisition system 
(Chart 5, v.4.2; AD Instruments, USA). Tissues were preloaded with 0.5 g of 
tension and allowed to equilibrate for 90 min under continuous superfusion with 
gassed (95% O2 and 5% CO2) Tyrode’s solution at 37°C.  
Immunofluorescence staining and confocal microscopy observation 
LM-MP fragments were isolated from the rat ileum as previously described. 
The LM-MP fragments were stretched to all directions and pinned onto Petri 
dishes coated with Sylgard®. The tissues, then, were fixed in PLP solution 
(paraformaldehyde 2%, lysine 0.075M, sodium phosphate 0.037M, sodium 
periodate 0.01 M) for 16 h at 4C. Following fixation, the preparations were 
washed three times for 10 min each using 0.1M phosphate buffer. At the end of 
the washout period, tissues were cryoprotected during 16 h with a solution 
containing anhydrous glycerol 20% and phosphate buffer 0.1M at 4C and, then, 
stored at −20C for further processing. Once defrosted, tissue fragments were 
washed with tamponated phosphate saline buffer (PBS) and incubated with a 
blocking buffer, consisting in foetal bovine serum 10%, bovine serum albumin 1%, 
triton X-100 1% in PBS, for 2 hours; washout was facilitated by constant stirring of 
the samples. After blocking and permeabilization, samples were incubated with 
selected primary antibodies (see Table 1) diluted in the incubation buffer (foetal 
bovine serum 5%, serum albumin 1%, Triton X-100 1% in PBS), at 4C, for 48 h. 
For double immunostaining, antibodies were combined before application to tissue 
samples. Following the washout of primary antibodies with PBS supplemented 
with Triton X 1% (3 cycles of 10 min), tissue samples were incubated with species-
specific secondary antibodies in the dark for two hours, at room temperature. 
Finally, tissue samples were mounted on optical-quality glass slides using 
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VectaShield as mounting media (VectorLabs) and stored at 4C. Observations 
were performed and analyzed with a laser scanning confocal microscope 
(Olympus FluoView, FV1000, Tokyo, Japan). 
 
Table 11: Primary and secondary antibodies used in immunohistochemistry experiments 
ANTIGEN CODE SPECIES DILUTION SUPPLIER 
 
Primary antibodies 
    
PGP 9.5 7863-1004 Mouse (ms) 1:500 Serotec 
NF200 ab8135 Rabbit (rb) 1:1000 ABCAM 
VaChT AB1588 Guinea-pig (gp) 1:500 Chemicon 
nNOS ab1376 Goat (gt) 1:300 ABCAM 
GFAP MAB360 Mouse (ms) 1:600 Chemicon 
S100 Ab868 Rabbit (rb) 1:400 ABCAM 
Vimentin M0725 Mouse (ms) 1/150 Dako 
Ano-1 Ab53212 Rabbit (rb) 1:100 ABCAM 
P2X7 APR-004 Rabbit (rb) 1/50 Alomone 
CD11B (OX42) Sc-53086 Mouse (ms) 1/50 Santa Cruz 
 
Secondary antibodies 
    
Alexa Fluor 488 anti-rb  A-21206 Donkey 1:1000 Molecular probes 
Alexa Fluor 488 anti-ms A21202 Donkey 1:1000 Molecular probes 
Alexa Fluor 568 anti-gt A11057 Donkey 1:1000 Molecular probes 
Alexa Fluor 568 anti-ms A-10037 Donkey 1:1000 Molecular probes 
Alexa Fluor 633 anti-ms A21052 Goat 1:1000 Molecular probes 
TRITC 568 anti-gp 706-025-148 Donkey 1:150 Jackson Immuno 
Research 
Dylight 649 anti-gp 706-025-148 Donkey 1:100 Jackson Immuno 
Research 
 
 
 Materials and solutions 
2,4,6-trinitrobenzenesulphonic acid (TNBS); carbenoxolone, choline 
chloride, paraformaldehyde (prills), lysine, sodium periodate, anhydrous glycerol, 
fetal bovine serum (Sigma, St Louis, MO, USA); serum albumin, triton X-100, 
metanol, potassium dihydrogen phosphate (KH2PO4) (Merck, Darmstadt, 
Germany); A438079, mibefradil dihydrochloride, L-NAME, tetrodotoxin (TTX) 
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(Tocris Cookson Inc., UK); Sodium Fluoroacetate (Supelco); [methyl-3H]-choline 
chloride (ethanol solution, 80 Ci mmol−1) (Amersham, UK); ATP bioluminescence 
assay kit HS II (Roche Applied Science, Indianapolis, Indiana); medetomidine 
hydrochloride (Domitor, Pfizer Animal Health); atipamezole hydrochloride 
(Antisedan, Orion, Espoo, Finland); ketamine hydrochloride (Imalgene, Merial, 
Lyon, France); Sodium chloride 0.9%, tramadol hydrochloride (Labesfal, Santiago 
de Besteiros, Portugal).  
 
All drugs were prepared in distilled water. All stock solutions were stored as 
frozen aliquots at −20C. Dilutions of these stock solutions were made daily and 
appropriate solvent controls were done. No statistically significant differences 
between control experiments, made in the absence or in the presence of the 
solvents at the maximal concentrations used (0.5% v/v), were observed. The pH of 
the perfusion solution did not change by the addition of the drugs in the maximum 
concentrations applied to the preparations. 
 
 
Presentation of data and statistical analysis 
The values are expressed as mean ± SEM, with 𝑛 indicating the number of 
animals used for a particular set of experiments. Statistical analysis of data was 
carried out using paired or unpaired Student’s t-test with Welch correction. P<0.05 
represents significant differences. 
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RESULTS 
 
Postinflammatory ileitis causes an increase in enteric glial cells (types III 
and IV) and a partial loss of pacemaker interstitial cells of Cajal / fibroblast-
like cells 
Structural changes accompanied by neuronal cell death have been 
observed in chronic intestinal inflammation (Sanovic et al., 1999; Linden et al., 
2005; Venkataramana et al., 2015). However, we found no obvious changes in the 
amount of neurons stained positively against (1) neurofilament NF200 expressed 
predominantly in Dogiel type I and II neurons (Hu et al., 2002), and (2) the pan-
neuronal marker, protein gene product 9.5 (PGP 9.5), in the myenteric plexus 7 
days after instillation of TNBS into the lumen of ileum compared to control rats 
treated with saline (Figure 23c-f). This is compatible with Moreels et al. (2001) 
findings showing that TNBS-induced ileitis in the rat lacks the chronic inflammatory 
phase and is characterized by an acute transmural inflammation that is 
accompanied by functional abnormalities of neuronal activity which persists for at 
least 8 weeks without obvious neuronal loss (Stewart et al., 2003; Nurgali et al., 
2007). Conversely, these authors found alterations in longitudinal muscle 
contractility which was attributed to structural thickness of the ileal wall.   
Confocal micrographs show that neuronal cells are grouped in small 
clusters (enteric ganglia), which are interconnected by nerve fibre bundles from 
whom emerge small diameter nerve terminals (see e.g. Furness, 2006). 
Inflammatory infiltrates consisting of monocytes/ macrophages exhibiting 
immunoreactivity against the integrin CD11B/OX42 were found surrounding the 
myenteric plexus of TNBS-treated rats (Figure 23b), but not in preparations from 
control animals (Figure 23a). The absence of inflammatory cells inside myenteric 
ganglia has been observed before (see e.g. Figures 24B and 27B) and this is why 
myenteric ganglia are considered an immune-privileged tissue (Bradley et al., 
1997).   
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Figure 23: Confocal micrographs of whole-mount preparations of the longitudinal muscle-
myenteric plexus of the ileum of control and TNBS-treated rats. Z-stacks illustrate the 
immunoreactivity against CD11B/αM (OX42) (marker of inflammatory cells) (a,b), NF200 
(neurofilament expressed in neurons) (c,d), PGP9.5 (pan-neuronal cell marker) (e,f), vimentin 
(intermediate filament of mesenchymal cells, like ICCs and FLCs) (g,h), GFAP (i,j) and S100β (k,l) 
(enteric glial cells markers). Images are representative of at least four individuals per group. Scale 
bars = 100 µm. 
 
Enteric glial cells express astrocytic cell markers, including the intermediate 
filament glial fibrillary acidic protein (GFAP) and the calcium-binding protein S100β 
(Gulbrasen & Sharkey, 2012). Subtypes of enteric glia are classified in: type I, 
intraganglionic cells; type II, within interganglionic fibers; type III, form a matrix in 
the extraganglionic region remaining in close association with neuronal bundles; 
and type IV, elongated glia running with nerve fibres within the musculature 
(Boesmans et al., 2015). Figure 23i-l shows that the myenteric plexus of rats 
treated with TNBS exhibits increased amounts of GFAP- and S100β-positive glial 
cells, which are particularly evident in extraganglionic (glial type III) and 
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intramuscular regions (glial type IV). Thus, in contrast to the absence of significant 
structural changes in the neuronal cell population, TNBS-induced ileitis stimulates 
enteric glial cells proliferation (Bradley et al., 1997) or, at least, the increase in 
expression and/or synthesis of glial protein cell markers (Cabarrocas et al., 2003), 
in a similar manner to that observed in astrocytes of the CNS (Lhermitte et al. 
1980; Rühl et al., 2004). 
Interstitial cells of Cajal and fibroblast-like cells (ICC/FLC) are known to act 
as pacemaker cells and integrators of nerve activity and smooth muscle 
contraction, respectively (Sanders, 1996). The number of these cells can 
significantly change in pathological conditions (Ekblad et al., 1998). Using 
vimentin, a characteristic intermediate filament of mesenchymal cells like 
ICC/FLC, we show here that the density of vimentin-positive cells decrease 
significantly in the myenteric plexus of TNBS-induced ileitis (Figure 23h) compared 
to control preparations (Figure 23g). Likewise, staining with anoctamine-1 (Ano-1), 
a calcium-activated chloride channel involved in the pacemaker activity of ICCs 
(Gomez-Pinilla et al., 2009), also decreased in density 7-days after instillation of 
TNBS into the lumen of the rat ileum (Figure 24A). The partial loss of Ano-1 
immunoreactivity was detected by confocal microscopy focusing in the ganglion 
layer (myenteric stellate cells; Figure 24Aa and 24Ab) and in the neuromuscular 
region (intramuscular spindle-shape cells, Figure 24Ac and 24Ad) of inflamed LM-
MP preparations. The presence of auto-fluorescent inflammatory cells (coloured in 
red) was more visible surrounding the myenteric ganglia than at the intramuscular 
layer of TNBS-treated rats (see inset of Figure 24A).  
The loss of ICC/FLC may affect the frequency of spontaneous enteric 
contractions (Kinoshita et al., 2007). In fact, myographic recordings demonstrate 
that the frequency of spontaneous contractions of LM-MP preparations of the 
ileum of TNBS-treated animals were less frequent (P<0.05) than those observed in 
control animals (Figure 24A).  
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Figure 24: The partial loss of anoctamine-1 (Ano-1)-positive interstitial cells in the myenteric plexus 
of TNBS-treated rats correlates with the reduction in the frequency of spontaneous contractions of 
the rat ileum. (A) Confocal micrographs of whole-mount preparations of the ileum of control and 
TNBS-injected rats taken at the myenteric ganglion level (a,b) and at the longitudinal smooth 
muscle layer (c,d). Shown is the immunoreactivity against Ano-1, a calcium-activated chloride 
channel involved in the pacemaker activity of ICCs. At the ganglion level, but not at the 
neuromuscular junction layer, it is possible to visualize autofluorescent inflammatory cells (stained 
in red, inset) infiltrating the myenteric plexus of TNBS-treated rats. Images are representative of at 
least five individuals per group. Scale bars = 100 µm. (B) Histograms representing the frequency of 
spontaneous myographic contractions of the ileum from control rats and TNBS-treated animals. 
The data are means ± SEM of a n number of animals. *P<0.05 (unpaired Student’s t-test with 
Welch correction) represents a significant difference from control animals. 
 
Myenteric neurons from the ileum of TNBS-treated rats release smaller 
amounts of [3H]ACh, but no relationship exists between cholinergic 
hypoactivity and nitrergic inhibitory signals 
ACh is the prime regulator of intestinal motility and is the most important 
excitatory neurotransmitter in the myenteric plexus (Costa et al., 1996). Figure 25A 
shows that cholinergic neurons from the myenteric plexus of TNBS-treated rats 
release significantly smaller amounts of [3H]ACh (see also Collins et al., 1992a; 
Davis et al., 1998), despite no obvious changes were detected by confocal 
microscopy in the density of cholinergic nerve fibres stained specifically against 
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the vesicular acetylcholine transporter (VAChT) (Arvidsson et al., 1997) (Figure 
25B).  
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Figure 25: Electrically-stimulated myenteric neurons of TNBS-treated rats release smaller amounts 
of [
3
H]ACh. (A) Shown is the amount of [
3
H]ACh released from electrically-stimulated (5 Hz, 1 ms, 
200 pulses) myenteric neurons of the ileum of control and TNBS-treated rats during S1 in 
desintegrations per min (DPM)/g of wet tissue. (B) Confocal micrographs of whole-mount 
preparations of the longitudinal muscle-myenteric plexus of the ileum from control and TNBS-
treated rats stained against the vesicular ACh transporter (VAChT). The z-stacks shown are 
representative of at least five individuals per group. Scale bar = 100 µm.  
 
These results prompted us to investigate whether cholinergic nerve 
hypoactivity had any relationship with increased inhibitory neurotransmission 
operated by NO, which can be released from neighbouring nitrergic nerves, enteric 
glia cells and/or infiltrating immunocytes (MacEachern et al., 2015; see also Figure 
26A). This was hypothesized because up-regulation of nitric oxide synthase (NOS) 
activity and enhancement of NO-mediated inhibitory neurotransmission were 
demonstrated in chronic inflammatory bowel diseases (Miller et al., 1993). Figure 
26B shows that inhibition of NOS activity with L-NAME (100 µM) had no effect on 
evoked [3H]ACh release from the LM-MP of the ileum of control and TNBS-treated 
rats, indicating that NO does not mediate inhibition of [3H]ACh release in TNBS-
induced ileitis. This was concluded despite the relative increase in neuronal NOS-
immunoreactivity in enteric ganglia cells of TNBS-treated animals (Figure 26Aii). 
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Figure 26: (A) Confocal micrographs of whole-mount preparations of the longitudinal muscle-
myenteric plexus of the ileum from control and TNBS-treated rats taken at the myenteric ganglion 
level (i,ii) and at the longitudinal smooth muscle layer (iii,iv). Shown is the immunoreactivity against 
neuronal NOS (nNOS); myenteric ganglia from TNBS-treated rats exhibit a higher number of 
nNOS-positive neuronal cell bodies than control tissues. The z-stack presented in panel (v) shows 
that nNOS-positive nitrergic nerve fibres (red) are adjacent, but do not co-localize, with VAChT 
immunoreactivity (green). Images are representative of at least four individuals per group. Scale 
bar = 100 µM. (B) Effect of the nitric oxide synthase (NOS) inhibitor, L-Name (100 µM), on [
3
H]ACh 
released from stimulated myenteric neurons of the ileum of control and TNBS-treated rats. After 
loading and washout periods, [
3
H]ACh release was elicited by two trains (S1 and S2) of electrical 
field stimulation, each consisting of 200 pulses delivered at a 5 Hz frequency. L-Name (100 μM) 
was applied 8 min before S2. The ordinates are changes in S2/S1 ratios compared to the S2/S1 ratio 
obtained without addition of any drug. The data are means ± SEM of four to six individuals. 
*P<0.05 (unpaired Student’s t-test with Welch correction) represent significant differences from 
control animals.  
  
Postinflammatory shift from neuronal to non-neuronal control of evoked 
[3H]ACh release from stimulated myenteric neurons 
Figure 27A shows that [3H]ACh release from electrical-stimulated ileal 
myenteric neurons of healthy rats was almost prevented (P<0.05) by the blockage 
of nerve action potentials with tetrodotoxin (TTX, 1 µM). This confirms our previous 
observations, where we also demonstrated that [3H]ACh exocytosis from 
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depolarized myenteric nerve terminals depend on Ca2+ influx through voltage-
sensitive channels (Duarte-Araújo et al., 2004a; 2004b; Correia-de-Sá et al., 
2006). Interestingly, inhibition of the electrically-driven [3H]ACh outflow from 
TNBS-treated preparations was much less sensitive to TTX (1 µM) than controls 
(Figure 27A), suggesting that [3H]ACh outflow in TNBS-induced ileitis is likely due 
to direct axonal activation by  a non-neuronal released activator (Broadhead et al., 
2012; Gulbransen et al., 2012). 
Under the present experimental conditions, the influence of smooth muscle 
contractions was ruled out since the Cav1 (L-type) channel blocker, nifedipine (1 
µM), depressed ACh-induced contractions of the longitudinal muscle without 
affecting the release of [3H]ACh from stimulated LM-MP of both control (Correia-
de-Sá et al., 2006) and TNBS-treated rats (unpublished observations). Likewise, 
we discarded the participation ICC/FLC in the regulation of evoked [3H]ACh 
release in both animal groups, because the transmitter release was not (P>0.05) 
affected when the experiments were performed in the presence of selective 
inhibitors of ICC/FLC activity, namely  mibefradil (3 µM) (Figure 27A) and apamin 
(3 µM) (data not shown), which block specifically voltage-sensitive Cav3 (T-type) 
and small-conductance KCa2 (SK3) channels characteristic of these cells, 
respectively (Fujita et al., 2003).  
Therefore, we tested whether inhibition of enteric glial metabolism with 
sodium fluoroacetate (5 mM) (MacEachern et al., 2015) could affect [3H]ACh 
release from stimulated myenteric neurons. Figure 27A, shows that while sodium 
fluoroacetate (5 mM)  was unable to change transmitter release in preparations 
from healthy rats, it significantly (P<0.05) decreased evoked [3H]ACh release from 
myenteric neurons of TNBS-treated animals. These results led us to the 
hypothesis that maintenance of minimal cholinergic tone in postinflammatory ileitis 
depends on the release of an excitatory gliotransmitter from proliferating enteric 
glial cells. 
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Figure 27: (A) Effects of TTX (1 μM, a nerve action potential blocker), sodium fluoroacetate (5 mM, 
a glial cell metabolism uncoupler), mibefradil (3 μM, an inhibitor of Cav3 (T-type) channels existing 
in ICC/FLC), carbenoxolone (10 µM, a pannexin-1 inhibitor) and A438079 (3 µM, a P2X7 receptor 
antagonists) on electrically-evoked [
3
H]-ACh release from the LM-MP of the rat ileum of control and 
TNBS-treated rats. After loading and washout periods, [
3
H]ACh release was elicited by two trains 
(S1 and S2) of electrical field stimulation, each consisting of 200 pulses delivered at a 5 Hz 
frequency. Drugs were applied 8 min before S2. Abscissa is changes in S2/S1 ratios compared to 
the S2/S1 ratio obtained without addition of any drug. The data are means ± SEM of four to seven 
individuals. *P<0.05 (unpaired Student’s t-test with Welch correction) represent significant 
differences from the situation where no drugs were added (dashed vertical line). (B) Confocal 
micrographs of whole-mount preparations of the longitudinal muscle-myenteric plexus of the ileum 
from control and TNBS-treated rats. Shown is the immunoreactivity against the P2X7 receptor and 
the enteric glial cell marker, S100β. Please note the presence of autofluorescent inflammatory cells 
(red dots) outside myenteric ganglia in TNBS-treated preparations. Z-stacks shown in the pictures 
are representative of at least four individuals per group. Scale bar=100 µm. 
 
ATP may be the putative excitatory gliotransmitter responsible for 
maintaining the cholinergic tone in postinflammatory ileitis 
The nature of the putative excitatory gliotransmitter regulating ACh release 
from inflamed myenteric neurons is uncertain. Considering our previous 
observations that (1) ATP can be released from both neuronal and non-neuronal 
cells, and that (2) it can increase the release of [3H]ACh from resting myenteric 
nerve terminals through the activation of ionotropic P2X receptors in the presence 
of TTX (Duarte-Araújo et al., 2009), we designed experiments to test if 
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endogenous ATP could play any role in the regulation of ACh release in TNBS-
induced ileitis.      
Recently, our group demonstrated that ATP can be released from non-
neuronal cells through hemichannels containing pannexin-1 and this mechanism 
can lead to a “vicious cycle” where ATP can induce the release of ATP via the 
activation of ionotropic P2X and metabotropic P2Y receptors under normal and 
pathological conditions (Pinheiro et al., 2013; Timóteo et al., 2014; Noronha-Matos 
et al., 2014; Silva et al., 2015; Certal et al., 2015). High extracellular ATP levels, 
such as those detected after an inflammatory insult, can stimulate low-affinity 
P2X7 receptors, which often but not exclusively couple to pannexin-1 to promote 
ATP outflow, via the pannexin-1 hemichannel or the P2X7 receptor pore (Diezmos 
et al., 2013; Gulbransen et al., 2012). This prompted us to investigate the role of 
pannexin-1 hemichannels and P2X7 receptors on [3H]ACh release from stimulated 
LM-MP preparations of control and TNBS-treated rats using specific inhibitors.  
Figure 27A, shows that selective blockage of pannexin-1 hemichannels and 
P2X7 receptors respectively with carbenoxolone (10 µM) and A438079 (3 µM) 
significantly (P<0.05) decreased [3H]ACh release from myenteric neurons of 
TNBS-treated rats, but not of their control littermates. The magnitude of the 
inhibitory effects on transmitter release produced by carbenoxolone (10 µM) and 
A438079 (3 µM) was about the same that observed upon blocking glial cells 
metabolism with sodium fluoroacetate (5 mM) (Figure 27A). Moreover, the 
distribution of the P2X7 immunoreactivity in the myenteric plexus of both groups of 
animals is remarkably similar to that of the glial cell marker, S100β (Figure 27B). 
Co-localization of the P2X7 receptor and the S100β glial marker was 
demonstrated in the rat myenteric plexus before (Vanderwinden et al., 2003; 
reviewed in Gulbransen & Sharkey, 2012).  
Postinflammatory myenteric glial cells release higher amounts of ATP  
In a previous study from our group, we demonstrated that ATP is released 
in higher amounts from electrically-stimulated TNBS-treated preparations than in 
control tissues (Vieira et al., 2014). High postinflammatory ATP levels are 
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comparable to those obtained in control LM-MP preparations submitted to 
blockage of action potentials generation, of glial cells metabolism and of ICC/FLC 
activation respectively with TTX (1 µM), sodium fluoroacetate (5 mM) and 
mibefradil (3 µM) (Figure 28A). These findings indicate that all these cells 
contribute to keep low extracellular ATP levels in normal physiological conditions. 
However, this scenario changes considerably in TNBS-induced ileitis. From the 
inhibitors used to target specifically the three resident cell types in the myenteric 
plexus, only sodium fluoroacetate (5 mM) was able to decrease significantly 
(P<0.05) the release of ATP in postinflammatory ileitis, while TTX (1 µM) and 
mibefradil (3 µM) were both ineffective (Figure 28A).  
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Figure 28: Differential effects of TTX (1 μM), sodium fluoroacetate (5 mM) and mibefradil (3 μM) 
on ATP and adenosine (plus inosine) ouflow from stimulated longitudinal muscle-myenteric plexus 
preparations of the ileum from control and TNBS-treated rats. Drugs were in contact with the 
preparations for at least 15 min before stimulus application (5 Hz frequency, 3000 pulses of 1 ms 
duration). Samples from the incubation media were collected and analysed in parallel using the 
luciferin-luciferase bioluminescence assay and HPLC with diode array detection to evaluate their 
content in ATP (A) and adenine nucleosides (B), respectively. Ordinates represent stimulation-
induced increases in ATP (A) and adenosine (plus inosine) (B) above baseline levels determined 
immediately before the stimulus application; results are expressed in pmol/mg of tissue. The data 
are means ± SEM of four to six individuals. *P<0.05 (unpaired Student’s t-test with Welch 
correction) represent significant differences from the amount of purines released in control 
conditions where no drugs were added to the preparations (dashed horizontal lines). 
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Thus, increased overflow of ATP after an inflammatory insult may possibly 
result from activation of proliferating glial cells. Interestingly, the pharmacology 
affecting ATP overflow from stimulated ileal preparations of TNBS-treated rats 
(Figure 28A) looks like that verified by measuring the release of [3H]ACh (Figure 
27A), further strengthening our hypothesis that ATP may be the putative excitatory 
gliotransmitter responsible for maintaining the cholinergic tone in TNBS-induced 
ileitis. 
Deficient extracellular adenosine accumulation in postinflammatory ileitis 
parallels the loss of ICC/FLC  
Although adenosine may be released from activated inflammatory cells 
(Marquardt et al., 1984) in the vicinity of myenteric neurons (Bogers et al., 2000), 
the loss of adenosine neuromodulatory control of evoked [3H]ACh release in 
TNBS-induced ileitis detected in a previous report results mainly from deficient 
accumulation of the nucleoside at the myenteric synapse (Vieira et al., 2014); this 
was verified despite the increase in ATP content of the same samples. Uncoupling 
between ATP overflow and adenosine levels in postinflammatory ileitis was 
ascribed to feed-forward inhibition of ecto-5’-nucleotidase/CD73 and upregulation 
of adenosine deaminase. Here, we decided to evaluate the putative contribution of 
inflammation-induced type-specific cell density changes in the myenteric plexus to 
adenosine deficiency. To this end, we measured the extracellular concentration of 
adenosine (plus inosine) in parallel with the ATP levels before and after electrical 
stimulation of LM-MP preparations of both control and TNBS-treated rats in the 
presence of cell-specific activity inhibitors. Figure 28B shows that the amounts of 
adenosine released into the extracellular fluid following stimulation of the LM-MP 
are much higher in healthy controls than in TNBS-treated rats.  
Stimulus-evoked adenosine release was partially dependent on neuronal 
activity in preparations from healthy rats, but not in the ileum of TNBS-treated 
animals. This was assumed because pre-treatment of the preparations with TTX 
(1 µM) reduced by about 50% the outflow of adenine nucleosides in control tissues 
with no effect on TNBS-treated preparations. This means that the neuronal source 
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of adenosine may be severely affected in TNBS-induced ileitis due to neuronal 
cells dysfunction (see above). Even though we considered unlikely that 
proliferating glial cells could contribute to adenosine deficits in the inflamed 
myenteric plexus of the rat ileum, we tested the effect of the glial cell metabolic 
uncoupler, sodium fluoroacetate (5 mM). Inhibition of glial cells metabolism had 
only a limited effect on adenosine outflow from stimulated LM-MP preparations of 
both control and TNBS-treated rats (Figure 28B). The inhibitory action of sodium 
fluoroacetate (5 mM) was slightly more evident in healthy tissues than in TNBS-
treated preparations, which is in agreement with the proposed uncoupling between 
ATP overflow and adenosine formation secondary to the inflammatory insult.  
Prevention of smooth muscle contractions with the voltage-sensitive Cav1 
(L-type) channel inhibitor, nifedipine (5 µM), did not affect the release of adenosine 
(plus inosine) in both animal groups (Correia-de-Sá et al., 2006; Vieira et al., 2009; 
2014). However, blockade of Cav3 (T-type) channels expressed in ICC/FLC with 
mibefradil (3 µM) significantly (P<0.05) attenuated the release of adenosine (plus 
inosine) from both control and TNBS-treated animals. Taking into consideration 
previous findings from our laboratory demonstrating that the nucleoside transport 
inhibitor, dipyridamole (0.5 µM), decreased proportionally and by a similar amount 
to that obtained with mibefradil (3 µM) the outflow of adenosine (plus inosine) from 
both control and inflamed tissues (Vieira et al., 2014), it is very likely that 
adenosine accumulated in the ileum following an inflammatory insult originates 
predominantly from activated ICC/FLC via equilibrative nucleoside transport. 
 
DISCUSSION AND CONCLUSIONS  
 
A number of key cellular players may be involved in the reaction to 
inflammatory insults by the gastrointestinal system. These include inflammatory 
cells, such as granulocytes, lymphocytes, mast cells, monocytes and 
macrophages, which release numerous cytokines, pro-inflammatory peptides, 
neuroactive and neurotrophic factors, noxious compounds, inflammatory enzymes 
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and other danger signalling molecules. Enteric plasticity comprises a wide range of 
structural and/or functional changes in enteric neurons, glial cells and interstitial 
cells (ICC/FLC). As a result of adaptive responses to different types of 
pathophysiological conditions, enteric neurons are able to rapidly change their 
structure, function and chemical phenotype in order to maintain homeostasis of gut 
functions. In contrast to long-term functional abnormalities in the activity of 
neuronal cells described by several authors (Stewart et al., 2003; Nurgali et al., 
2007) and confirmed in the present study by denoting hypoactivity of cholinergic 
neurotransmission, we found no obvious modifications in cellular density and 
distribution of specific neuronal cell markers (e.g. NF200, PGP 9.5) in TNBS-
induced ileitis. In this sense, ileitis caused by TNBS differs from other chronic 
inflammatory disease models because it lacks the chronic inflammatory phase 
(Moreels et al., 2001) that is usually accompanied by neuronal cell loss (Sanovic 
et al., 1999; Linden et al., 2005; Venkataramana et al., 2015). Notwithstanding, 
this constrain may be turned into an advantage characteristic of this animal model 
if one wants to investigate the adaptive changes of neuronal to non-neuronal cells 
communication after a transient inflammatory insult, as we aimed in this work.          
Results show that stimulated myenteric neurons release smaller amounts of 
[3H]ACh in the ileum of TNBS-treated rats compared to their control littermates,  
without evidence of any alteration of VAChT-positive cholinergic nerve fibres in the 
myenteric plexus. Likewise, significant decreases in [3H]choline uptake, 
acetylcholine release and contractile responses to stimulation of enteric nerves 
have been observed in rats with colitis induced by TNBS (Poli et al., 2001). These 
results imply a functional loss, not corresponding to cellular depletion, of 
cholinergic neurotransmission in inflamed tissues (Collins et al.,1992a). The 
mechanism underlying attenuation of ACh release in the inflamed rat intestine has 
been a matter of debate in the literature, but so far there is no unifying theory 
given the contradictory findings when looking at different immune cell players and 
inflammatory mediators (e.g. Davis et al., 1998). This is so, even though 
evidences have been produced showing that cytokines may directly change 
neurotransmitters content and release (Collins et al., 1992b). This strengthens our 
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hypothesis that functional and structural adaptations of resident myenteric cell 
populations of the rat ileum may also play a relevant role in the mechanisms 
underlying downregulation of cholinergic neurotransmission in TNBS-induced 
ileitis.    
Using immunofluorescence confocal microscopy, we show here that the 
LM-MP of the rat ileum becomes deficient in Ano-1 positive ICCs, both in the 
ganglion layer (myenteric stellate cells) and at the neuromuscular region 
(intramuscular spindle-shape cells). The same occurred regarding immunostaining 
against vimentin, which is an intermediate filament protein also present in FLC. 
Notwithstanding the fact that vimentin can stain more strongly ICC compared to 
FLC, since the former is enriched in intermediate filament fibres (Fujita et al., 
2003; Komuro et al., 1996), we were unable to conclusively distinguish the two cell 
types in this work and, for the sake of transparency, we prefer referring to these 
cells as interstitial cells or ICC/FLC. Investigations about many aspects of the role 
played by each of these cell types are deeply needed. In the more severe colitis 
rat model, muscularis resident macrophages have been implicated in the loss of 
ICC/FLC detected 7-days after instillation of TNBS (Kinoshita et al., 2007). An 
association between low numbers of CD206-positive anti-inflammatory 
macrophages with a loss of interstitial cells have been observed in patients with 
diabetic gastroparesis (Bernard et al., 2014). Porcher et al. (2002) demonstrated 
an almost complete abolition of interstitial cells in biopsy samples from patients 
with Crohn’s disease. The loss of ICCs may account for the decrease in the 
frequency of spontaneous contractions of LM-MP preparations of the ileum of 
TNBS-treated rats (this study), since these cells have been implicated in the 
generation of electrical slow waves regulating the phasic contractile activity of the 
gastrointestinal smooth muscle (Kinoshita et al., 2007). 
To our knowledge, this is the first time that a loss of ICC/FLC in the 
myenteric plexus of the rat ileum following an inflammatory insult is associated 
with the depletion of the extracellular adenosine levels compared to normal 
physiological condition. This was suggested because the lowest extracellular 
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adenosine levels in the ileum were detected upon blocking ICC/FLC activity with 
the Cav3 (T-type) channel inhibitor, mibefradil, both in control conditions and after 
the inflammatory insult with TNBS. Therefore, it is highly likely that this 
mechanism, together with the feed-forward inhibition of ecto-5’-nucleotidase/CD73 
and upregulation of adenosine deaminase shown in a previous study (see Vieira et 
al., 2014), may concur to prevent adenosine-mediated actions in TNBS-induced 
ileitis. Considering that, under normal physiological conditions, endogenous 
adenosine facilitates [3H]ACh release from stimulated myenteric neurons through 
the preferential activation of prejunctional A2A receptors (Duarte-Araújo et al., 
2004a), one may speculate that cholinergic hypoactivity in TNBS-induced ileitis is 
dependent on the loss of adenosine A2A receptor-mediated neurofacilitation. 
Moreover, one must not forget that neurons are also an important source of 
extracellular adenosine in the ileum of healthy animals (Correia-de-Sá et al., 2006) 
and this resource may turn to be deficient accompanying inflammation-induced 
functional abnormalities of myenteric neurons, which cannot be compensated by 
the loss of ICC/FLC.    
Purinergic re-enforcement to maintain cholinergic neurotransmission during 
high enteric nerve activity or whenever endogenous levels of adenosine become 
elevated has been observed in hypoxia, inflammation and postoperative ileum 
(Milusheva et al., 1990; De Man et al., 2003; Kadowaki et al., 2003). In a previous 
study, we provided evidences suggesting that muscarinic M3 receptors activation 
by neuronally-released ACh triggers a positive feedback loop leading to facilitation 
of transmitter release that is indirectly mediated by adenosine outflow and 
activation of prejunctional A2A receptors (Vieira et al., 2009), but at that time we 
had no information regarding the cellular players of the SIP syncytium involved in 
this pathway. Nowadays, we learned that ICC/FLC are endowed with muscarinic 
M3 receptors coupled to Gq/11 (reviewed in Goyal, 2013) and these receptors can 
be activated by inhibiting endogenous ACh breakdown with physostigmine 
resulting in adenosine overflow from the myenteric plexus of healthy rats (Vieira et 
al., 2009). Activation of phospholipase C (PLC) by muscarinic M3 receptors causes 
the formation of IP3 and DAG with subsequent recruitment of intracellular Ca
2+ and 
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protein kinase C activation, respectively (Koh & Rhee, 2013). Increases in 
intracellular Ca2+ can strengthen activation of protein kinase C, which 
subsequently stimulates adenosine outflow via the equilibrative transporter ENT1 
(Coe et al., 2002). Increase in protein kinase C activity might also stimulate 5’-
nucleotidase inside cells (Obata et al., 2001) and/or inhibit adenosine kinase 
(Sinclair et al., 2000), enhancing intracellular adenosine accumulation and the 
efflux of the nucleoside from the cells. These hypotheses were confirmed in the 
myenteric plexus of healthy rats incubated with the protein kinase C activator, 
phorbol 12-myristate 13-acetate, whereas extracellular adenosine accumulation 
was prevented by inhibiting the equilibrative nucleoside transport system with 
dipyridamole (Vieira et al., 2009). 
In this context, our current vision about these processes is that the loss of 
ICC/FLC expressing muscarinic M3 receptors in TNBS-induced ileitis contributes to 
reduce extracellular adenosine accumulation, breaking down the amplification loop 
initiated by ACh release from myenteric neurons, mediated by muscarinic M3 
receptors-induced adenosine overflow from ICC/FLC, and concluded through the 
activation of facilitatory A2A receptors on cholinergic nerve terminals. To our 
knowledge, this is the first time adenosine release from myenteric ICC/FLC is 
implicated in functional cholinergic nerve abnormalities in postinflammatory ileitis.  
While the findings discussed so far may justify the downregulation of 
cholinergic neurotransmission in TNBS-induced ileitis, they fail to explain why ACh 
release from inflamed myenteric neurons becomes resistant to blockade of nerve 
action potentials with TTX and the mechanism(s) underlying the TTX-resistant 
transmitter release that is still significant in inflamed preparations. The appearance 
of TTX-resistant sodium currents has been observed before in TNBS-induced 
ileitis (Stewart et al., 2003). Interestingly, the pharmacology concerning the 
modulation of [3H]ACh release from myenteric motor neurons of TNBS-treated rats 
is remarkably similar to that obtained when attempting to control ATP release in 
the same preparations. Notwithstanding the fact that inflammation-induced 
variations in the myenteric concentrations of ACh and ATP diverge (i.e. ACh 
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decreases and ATP increases), the release of the two transmitters were 
significantly reduced in the presence of the gliotoxin, sodium fluoroacetate, but it 
was not affected by the neuronal activation blocker, TTX. These results led us to 
suggest that enteric glia cells are crucial to maintain ACh release from inflamed 
myenteric neurons and that ATP released from these cells may be the excitatory 
gliotransmitter responsible for keeping a minimal cholinergic tone in TNBS-induced 
ileitis. 
As a matter of fact, we observed increases in GFAP- and S100β-
immunoreactivities in TNBS-induced ileitis suggesting that the inflammatory insult 
may stimulate enteric glial cells proliferation (Bradley et al., 1997) and/or activate 
the expression/synthesis of glial protein cell markers (Cabarrocas et al., 2003). 
The release of cytokines and growth factors from inflammatory and immune cells 
may promote glial cells proliferation (Fields & Burnstock, 2006). On the other, 
enteric glial cells may secrete high amounts of neurotrophic factors, like NGF and 
GDNF, which may change the neurochemical code and content of 
neurotransmitters in myenteric neurons, even if they do not vary in terms of 
density (Von Boyen & Steinkamp, 2010).  Enteric glia cells may also be a source 
of pro-inflammatory cytokines, such as IL-6 and IL-1β (Stoffels et al., 2014), with 
IL-1β being associated with the suppression of ACh release from the myenteric 
plexus (Van Assche & Collins, 1996). However, if this were the case in TNBS-
induced ileitis, blockade of enteric glia cells metabolism would enhance, rather 
than decrease, evoked [3H]ACh release from myenteric motor neurons. Moreover, 
enteric glia contain neurotransmitter precursors, uptake and degrade neuroactive 
substances, express neurotransmitter receptors and provide neurosupportive 
actions (Vasina et al., 2006). Regarding recovery from inflammatory adaptive cell 
changes, it appears that enteric glial dysfunction does not persist after the 
resolution of intestinal inflammation in TNBS-treated animals, indicating that 
attempts to correct glial cells dysfunction may be restricted to the course of 
inflammatory adaptations (MacEachern et al., 2015).     
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The function of enteric glial cells is intimately tied to the levels of purines 
and membrane-bound ectonucleotidases, which regulate the availability of P2 
receptor ligands (Braun et al., 2004; Lavoie et al., 2011). Data from this study 
suggest that surplus ATP released by the myenteric plexus after an inflammatory 
insult may originate from proliferating glial cells, because ATP accumulation was 
reduced to control levels in the presence of the glial metabolic uncoupler, sodium 
fluoroacetate. ATP released from glial cells, acting most likely via prejunctional 
homodimer P2X2 or heterodimer P2X2/3 receptors, may trigger the release of 
ACh directly from cholinergic nerve terminals (Galligan, 2002; Castelluci et al., 
2002; Ren et al., 2003; Ohta et al., 2005;  Duarte-Araújo et al., 2009). Ionotropic 
P2X receptor subtypes are Ca2+ permeable non-selective cation channels (also 
permeable to Na+), which can also inhibit membrane potassium conductance in 
enteric neurons (Barajas-López et al., 1994). Via these mechanisms, ATP can 
cause membrane depolarization leading to a secondary opening of voltage-gated 
Ca2+ channels and to transmitter release in the absence of action potential 
generation (Duarte-Araújo et al., 2009; see also Barthó et al., 2006). Redistribution 
of NTPDase2, but not NTPDase3 from ganglia to the neuromuscular region leads 
to preferential ADP accumulation from released ATP, particularly when 
extracellular ATP levels reach the Vmax for NTPDase3 (Duarte-Araújo et al., 2009) 
like that occurring in inflamed neuromuscular synapses (Vieira et al., 2014). 
Inflammation-induced increase in the expression of NTPDase2 in intramuscular 
glia may also contribute to restrain nerve-evoked ACh release in TNBS-induced 
ileitis via the activation of ADP-sensitive inhibitory P2Y1 receptors in myenteric 
nerve terminals (Duarte-Araújo et al., 2009), yet this hypothesis needs 
experimental confirmation.        
Next we tried to investigate the mechanism underlying the control shift from 
neuronal to non-neuronal of ACh release in TNBS-induced ileitis. Results show 
that evoked ACh release from inflamed myenteric neurons was attenuated by 
blocking the P2X7 receptor-pannexin-1 pathway respectively with A438079 and 
carbenoxolone in a similar manner to that verified with sodium fluoroacetate. 
Interestingly, the P2X7 receptor immunoreactivity in the myenteric plexus of the rat 
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ileum is remarkably similar to that obtained for the glial cell marker, S100β, 
indicating that they may co-localize (Vanderwinden et al., 2003; reviewed in 
Gulbransen & Sharkey, 2012). Despite this, the P2X7 receptor is also expressed 
in neuronal soma and nerve terminals, but it is absent from smooth muscle fibres, 
ICC and FLC.  
The ionotropic P2X7 receptor is a non-selective cation channel allowing Na+ 
and Ca2+ influx and K+ efflux in the presence of high-micromolar ATP 
concentrations (Morandini et al., 2014). This receptor has been largely associated 
with inflammatory diseases, including inflammatory bowel diseases (Diezmos et 
al., 2013), and it can signal through caspase-1 to cause the production of IL-1β 
and IL-18 (Kurashima et al., 2012), as well as TNF-α and nitric oxide (Alves et al., 
2013), mostly from inflammatory cells. Likewise, pannexin-1 is expressed in a 
variety of immune cells and is required for caspase-1 cleavage in response to 
P2X7 receptor activation (Pelegrin & Surprenant, 2006). Interestingly, 
downregulation of pannexin-1 is associated with pro-inflammatory responses, 
whereas the opposite promotes anti-inflammatory reactions (Sáez et al., 2014). 
Pannexin-1, along with pannexin-2, is expressed in all layers of the human colon, 
including the mucosa, muscularis mucosa, submucosa and muscularis externa, 
where it is found preferentially in enteric ganglia, but also in the endothelium of 
blood vessels, epithelial cells and goblet cells (Diezmos et al., 2013; Maes et al., 
2015). The P2X7 receptor and pannexin-1 hemichannels form signalling 
complexes in several cell types and both structures may concur to release ATP 
from non-neuronal cells under physiological and pathological conditions. 
Interestingly, the selective P2X7 receptor antagonist, A438079, and the specific 
pannexin-1 inhibitor, carbenoxolone, did not modify evoked ACh release in the 
ileum of healthy rats where myenteric ATP levels are low, but they significantly 
decreased [3H]ACh overflow from preparations of TNBS-treated rats in conditions 
where extracellular ATP release from proliferating glial cells is assumed to be high. 
It has also been shown that activation of the P2X7 receptor in enteric neurons may 
elicit ATP release through pannexin-1 hemichannels and this may act as a danger 
signal for neurons (Gulbransen et al., 2012). However, this mechanism is unlikely 
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to modulate [3H]ACh outflow in postinflammatory ileitis because no substantial 
neuronal loss was observed in our experimental conditions and the transmitter 
release in TNBS-induced ileitis was TTX-resistant, yet fluoroacetate-sensitive, 
indicating a dominant participation of enteric glial cells. 
It has been proposed that enteric glial cells may play a critical role in 
maintaining the integrity of the bowel and that their loss or dysfunction might 
contribute to cellular mechanisms of inflammatory bowel diseases. In this respect, 
a fulminating and fatal jejuno-ileitis is produced 7-14 days after ablation of enteric 
glia in adult transgenic mice, with almost none effects in other parts of the GI tract 
including the colon (Bush et al., 1998). The most striking finding from that study is 
that this pathology can be verified with only moderate degeneration of myenteric 
neurons, resulting in moderate distension of the bowel and minor changes in stool 
pellet propulsion, suggesting that neuronal dysfunction is more relevant than 
structural abnormalities in order to disrupt gut motility, as we detected in the 
TNBS-induced ileitis rat model. Pathological lesions are patchy and start always at 
the mucosal surface progressing to the muscularis externa, including pronounced 
dilation of capillaries with inflammatory cell infiltrates and erythrostasis, but are 
relatively independent of bacterial overgrowth resulting from disturbed gut motility 
due to neuronal degeneration. The functional defects observed in the transgenic 
animal model are comparable to those detected when glial ablation was produced 
with fluorocitrate, where alterations in the mucosal function were not seen 
(reviewed in Gulbransen & Sharkey, 2012). These findings suggest that it is the 
inflammatory insult, and not altered glial function, that underlies mucosal 
alterations. However, it remains to be explored whether deficits in ATP outflow 
from deficient glial cells play a role in triggering this disease process. This would 
be clinically relevant, since we predicted here that the nucleotide may be an 
important gliotransmitter responsible for sustaining cholinergic tone after an 
inflammatory insult and this might contribute to avoid degeneration of myenteric 
neurons as already proved for glutamate in the CNS (Bush et al., 1999). In this 
context, the vasoactive properties of released adenine nucleotides and 
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nucleosides may also contribute to microvascular disturbances and certain 
changes resembling ischemic bowel (see e.g. Mendes et al., 2015).  
Thus, similarities in the appearance of end-stage pathology in various 
bowel conditions (e.g. inflammation, hypoxia/ischemia, diabetes) suggest that the 
gut may have limited ways of responding when it is defective (Bush et al., 1998). 
For this reason it is important to identify single events that are able to trigger 
complex pathological cascades. Our working hypothesis in this study was that 
inflammation-induced cell density changes in the myenteric plexus may unbalance 
the release of purines and, thus, their influence on ACh release from stimulated 
enteric nerves. We clearly demonstrated that inflammation-induced cholinergic 
hypoactivity is deeply dependent on the purinergic shift from a preferential 
adenosinergic tone under physiological conditions to a more prevalent ATP-
mediated control of ACh release in TNBS-induced ileitis. The adenosine 
neuromodulation deficit parallels the partial loss of ICC/FLC population in the 
inflamed myenteric plexus and contributes to explain the brake of the cholinergic 
amplification loop operated by facilitatory muscarinic M3 and adenosine A2A 
receptors, which is responsible for keeping the safety margin of myenteric 
neuromuscular transmission under stressful conditions. On the other hand, 
proliferating and/or reactive enteric glial cells markedly influence the amount of 
ATP at the inflamed myenteric synapse by creating a vicious cycle that promote 
the release of the nucleotide through a mechanism involving the P2X7 
receptor/pannexin-1 pathway. Data suggest that ATP may be the excitatory 
gliotransmitter responsible for keeping the cholinergic tone above a critical 
minimum in postinflammatory ileitis. Inflammation may, thus, recapitulate an 
ancestral mechanism by which ATP released by glial cells directly (via ionotropic 
P2X receptors) stimulates ACh release from cholinergic nerve terminals even 
when these cells are disturbed and unable to generate normal action potentials. In 
conclusion, this study provides a deeper understanding of the pathophysiological 
impact of purines in the communication between non-neuronal cells and neurons 
underlying the dysregulation of cholinergic neurotransmission in postinflammatory 
ileitis. Data suggest that the purinergic cascade (e.g. ATP release mechanisms, 
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ecto-nucleotidase enzymes and purinoceptors activation) may offer novel 
therapeutic targets to overcome long-term cholinergic neurotransmission deficits 
affecting motility in inflammatory bowel diseases. 
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VII. CONCLUDING REMARKS 
 
Inflammation of the intestine leads to long-lasting structural and functional 
changes in the ENS, which may be observed in remote regions from the 
inflammation site. These modifications are usually accompanied by notorious 
changes in the purinergic signalling cascade affecting both immune responses and 
synaptic neurotransmission, although the underlying mechanisms and 
consequences of this diversity are not completely understood. This study aimed at 
investigating the nature and activity of resident purine-releasing cells in the 
myenteric plexus, the mechanisms responsible for the release of these mediators 
from cells, the kinetics of their extracellular metabolism/ inactivation cycle and the 
purinoceptor subtypes most implicated in postinflammatory ileitis. Because 
adenine nucleotides and nucleosides can be released from infiltrating 
inflammatory cells, as well as from resident neuronal and non-neuronal enteric 
cells, there is an increasing interest in studying the mechanism by which purines 
can control inflammatory reactions, synaptic neurotransmission and 
motility/secretion in the gut following inflammatory insults. Fulfiling these 
objectives, one may be able to suggest novel therapeutic targets to control enteric 
inflammatory diseases.    
Most studies pursuiting this goal, were done in experimental colitis animal 
models induced by TNBS or DSS. These are severe models of inflammatory 
colitis, where lesions span the whole thickness of the gut wall, exhibit 
characteristics of chronic inflammation and causes irreversible losses of enteric 
neurons. However, in this study we wanted to investigate neuronal to non-
neuronal cell communication adaptations carried out reversibly by purines and, 
therefore, we focused on the postinflammatory ileitis rat model induced by 
intraluminal instillation of TNBS in the rat 7 days before experimental protocols. 
Under these circunstances, the inflammatory reaction affects mainly the 
submucosa, with the presence of inflammatory infiltrates such as eosinophils, 
lymphocytes, macrophages, mononuclear and giant cells reaching myenteric 
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ganglia, without penetrating the boundaries of this structure. In this sense, ileitis 
caused by TNBS differs from other chronic inflammatory disease models because 
it lacks the chronic inflammatory phase (Moreels et al., 2001b) that is usually 
accompanied by neuronal cell loss (Sanovic et al., 1999; Linden et al., 2005; 
Venkataramana et al., 2015).  
Postinflammatory ileitis increased the gastrointestinal transit measured by 
methylene blue gavage progression, while, paradoxically, we detected 
hypocontractility of the longitudinal muscle and a decrease in the frequency of 
spontaneous contractions that is compatible with the observed loss of pacemaker 
interstitial cells of Cajal.  Several authors attributed muscle contraction changes to 
structural abnormalities of the smooth muscle layer due to oedema and smooth 
muscle hypertrophy. Structural modifications of the enteric wall may also reduce 
the lumen size of the gut resulting in faster progression of liquids (e.g. methylene 
blue), although one cannot exclude the existence of plastic changes in the 
neuronal network as a cause for acceleration in the gastrointestinal transit. 
Data from this and other studies show that cholinergic neurotransmission is 
impaired in postinflammatory ileitis (see e.g. Poli et al., 2001; Collins et al., 1992a), 
without evidence of any modifications in the density and cellular distribution of 
VAChT-positive cholinergic neurons. The mechanisms underlying downregulation 
of ACh release in the inflamed ileum have been a matter of debate in the literature, 
but no unifying theory is available. Contradictory findings were produced when 
looking at the pathophysiological influence of immune cells and inflammatory 
mediators. Here, we put forward several hypotheses to explain inflammation-
induced cholinergic hypoactivity based on the purinergic shift from a preferential 
adenosinergic tone under healthy conditions to a dominant ATP-mediated control 
of ACh release in TNBS-induced ileitis.  
Regarding the adenosine neuromodulation deficit observed in 
postinflammatory ileitis, it may result, at least in part, from the partial loss of 
interstitial cells (ICC/FLC) population in the inflamed myenteric plexus. These cells 
are endowed with muscarinic M3 receptors coupled to PLC/ IP3 / PKC, whose 
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activation facilitates adenosine release from ENTs. This mechanism is significantly 
impaired after an inflammatory insult because the number of ICC/FLC decreases 
and ACh released from dysfunctional cholinergic nerve terminals might not reach 
high enough concentrations to stimulate M3 receptors in these cells. In addition, 
we demonstrated that adenosine deficits may also result from deficient conversion 
of adenine nucleotides (AMP) into adenosine due to feed-forward inhibition of 
ecto-5’-nucleotidase/CD73 by high amounts of ATP and/or ADP generated in the 
inflamed myenteric synapse. The lack of adenosine release per se via equilibrative 
nucleotide transporters and/or its formation from released adenine nucleotides is 
affected further by the upregulation of ADA activity, which inactivates adenosine 
into inosine in the extracellular fluid (Vieira et al., 2014). Interestingly, both 
membrane-bound and soluble forms of ecto-5’-nucleotidase/CD73 and ADA were 
detected in the inflamed myenteric plexus. Secretion of these enzymes is 
increased in TNBS-induced ileitis, thus contributing to unbalance the bulk 
production and/or inactivation of adenosine way from its location in the native 
tissue – the myenteric neuromuscular synapse. The result from these adaptations 
is more widespread organ affection. All these mechanisms ultimately contribute to 
brake of the cholinergic amplification loop operated by facilitatory muscarinic M3 
and adenosine A2A receptors that is responsible for keeping the safety margin of 
myenteric neuromuscular transmission under stressful conditions.  
Inflammation-induced glial cells proliferation significantly increases the 
amount of ATP in the myenteric synapse. This may be due to a vicious cycle that 
promotes the release of the nucleotide from these cells through a mechanism 
involving P2X7 receptors and pannexin-1 hemichannels. While ATP is critical for 
keeping the cholinergic tone above a minimum in postinflammatory ileitis, it upon 
hydrolysis into ADP by NTPDase2 may contribute to restrain nerve-evoked ACh 
release from inflamed cholinergic motor neurons. The major difference between 
these apparent contradictory actions of ATP is that the nucleotide can stimulate 
(via ionotropic P2X receptors) ACh release directly from cholinergic nerve 
terminals even when these cells are pathologically affected and unable to 
 CONCLUDING REMARKS 
 
 
140    PhD Thesis: Cátia Andreia Rodrigues Vieira 
 
 
generate normal action potentials, whereas activation of metabotropic P2Y1 
receptors requires nerve stimulation in order to downregulate ACh release.  
Redistribution of NTPDase2, but not NTPDase3, from the ganglion region 
to the neuromuscular myenteric synapse leads to preferential ADP accumulation 
from released ATP, thus contributing to prolong inhibition of muscle-bound ecto-5’-
nucleotidase/CD73, thereby delaying adenosine formation, and to promote 
activation of prejunctional inhibitory P2Y1 receptors at the inflamed myenteric 
synapse.       
Thus, this study provides a deeper understanding of the pathophysiological 
impact of purines in the communication between non-neuronal cells and neurons 
underlying dysregulation of cholinergic neurotransmission in postinflammatory 
ileitis. Data suggest that the purinergic cascade (e.g. ATP release mechanisms, 
ecto-nucleotidase enzymes and purinoceptors activation) may offer novel 
therapeutic targets to overcome long-term cholinergic neurotransmission deficits 
affecting motility in inflammatory enteric diseases.        
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